
<html lang="en"     class="pb-page"  data-request-id="ffd45b35-064b-4e2d-ba1b-f6f157649b65"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2013.56.issue-6;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm3007933"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR)" /></meta><meta name="dc.Creator" content="Craig S.  Takeuchi" /></meta><meta name="dc.Creator" content="Byung Gyu  Kim" /></meta><meta name="dc.Creator" content="Charles M.  Blazey" /></meta><meta name="dc.Creator" content="Sunghoon  Ma" /></meta><meta name="dc.Creator" content="Henry W. B.  Johnson" /></meta><meta name="dc.Creator" content="Neel K.  Anand" /></meta><meta name="dc.Creator" content="Arlyn  Arcalas" /></meta><meta name="dc.Creator" content="Tae Gon  Baik" /></meta><meta name="dc.Creator" content="Chris A.  Buhr" /></meta><meta name="dc.Creator" content="Jonah  Cannoy" /></meta><meta name="dc.Creator" content="Sergey  Epshteyn" /></meta><meta name="dc.Creator" content="Anagha  Joshi" /></meta><meta name="dc.Creator" content="Katherine  Lara" /></meta><meta name="dc.Creator" content="Matthew S.  Lee" /></meta><meta name="dc.Creator" content="Longcheng  Wang" /></meta><meta name="dc.Creator" content="James W.  Leahy" /></meta><meta name="dc.Creator" content="John M.  Nuss" /></meta><meta name="dc.Creator" content="Naing  Aay" /></meta><meta name="dc.Creator" content="Ron  Aoyama" /></meta><meta name="dc.Creator" content="Paul  Foster" /></meta><meta name="dc.Creator" content="Jae  Lee" /></meta><meta name="dc.Creator" content="Isabelle  Lehoux" /></meta><meta name="dc.Creator" content="Narsimha  Munagala" /></meta><meta name="dc.Creator" content="Arthur  Plonowski" /></meta><meta name="dc.Creator" content="Sharmila  Rajan" /></meta><meta name="dc.Creator" content="John  Woolfrey" /></meta><meta name="dc.Creator" content="Kyoko  Yamaguchi" /></meta><meta name="dc.Creator" content="Peter  Lamb" /></meta><meta name="dc.Creator" content="Nicole  Miller" /></meta><meta name="dc.Description" content="A series of novel, highly potent, selective, and ATP-competitive mammalian target of rapamycin (mTOR) inhibitors based on a benzoxazepine scaffold have been identified. Lead optimization resulted i..." /></meta><meta name="Description" content="A series of novel, highly potent, selective, and ATP-competitive mammalian target of rapamycin (mTOR) inhibitors based on a benzoxazepine scaffold have been identified. Lead optimization resulted i..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 7, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3007933" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3007933" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3007933" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3007933" /></link>
        
    
    

<title>Discovery of a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3007933" /></meta><meta property="og:title" content="Discovery of a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0022.jpeg" /></meta><meta property="og:description" content="A series of novel, highly potent, selective, and ATP-competitive mammalian target of rapamycin (mTOR) inhibitors based on a benzoxazepine scaffold have been identified. Lead optimization resulted in the discovery of inhibitors with low nanomolar activity and greater than 1000-fold selectivity over the closely related PI3K kinases. Compound 28 (XL388) inhibited cellular phosphorylation of mTOR complex 1 (p-p70S6K, pS6, and p-4E-BP1) and mTOR complex 2 (pAKT (S473)) substrates. Furthermore, this compound displayed good pharmacokinetics and oral exposure in multiple species with moderate bioavailability. Oral administration of compound 28 to athymic nude mice implanted with human tumor xenografts afforded significant and dose-dependent antitumor activity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3007933"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3007933">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3007933&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3007933&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3007933&amp;href=/doi/10.1021/jm3007933" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2218-2234</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3017078" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm3009629" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Craig+S.++Takeuchi">Craig S. Takeuchi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Byung+Gyu++Kim">Byung Gyu Kim</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+M.++Blazey">Charles M. Blazey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sunghoon++Ma">Sunghoon Ma</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henry+W.+B.++Johnson">Henry W. B. Johnson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neel+K.++Anand">Neel K. Anand</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arlyn++Arcalas">Arlyn Arcalas</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tae+Gon++Baik">Tae Gon Baik</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chris+A.++Buhr">Chris A. Buhr</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonah++Cannoy">Jonah Cannoy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sergey++Epshteyn">Sergey Epshteyn</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anagha++Joshi">Anagha Joshi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katherine++Lara">Katherine Lara</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+S.++Lee">Matthew S. Lee</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Longcheng++Wang">Longcheng Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+W.++Leahy">James W. Leahy</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+M.++Nuss">John M. Nuss</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naing++Aay">Naing Aay</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ron++Aoyama">Ron Aoyama</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Foster">Paul Foster</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jae++Lee">Jae Lee</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isabelle++Lehoux">Isabelle Lehoux</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Narsimha++Munagala">Narsimha Munagala</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arthur++Plonowski">Arthur Plonowski</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sharmila++Rajan">Sharmila Rajan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Woolfrey">John Woolfrey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyoko++Yamaguchi">Kyoko Yamaguchi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Lamb">Peter Lamb</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicole++Miller">Nicole Miller</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 82-2-470-9602 (B.G.K.); (813) 974-4642 (J.W.L.). E-mail: <a href="/cdn-cgi/l/email-protection#f09289859e97978985c7c29b999db0979d91999cde939f9d"><span class="__cf_email__" data-cfemail="204259554e4747595517124b494d60474d41494c0e434f4d">[email protected]</span></a> (B.G.K.); <a href="/cdn-cgi/l/email-protection#355f425950545d4c754046531b505140"><span class="__cf_email__" data-cfemail="e58f928980848d9ca5909683cb808190">[email protected]</span></a> (J.W.L.).</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3007933&amp;href=/doi/10.1021%2Fjm3007933" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2218–2234</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 8, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 June 2012</li><li><span class="item_label"><b>Published</b> online</span>7 March 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 March 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3007933" title="DOI URL">https://doi.org/10.1021/jm3007933</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2218%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DCraig%2BS.%2BTakeuchi%252C%2BByung%2BGyu%2BKim%252C%2BCharles%2BM.%2BBlazey%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D6%26contentID%3Djm3007933%26title%3DDiscovery%2Bof%2Ba%2BNovel%2BClass%2Bof%2BHighly%2BPotent%252C%2BSelective%252C%2BATP-Competitive%252C%2Band%2BOrally%2BBioavailable%2BInhibitors%2Bof%2Bthe%2BMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2234%26publicationDate%3DMarch%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3007933"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3681</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">37</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3007933" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;S. Takeuchi&quot;},{&quot;first_name&quot;:&quot;Byung&quot;,&quot;last_name&quot;:&quot;Gyu Kim&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;M. Blazey&quot;},{&quot;first_name&quot;:&quot;Sunghoon&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Henry&quot;,&quot;last_name&quot;:&quot;W. B. Johnson&quot;},{&quot;first_name&quot;:&quot;Neel&quot;,&quot;last_name&quot;:&quot;K. Anand&quot;},{&quot;first_name&quot;:&quot;Arlyn&quot;,&quot;last_name&quot;:&quot;Arcalas&quot;},{&quot;first_name&quot;:&quot;Tae&quot;,&quot;last_name&quot;:&quot;Gon Baik&quot;},{&quot;first_name&quot;:&quot;Chris&quot;,&quot;last_name&quot;:&quot;A. Buhr&quot;},{&quot;first_name&quot;:&quot;Jonah&quot;,&quot;last_name&quot;:&quot;Cannoy&quot;},{&quot;first_name&quot;:&quot;Sergey&quot;,&quot;last_name&quot;:&quot;Epshteyn&quot;},{&quot;first_name&quot;:&quot;Anagha&quot;,&quot;last_name&quot;:&quot;Joshi&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;Lara&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;S. Lee&quot;},{&quot;first_name&quot;:&quot;Longcheng&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;W. Leahy&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;M. Nuss&quot;},{&quot;first_name&quot;:&quot;Naing&quot;,&quot;last_name&quot;:&quot;Aay&quot;},{&quot;first_name&quot;:&quot;Ron&quot;,&quot;last_name&quot;:&quot;Aoyama&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Foster&quot;},{&quot;first_name&quot;:&quot;Jae&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Isabelle&quot;,&quot;last_name&quot;:&quot;Lehoux&quot;},{&quot;first_name&quot;:&quot;Narsimha&quot;,&quot;last_name&quot;:&quot;Munagala&quot;},{&quot;first_name&quot;:&quot;Arthur&quot;,&quot;last_name&quot;:&quot;Plonowski&quot;},{&quot;first_name&quot;:&quot;Sharmila&quot;,&quot;last_name&quot;:&quot;Rajan&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Woolfrey&quot;},{&quot;first_name&quot;:&quot;Kyoko&quot;,&quot;last_name&quot;:&quot;Yamaguchi&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Lamb&quot;},{&quot;first_name&quot;:&quot;Nicole&quot;,&quot;last_name&quot;:&quot;Miller&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;2218-2234&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3007933&quot;},&quot;abstract&quot;:&quot;A series of novel, highly potent, selective, and ATP-competitive mammalian target of rapamycin (mTOR) inhibitors based on a benzoxazepine scaffold have been identified. Lead optimization resulted in the discovery of inhibitors with low nanomolar activity and greater than 1000-fold selectivity over the closely related PI3K kinases. Compound 28 (XL388) inhibited cellular phosphorylation of mTOR complex 1 (p-p70S6K, pS6, and p-4E-BP1) and mTOR complex 2 (pAKT (S473)) substrates. Furthermore, this compound displayed good pharmacokinetics and oral exposure in multiple species with moderate bioavailability. Oral administration of compound 28 to athymic nude mice implanted with human tumor xenografts afforded significant and dose-dependent antitumor activity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3007933&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007933" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3007933&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007933" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3007933&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007933" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3007933&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007933&amp;href=/doi/10.1021/jm3007933" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3007933" /></input><a href="/doi/pdf/10.1021/jm3007933" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3007933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3007933%26sid%3Dliteratum%253Aachs%26pmid%3D23394126%26genre%3Darticle%26aulast%3DTakeuchi%26date%3D2013%26atitle%3DDiscovery%2Bof%2Ba%2BNovel%2BClass%2Bof%2BHighly%2BPotent%252C%2BSelective%252C%2BATP-Competitive%252C%2Band%2BOrally%2BBioavailable%2BInhibitors%2Bof%2Bthe%2BMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D6%26spage%3D2218%26epage%3D2234%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jmcmar.2013.56.issue-6/production/jmcmar.2013.56.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of novel, highly potent, selective, and ATP-competitive mammalian target of rapamycin (mTOR) inhibitors based on a benzoxazepine scaffold have been identified. Lead optimization resulted in the discovery of inhibitors with low nanomolar activity and greater than 1000-fold selectivity over the closely related PI3K kinases. Compound <b>28</b> (XL388) inhibited cellular phosphorylation of mTOR complex 1 (p-p70S6K, pS6, and p-4E-BP1) and mTOR complex 2 (pAKT (S473)) substrates. Furthermore, this compound displayed good pharmacokinetics and oral exposure in multiple species with moderate bioavailability. Oral administration of compound <b>28</b> to athymic nude mice implanted with human tumor xenografts afforded significant and dose-dependent antitumor activity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46371" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46371" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The mammalian target of rapamycin (mTOR) is a large protein kinase that integrates both extracellular and intracellular signals of cellular growth, proliferation, and survival. Both extracellular mitogenic growth factor signaling from cell surface receptors and intracellular signals that convey hypoxic stress, energy, and nutrient status converge at mTOR.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> mTOR exists in two distinct multiprotein complexes: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). mTORC1 is a key mediator of translation and cell growth, via its substrates p70S6 kinase (p70S6K) and eIF4E binding protein 1 (4E-BP1), and promotes cell survival via the serum and glucocorticoid-activated kinase (SGK), whereas mTORC2 promotes activation of prosurvival kinase AKT.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a> mTORC1, but not mTORC2, can be inhibited by an intracellular complex between rapamycin and FK506 binding protein (FKBP).<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> However, rapamycin–FKBP may indirectly inhibit mTORC2 in some cells by sequestering mTOR protein and thereby inhibiting assembly of mTORC2.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Given the role of mTOR signaling in cellular growth, proliferation, and survival as well as its frequent deregulation in cancers, several rapamycin analogues (rapalogues) that are selective allosteric mTORC1 inhibitors have been extensively evaluated in a number of cancer clinical trials. Demonstrated clinical efficacy for rapalogues is currently limited to patients with advanced, metastatic renal cell carcinoma (RCC) despite extensive development efforts. This result is likely attributed not only to a lack of inhibition of mTORC2 by rapalogues that leads to upregulation of Akt through a negative feedback loop, but also to only partial inhibition of mTORC1.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Therefore, ATP-competitive mTOR inhibitors that should simultaneously inhibit both mTORC1 and mTORC2 may offer a clinical advantage over rapalogues.</div><div class="NLM_p">As a key component of the phosphoinositide 3-kinase-related kinase (PIKK) family, which is comprised of phosphoinositide 3-kinases (PI3Ks), DNA-PK, ATM, and ATR, mTOR shares the highly conserved ATP binding pockets of the PI3K family with sequence similarity of 25% in the kinase catalytic domain.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In light of this fact, it is not surprising that many of the first reported ATP-competitive mTOR inhibitors such as BEZ235 and GDC-0980 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) also inhibited PI3Ks.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a> PI3Ks are responsible for the production of 3-phosphoinositide lipid second messengers such as phosphatidylinositol 3,4,5-triphosphate (PIP3), which are involved in a number of critical cellular processes, including cell proliferation, cell survival, angiogenesis, cell adhesion, and insulin signaling. Therefore, the development of ATP-competitive mTOR inhibitors that are selective over PI3Ks may offer an improved therapeutic potential relative to rapalogues as well as dual PI3K/mTOR inhibitors. Recently, several selective ATP-competitive mTOR inhibitors such as Torin 2 and AZD8055 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) have been reported with sufficient promise to warrant clinical trials.<a onclick="showRef(event, 'ref11 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref11 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26">(11, 19-26)</a> Herein we describe the identification, characterization, and lead optimization of a structurally novel class of mTOR inhibitors exemplified by compound <b>28</b>, derived from a benzoxazepine scaffold.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Literature examples of dual PI3K/mTOR and selective ATP-competitive mTOR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53661" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53661" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Efforts directed toward the identification of mTOR-selective inhibitors were initiated by high-throughput screening (HTS) of our in-house compound library against mTOR. The measurement of mTOR activity was performed in an ELISA assay format following the phosphorylation of 4E-BP1 protein in a 384-well format. We found a number of potential candidates suitable for lead optimization studies, but one that we found to be particularly attractive was benzoxazepine <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). It was a potent inhibitor of mTOR (IC<sub>50</sub> = 95 nM) with 4-fold selectivity over PI3Kα (IC<sub>50</sub> = 398 nM) and much more pronounced selectivity over other kinases in a preliminary screen. With a molecular weight below 500, a cLogP below 5, a topological polar surface area below 60 Å<sup>2</sup>, five rotatable bonds, four hydrogen bond acceptors, and no hydrogen bond donors, it falls within traditionally desirable druglike parameters. Given these characteristics, we were therefore surprised that the benzoxazepine scaffold has received relatively little attention in drug discovery.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Early benzoxazepine derivatives of HTS hit <b>1</b>. Note 1: average IC<sub>50</sub> (<i>n</i> ≥ 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While reconfirming the activity of our initial lead, we also performed a rapid assessment of simple perturbations around the benzoxazepine scaffold which suggested that both substituents were critical. Analogues lacking the quinoline at the 7-position (<b>1a</b>) and the 4-ketobenzamide at the 4-position (<b>1b</b>) displayed none of the activity of the original lead. Simplified benzamide <b>1c</b>, however, was only slightly less potent than <b>1</b> with modestly improved selectivity over PI3Kα. This provided us with some confidence that further optimization was possible.</div><div class="NLM_p">While we were encouraged by the potential of <b>1</b> as an initial candidate, it was unclear exactly how it was interacting with the target, and we did not have crystallographic mTOR assets to provide any insight. An examination of how compounds such as BEZ235 interact with the structurally similar PI3K suggested a critical hydrogen bond between the core imidazoquinoline ring and the hinge region valine and provided a schematic model for the binding pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> One possible binding orientation for <b>1</b> involved the quinoline interacting in a similar fashion to form a hydrogen bond at the same site. Alternatively, the ring oxygen of the benzoxazepine core could be envisioned to perform this function. The latter possibility represents a binding orientation that has never been described, but seemed plausible in light of the numerous morpholine oxygens such as in GDC-0980 that have been reported to play a similar role.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Proposed binding orientation of BEZ235 in PI3Kγ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E8Z">1E8Z</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (B) Potential binding orientation of <b>1</b> where benzoxazepine oxygen forms a hinge region hydrogen bond. (C) Potential binding orientation of <b>1</b> where quinoline nitrogen forms a hinge region hydrogen bond.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, even though we were intrigued by the promising characteristics of <b>1</b>, we knew that there was plenty of room for improvement. In addition to increasing potency and selectivity, we needed to find analogues with cellular activity and improved ADME (absorption, distribution, metabolism, and excretion) properties such as poor mouse liver microsome stability (23% remained after 30 min), moderate kinetic solubility (<i>K</i><sub>sol</sub> = 40.1 μM), and poor cell permeability (Madin–Darby canine kidney (MDCK) <i>P</i><sub>app</sub> = 16.9 nm/s). Toward that end, in vitro cellular activity was examined by assessing inhibition of phosphorylation of pS6 (S240/244), a downstream protein in mTORC1 signaling, in a PC-3 cell line.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Inhibition of growth-factor-stimulated phosphorylation of AKT (S473), a downstream protein in mTORC2 signaling, was also determined in the same cell line for compounds with >100-fold selectivity and >200 nM IC<sub>50</sub> against PI3Kα.</div><div class="NLM_p">We initiated our structure–activity relationship (SAR) efforts with the goal in mind of determining which of the two likely binding orientations was responsible for our activity. Naphthalene derivative <b>2</b> rapidly provided the answer (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Retention of the mTOR activity of <b>2</b> effectively ruled out the potential binding orientation depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C and prompted us to focus our attention on the prospects of the novel binding orientation in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B. Furthermore, this simple change afforded a substantial improvement in the selectivity for mTOR activity over PI3Kα, and even the simple phenyl substituent <b>3</b> was reasonably active. Addition of polar functionality has a dramatic impact on activity, especially when appended in a slightly extended orientation. For example, installation of an acetamide such as in <b>5</b> leads to a substantial increase in activity against PI3Kα with virtually no impact on mTOR activity. The more constrained indazole group provided analogues with significantly greater mTOR activity and restored selectivity over PI3Kα. We were also gratified to note that both indazole analogues <b>6</b> and <b>7</b> exhibited submicromolar cellular activity as well. The impact of functionality capable of serving as a proton donor appears to be substantial, as methylated analogue <b>9</b> leads to a >20-fold loss in potency versus desmethyl derivative <b>8</b>. Additionally, the drop in activity of the truncated pyrazole analogue <b>10</b> demonstrated the value of the phenyl “spacer”. The best group found from these initial efforts was the benzimidazole (<b>11</b> and <b>12</b>), with <b>12</b> being the most potent in our biochemical assay thus far. In fact, <b>12</b> was the first subnanomolar mTOR inhibitor we found with greater than 100-fold selectivity over PI3Kα. The benzimidazole was a particularly intriguing alternative, as the tautomeric nature allows for multiple orientations that could serve as a proton donor. We were pleased to note a corresponding increase in cellular potency for the benzimidazoles. In addition, both <b>11</b> and <b>12</b> showed comparable stability in a mouse liver microsome stability study with approximately 50% of both compounds remaining after 30 min. These data translated to similar mouse plasma exposure levels of both <b>11</b> (1.5 μM at 1 h and 0.4 μM at 4 h) and <b>12</b> (1.0 μM at 1 h and 0.2 μM at 4 h) when dosed orally at 100 mg/kg. We considered <b>11</b> to be slightly superior to <b>12</b> due to increased cellular potency and higher oral exposure in mouse. However, <b>11</b> suffered from poor ADME characteristics such as low kinetic solubility (<i>K</i><sub>sol</sub> < 1.0 μM), poor cell permeability (MDCK <i>P</i><sub>app</sub> = 9.8 nm/s), and inhibition of <3 μM against CYP 2C9 and 3A4 isoforms. Additionally, we were interested in compounds with a greater level of selectivity against PI3Kα.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. mTOR Activity, PI3Kα Activity, Cellular Activity, MLM, and CYP Inhibition Data for Right-Hand-Side Modifications of <b>1</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0016.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0017.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Notes: (1) average IC<sub>50</sub> (<i>n</i> ≥ 2); (2) pS6 (S240/244) in PC-3; (3) percent remaining after 30 min; (4) Not determined.</p></div></div><div></div></div><div class="NLM_p">In light of the evidence that suggested the binding orientation depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B, we were reasonably confident that substitution at any other position around the aromatic portion of the benzoxazepine core would interfere with mTOR binding. All attempts to explore even the simplest analogues led to a complete loss of activity and were quickly abandoned. We therefore turned our attention to exploring substitution about the oxazepine ring.</div><div class="NLM_p">We anticipated that the trifluoromethyl ketone functionality on our initial hit represented an opportunity for optimization of the ADME characteristics. We therefore prepared a number of amide derivatives using the benzimidazole as a standard substituent. Given the dramatic drop in activity we observed in our initial SAR efforts when we removed the para substituent, we decided to focus on those derivatives. We were pleased to discover that a variety of substituents were well tolerated (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) with respect to mTOR activity. Extrusion of the ketone carbonyl group (<b>13</b>) significantly improved mTOR selectivity over PI3Kα without any substantial loss of activity in our primary assays. In addition, this simple change conveyed some stability upon exposure to mouse liver microsomes, although it did not improve upon the CYP inhibition of <b>11</b>. A number of analogues were identified that demonstrated >100-fold selectivity for mTOR over PI3Kα, which allowed us to focus on those with improved ADME profiles. Sulfonamides <b>14</b> and <b>15</b>, for example, suggested that the poor permeability (MDCK <i>P</i><sub>app</sub> = 42 nm/s) of the former correlated well with a lack of cellular activity. Among the best of these initial congeners were the alkyl sulfones. Methyl sulfone <b>16</b> presented an improvement in CYP inhibition and mouse liver microsome stability compared to <b>11</b> and exhibited significantly higher mouse plasma exposure (7.8 μM (at 1 h) and 1.0 μM (at 4 h)) when dosed orally at 100 mg/kg. We felt that these attributes made <b>16</b> more attractive than ethyl sulfone <b>17</b> despite the increased mTOR selectivity of the latter compound.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. mTOR Activity, PI3Kα Activity, Cellular Activity, MLM, and CYP Inhibition Data for Right-Hand-Side Modifications of <b>11</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0018.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">CYP inhibition (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center" char=".">mTOR IC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kα IC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">cell<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> IC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">MLM<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">2C8</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>11</b></td><td class="colsep0 rowsep0" align="left">COCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="left">151/–</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">1092</td><td class="colsep0 rowsep0" align="left">306/680</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">763</td><td class="colsep0 rowsep0" align="left">1801/1672</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">13.9</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>15</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NHMe</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">1090</td><td class="colsep0 rowsep0" align="left">451/812</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>16</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">670</td><td class="colsep0 rowsep0" align="left">342/805</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>17</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">2172</td><td class="colsep0 rowsep0" align="left">343/1077</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Average IC<sub>50</sub> (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">pS6 (S240/244)/pAKT (S473) in PC-3.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Percent remaining after 30 min.</p></div></div></div><div class="NLM_p">Using the methyl sulfone as a reference, we initiated an exploration of additional substitution around the benzamide ring. The introduction of small alkyl groups ortho to the carbonyl such as in <b>18</b> and <b>19</b> conferred additional selectivity for mTOR over PI3Kα (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The erosion of activity of <i>n</i>-propyl derivative <b>20</b> suggests a spatial limitation to perturbations at this position, and the more significant loss of activity of the isosteric <b>21</b> infers that the potential internal hydrogen bond between the NH and the carbonyl is not favored. Other types of ortho substituents such as the halogenated analogues <b>22</b> and <b>23</b> were tolerated, but did not lead to any discernible improvement. Likewise, monosubstitution at the position ortho to the sulfonyl group such as in <b>24</b> failed to impart any benefit over <b>16</b>. However, substitution at both positions proved beneficial. For example, fluorinated analogues <b>25</b> and <b>26</b> are both more than 1000-fold selective for mTOR over PI3Kα. Additionally, the mouse liver microsome stability of <b>25</b> was particularly attractive, as >90% remained after incubation for 30 min.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. mTOR Activity, PI3Kα Activity, Cellular Activity, MLM, and CYP Inhibition Data of Substituted Modifications of <b>16</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0019.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">CYP inhibition (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">mTOR IC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kα IC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">cell<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> IC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">MLM<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">2C8</th><th class="colsep0 rowsep0" align="center">2C9</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>16</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">670</td><td class="colsep0 rowsep0" align="left">343/805</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">8.1</td><td class="colsep0 rowsep0" align="left">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>18</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">>3000</td><td class="colsep0 rowsep0" align="left">422/1007</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>19</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">>3000</td><td class="colsep0 rowsep0" align="left">233/689</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20</b></td><td class="colsep0 rowsep0" align="left">n-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">28.0</td><td class="colsep0 rowsep0" align="char" char=".">>3000</td><td class="colsep0 rowsep0" align="left">1184/3302</td><td class="colsep0 rowsep0" align="left">87</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>21</b></td><td class="colsep0 rowsep0" align="left">NHEt</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">204</td><td class="colsep0 rowsep0" align="char" char=".">>3000</td><td class="colsep0 rowsep0" align="left">nd/nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>22</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">23.2</td><td class="colsep0 rowsep0" align="char" char=".">705</td><td class="colsep0 rowsep0" align="left">337/1062</td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>23</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">693</td><td class="colsep0 rowsep0" align="left">343/453</td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>24</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">459</td><td class="colsep0 rowsep0" align="left">591/1219</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>25</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">2344</td><td class="colsep0 rowsep0" align="left">329/437</td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="left">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>26</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">>3000</td><td class="colsep0 rowsep0" align="left">152/277</td><td class="colsep0 rowsep0" align="left">59</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">11.5</td><td class="colsep0 rowsep0" align="left">2.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Average IC<sub>50</sub> (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">pS6 (S240/244)/pAKT (S473) in PC-3.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Percent remaining after 30 min.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Not determined.</p></div></div></div><div class="NLM_p">Equipped with an improved amide alternative, we revisited the benzimidazole standard with the intent of improving the CYP inhibition profile. After extensive evaluation, the aminopyridine proved to be the best alternative. Comparison of <b>16</b> with <b>27</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) shows that the CYP and mouse liver microsome profile for the aminopyridine analogue is a considerable improvement over that of the original benzimidazole, even though that improvement comes with approximately a 3-fold loss in potency. We reasoned that the use of the optimized amide would restore some of that lost activity, which was confirmed by comparison of benzimidazole <b>25</b> to aminopyridine <b>28</b> (XL388).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> It should be noted at this point that our biochemical assay proved to be reasonably robust. Over the course of 35 different IC<sub>50</sub> determinations for <b>28</b>, we observed a range between 14.7 and 4.3 nM with a standard deviation of 2.8. We were delighted to see that <b>28</b> was not only very active and selective in our biochemical and cellular assays, but exhibited an attractive in vitro ADME and physicochemical profile. Our initial screen of CYP isoform inhibition did not reveal significant inhibition below a concentration of 10 μM, but did reveal a reasonable mouse liver microsome stability of 75% after incubation for 30 min along with acceptable permeability (MDCK <i>P</i><sub>app</sub> = 151 nm/s) and kinetic solubility (<i>K</i><sub>sol</sub> = 232 μM).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summarized Data of Advanced Compounds<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0020.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0021.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Notes: (1) average IC<sub>50</sub> (<i>n</i> ≥ 2); (2) pS6 (S240/244)/pAKT (S473) in PC-3; (3) percent remaining after 30 min.</p></div></div><div></div></div><div class="NLM_p">In light of the promising in vitro characteristics of <b>28</b>, we undertook an investigation of its in vivo parameters. The mean plasma protein binding of <b>28</b> in human, monkey, dog, rat, and mouse plasma was evaluated at 5 μM and was determined to be 86%, 90%, 89%, 85%, and 84%, respectively, suggesting a significant free concentration of <b>28</b> in the plasma. An initial examination in a mouse study revealed substantial and sustained plasma exposure (22.0 μM at 1 h and 17.8 μM at 4 h) following an oral dose at 100 mg/kg. Further examination of the liver microsomal stability of <b>28</b> in a mammalian panel revealed that 93%, 65%, 82%, and 78% for human, monkey, dog, and rat, respectively remained after 30 min. Gratifyingly, this promising stability data translated to reasonable oral exposure in expanded pharmacokinetic studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The dog pharmacokinetic profile of <b>28</b> dosed as a solution at 3 mg/kg is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. PK Properties of <b>28</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub>, iv/po</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub>, po</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–∞</sub> (μM·h), iv/po</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h), iv</th><th class="colsep0 rowsep0" align="center" char=".">CL (L/kg/h), iv</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub>(L/kg), iv</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%), po</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a>(10 mg/kg)</td><td class="colsep0 rowsep0" align="left">9.14/1.30</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left">8.00/2.51</td><td class="colsep0 rowsep0" align="char" char=".">1.35</td><td class="colsep0 rowsep0" align="char" char=".">2.75</td><td class="colsep0 rowsep0" align="char" char=".">1.96</td><td class="colsep0 rowsep0" align="char" char=".">31.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a>(3 mg/kg)</td><td class="colsep0 rowsep0" align="left">4.12/0.707</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left">3.72/0.952</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="char" char=".">1.27</td><td class="colsep0 rowsep0" align="char" char=".">1.27</td><td class="colsep0 rowsep0" align="char" char=".">25.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a>(3 mg/kg)</td><td class="colsep0 rowsep0" align="left">2.28/1.66</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">11.0/7.66</td><td class="colsep0 rowsep0" align="char" char=".">6.11</td><td class="colsep0 rowsep0" align="char" char=".">0.598</td><td class="colsep0 rowsep0" align="char" char=".">3.15</td><td class="colsep0 rowsep0" align="char" char=".">69.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cyno<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a>(3 mg/kg)</td><td class="colsep0 rowsep0" align="left">0.95/0.25</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="left">1.31/0.70</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">5.05</td><td class="colsep0 rowsep0" align="char" char=".">6.42</td><td class="colsep0 rowsep0" align="char" char=".">53.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Formulation EPW (5% EtOH/45% PEG400/water + 1:2 HCl (m/m).</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Formulation EPW (5% EtOH/45% PEG400/water + 1:1.5 HCl (m/m).</p></div></div></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Pharmacokinetic profile of <b>28</b> in dogs. Compound <b>28</b> was dosed at 3 mg/kg in male beagles. Data are reported as the mean ± SD (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To ascertain the mode of inhibition of mTOR by <b>28</b>, we determined the IC<sub>50</sub> values at varying ATP concentrations.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> These results revealed that <b>28</b> acts in an ATP-competitive manner, with a linear increase in IC<sub>50</sub> values with increasing ATP concentration (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Additionally, <b>28</b> demonstrated rapidly reversible inhibition of mTOR activity. A solution of mTOR saturated with <b>28</b> was diluted with a mixture containing 1 mM ATP, revealing rapid and complete recovery of enzyme activity (<i>t</i><sub>1/2</sub> < 2 min) compared to an enzyme control in the absence of inhibitor. In addition, <b>28</b> showed no cross-reactivity (<3000 nM) with members of the PI3KK lipid kinase superfamily as well as a panel of 141 protein kinases tested in house or by Millipore (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The hERG (manual Patchclamp, 15.9 μM), P-glycoprotein (>20 μM), and PXP CYP3A4 induction (50 μM) of <b>28</b> was also characterized. Collectively, the attractive in vitro and in vivo ADME profile along with high mTOR biochemical and cell potency of <b>28</b> provided validation that it could serve as a viable selective and ATP-competitive mTOR inhibitor.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. IC<sub>50</sub> for <b>28</b> as a function of the ATP concentration. Error bars represent the standard error of the mean on four IC<sub>50</sub> values at each ATP concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Kinase Profile of <b>28</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kα</td><td class="colsep0 rowsep0" align="center">>3000<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kβ</td><td class="colsep0 rowsep0" align="center">>5000<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kγ</td><td class="colsep0 rowsep0" align="center">>5000<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="center">>5000<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DNA-PK</td><td class="colsep0 rowsep0" align="center">8831<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VPS34</td><td class="colsep0 rowsep0" align="center">>3500<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKT1; ALK; CDC7; CHK1; cRAF1; EGFR; ERBB2; FAK; FLT1; FLT3; HSP90; IRK; JAK2; KDR; KIT; MEK1; MET; p70S6K; PDGFRβ; PDK1; PIM1; SRC</td><td class="colsep0 rowsep0" align="center">>3500<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EPH4; FGFR1; FGFR2; FGFR3; FGFR4; IPFK2; RSK2</td><td class="colsep0 rowsep0" align="center">>10000<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ABL; ACK1; ARG; AMPK; ASK1; AKT2; AKT3; Aurora-A; AXL; BLK; BRK; BRSK1; CaMKI; CaMKIV; CDK3/CyclinE; CDK5/p25; CHK2; CK1δ; CK2; CLK2; CSK; DAPK2; DDR2; DYRK2; EPHA2; EPHB1; FES; GCK; GRK5; GSK3α; GSK3β; Haspin; HCK; HIPK2; IGF-1R; IKKα; IKKβ; IRAK1; ITK; JNK1α1; JNK2α2; JNK3; LIMK1; LKB1; LOK; LYN; MAPK1; MAPK2; MAPKAP-K3; MARK1; MER; MINK; MKK4; MKK6; MKK7β; MLK1; MNK2; MSK1; MSSK1; MST1; MuSK; NEK2; NEK7; NLK; PAK3; PAK6; PASK; PDK1; PKA; PKCα; PKCβI; PKCβII; PKCγ; PKCδ; PKCε; PKCη; PKCι; PKCμ; PKCθ; PKCζ; PKD2; PKG1β; PLK1; PLK3; PRAK; PRK2; PYK2; RET; RIPK2; ROCK-I; ROCK-II; ROS; RSE; RSK1; RSK3; RSK4; SGK; SGK2; SGK3; STK33; TAK1; TAO1; TBK1; TSSK1; ULK2; WNK2; VRK2; YES; ZAP-70; ZIPK</td><td class="colsep0 rowsep0" align="center">>10000<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Average IC<sub>50</sub> (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Kinases tested in house.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Highest concentration tested.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">Kinases tested by Millipore (Charlottesville, VA).</p></div></div></div><div class="NLM_p">To assess the pharmacodynamic effects of our inhibitor on the mTOR pathway signaling, athymic nude mice bearing PC-3 prostate tumors were dosed orally at 100 mg/kg of <b>28</b>. Rapamycin was also administered intraperitoneally at 5 mg/kg as a reference. Plasma and tumor samples were collected at 1, 4, 8, 16, 24, and 32 h for <b>28</b> and at 4 h for rapamycin after dosing and homogenized with buffer. Tumor lysates from each animal (<i>n</i> = 5) were then pooled for each group and analyzed by immunoblot for levels of phosphorylated p70S6K, S6, 4E-BP1, and AKT. Strong inhibition of both mTORC1 readout (p-p70S6K, p-S6, p-4E-BP1) and mTORC2 readout (p-AKT (S473)) was achieved 4–8 h following administration of <b>28</b>, which diminished to near-basal levels of phosphorylation by 16 h postdose (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Modest inhibition (39–45%) of phosphorylation of the PI3K target AKT (T308) was also observed 4–8 h postdose, returning to basal levels of phosphorylation by 16 h postdose. Rapamycin resulted in strong inhition of the mTORC1 biomarkers but had no effect on the mTORC2 biomarker as expected. Similar levels of pharmacodynamic effects of <b>28</b> on the mTOR signaling pathway were also observed in athymic nude mice bearing MCF-7 xenograft tumors when dosed orally at 100 mg/kg.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Maximal inhibition (85–96%) of phosphorylation of mTORC1 readout (p70S6K, S6, 4E-BP1) as well as mTORC2 readout (AKT (S473)) was achieved 1 h following administration of <b>28</b> and was sustained through 8 h postdose (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Significantly, moderate to strong (36–69%) inhibition of phosphorylation was still observed through 16 h postdose before returning to basal levels by the 24 h time point.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition (%) of phosphorylation of p70S6K, S6, 4E-BP1, and AKT in PC-3 xenograft tumors and exposure data after a single oral dose (100 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibition (%) of phosphorylation of p70S6K, S6, 4E-BP1, and AKT in MCF-7 xenograft tumors and exposure data after a single oral dose (100 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having identified a potent and selective inhibitor of mTOR with strong pharmacodynamic effects and good mouse oral exposure, we decided to assess its antitumor efficacy. Specifically, <b>28</b> was administered to animals implanted with MCF-7 xenograft tumors to determine its effects on tumor growth. Rapamycin was used as a control to compare the results to those of a selective mTORC1 inhibitor. Tumors were established in female athymic nude mice and staged when the average tumor mass reached 102 ± 17.7 mg. Compound <b>28</b> was orally administered as a solution/fine suspension in water (with 1:1 molar ratio of HCl) once daily (qd) at 50 and 100 mg/kg for 14 days. Rapamycin, formulated at 5 mg/kg in 12.5 ethanol, 12.5 cremophor, and 75% Hank’s balanced salt solution (HBSS), was administered intraperitoneally (ip) once daily also for 14 days. Compound <b>28</b> resulted in complete inhibition of MCF-7 xenograft tumor growth at both doses (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), with significant tumor regression of 22% and 40% below pretreatment values at the 50 and 100 mg/kg doses, respectively. Furthermore, <b>28</b> does not appear to show significant toxicity. Mice in the 50 mg/kg cohort over the course of the study gained on average 2.2% additional mass, while those in the 100 mg/kg cohort lost on average 2.8% of their body mass. These results correlate well with the pharmacodynamic activity of <b>28</b> and taken in conjunction with its inhibition of cell proliferation (proliferation IC<sub>50</sub> = 1.37 μM in MCF-7 cell line) suggest that blockade of mTOR signaling is a viable target for antitumor activity. Rapamycin also resulted in complete inhibition of tumor growth, although significant tumor regression below pretreatment values was not achieved at 5 mg/kg.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. In vivo efficacy of <b>28</b> in MCF-7 xenograft tumors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38636" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38636" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We recognized from the outset that benzoxazepine <b>29</b> was going to be a critical synthetic intermediate in this project. While we initially accessed this compound via the previously reported synthesis,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> subsequently a new synthetic route was designed which was more amendable to a larger scale preparation of the intermediate in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. We envisioned that the benzoxazepine core could be accessible from intermediate <b>30</b>, which could be generated from commercially available 5-bromosalicylaldehyde. Reductive amination of 5-bromosalicylaldehyde with 2-aminoethanol followed by Boc protection provided <b>30</b>, which was then converted to benzoxazepine <b>29</b> through a Mitsunobu reaction. Particularly noteworthy about this new route is that we could routinely prepare over 200 g of benzoxazepine <b>29</b> in a single batch. Metal–halogen exchange of <b>29</b> with <i>n</i>-BuLi at −78 °C in the presence of triisopropoxyborate afforded benzoxazepinylboronic acid <b>31</b>, another useful synthetic intermediate.</div><figure id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-aminoethanol, NaBH<sub>4</sub>, MeOH, Boc<sub>2</sub>O; (b) (Ph)<sub>3</sub>P, DIAD, THF, (c) <i>n</i>-BuLi, THF, triisopropyl borate, −78 °C, HCl.</p></p></figure><div class="NLM_p">We also required a synthetic route that would provide access to noncommercially available 4-(methylsulfonyl)benzoic acid derivatives. Toward that end, treatment of 2-bromo-4-(methylsulfonyl)benzoic acid<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> with (trimethylsilyl)diazomethane in THF/MeOH afforded methyl 2-bromo-4-(methylsulfonyl)benzoate (<b>32</b>) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Silver-promoted Suzuki–Miyaura coupling of <b>32</b> with ethylboronic acid followed by hydrolysis provided benzoic acid <b>33</b>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In a similar manner, <i>n</i>-propyl derivative <b>33</b> was prepared. Buchwald–Hartwig amination of <b>32</b> with ethylamine in the presence of xantphos gave the corresponding anthranilate,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> which was hydrolyzed to yield acid <b>35</b>.</div><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (TMS)CHN<sub>2</sub>, THF/MeOH (2:1), 0 °C; (b) RB(OH)<sub>2</sub>, [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane, K<sub>2</sub>CO<sub>3</sub>, Ag<sub>2</sub>O, THF, 85 °C; (c) MeOH, 1 N NaOH, 45 °C; (d) ethylamine, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 95 °C; (e) CH<sub>2</sub>Cl<sub>2</sub>/MeOH (1:1), 1 N NaOH, 45 °C.</p></p></figure><div class="NLM_p">The synthesis of tetrasubstituted carboxylate <b>37</b> began with bromination of 2,3-difluorotoluene followed by selective metal–halogen exchange of the bromide and trapping with CO<sub>2</sub> to give acid <b>36</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Selective displacement of the fluoride para to the carboxylate with sodium thiomethoxide and subsequent oxidation with Oxone afforded 3-fluoro-2-methyl-4-(methylsulfonyl)benzoic acid (<b>37</b>). A similar approach was used for the preparation of ethyl derivative <b>39</b>, but we required a convenient source of the requisite 2,3-difluoroethylbenzene. Borane reduction of the corresponding commercially available acetic acid produced the anticipated primary alcohol (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>), which was efficiently converted to <b>38</b> via tosylation, bromination, and reductive dehalogenation. With the appropriate ethyl starting material in hand, acid <b>39</b> was generated without incident following the previously developed protocol.</div><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Fe, Br<sub>2</sub>, CHCl<sub>3</sub>; (b) <sup>i</sup>PrMgCl, THF, CO<sub>2</sub>; (c) NaSCH<sub>3</sub>, DMF, Oxone, NaOH, NaHCO<sub>3</sub>, acetone/H<sub>2</sub>O (1:1), 0 °C.</p></p></figure><figure id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BH<sub>3</sub>–SMe<sub>2</sub>, THF; (b) TsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, LiBr, acetone; (c) Mg, Et<sub>2</sub>O, BrCH<sub>2</sub>CH<sub>2</sub>Br, aqueous NH<sub>4</sub>Cl; (d) Fe, Br<sub>2</sub>, CHCl<sub>3</sub>; (e) <sup>i</sup>PrMgCl, THF, CO<sub>2</sub>; (f) NaSCH<sub>3</sub>, DMF, Oxone, NaOH, NaHCO<sub>3</sub>, acetone/H<sub>2</sub>O (1:1), 0 °C.</p></p></figure><div class="NLM_p">Our plan from the outset was to install the left-hand-side functionality via a Suzuki–Miyaura coupling. For coupling partners where the desired boronic acid was commercially available, direct coupling with bromide <b>29</b> formed the desired carbon–carbon bond such as for <b>40</b> in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Standard Boc deprotection in acid followed by HATU (<i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate) coupling with 4-(2,2,2-trifluoroacetyl)benzoic acid afforded compound <b>1</b>. Compounds <b>1a</b>–<b>c</b>, <b>2</b>–<b>5</b>, and <b>10</b> were synthesized in a similar manner. Alternatively, the Suzuki–Miyaura coupling reaction could be performed using the boronic acid of the benzoxazepine previously described. For example, reaction of <b>31</b> with 6-bromo-1<i>H</i>-indazole smoothly formed the anticipated product <b>41</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>), which was then subjected to the same deprotection/esterification sequence to yield <b>6</b>. This latter route was used for the synthesis of <b>7</b>–<b>9</b> and <b>11</b>–<b>28</b> and was sufficiently scalable that it was used to prepare over 100 g of <b>28</b> in a single batch.</div><figure id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) quinolin-3-ylboronic acid, [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane, triethylamine, 1,4-dioxane, H<sub>2</sub>O, 85 °C; (b) 4 N HCl, 1,4-dioxane, rt; (c) <i>N</i>,<i>N</i>-diisopropylethylamine, HATU, DMF, 4-(2,2,2-trifluoroacetyl)benzoic acid, rt.</p></p></figure><figure id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 6-bromo-1<i>H</i>-indazole, 1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane, triethylamine, 1,4-dioxane, H<sub>2</sub>O, 85 °C; (b) 4 N HCl, 1,4-dioxane, rt; (c) <i>N</i>,<i>N</i>-diisopropylethylamine, HATU, DMF, 4-(2,2,2-trifluoroacetyl)benzoic acid, rt.</p></p></figure><div class="NLM_p last">In conclusion, a series of structurally novel and highly potent mTOR inhibitors with complete selectivity over the PI3Ks were discovered. Starting from HTS hit <b>1</b>, lead optimization efforts on both the left- and right-hand sides of the benzoxazepine core led to the identification of <b>28</b>, which inhibits mTOR at low nanomolar concentration while exhibiting exquisite selectivity over a large panel of kinases tested. Compound <b>28</b> also exhibited good in vitro multispecies liver microsome stability and showed good oral exposure with moderate to good half-lives in several species. Profound pharmacodynamic effects were observed with <b>28</b> in both PC-3 and MCF-7 xenograft models. Furthermore, an efficacy study in mice bearing MCF-7 xenograft tumors revealed complete tumor growth inhibition. On the basis of these results, compound <b>28</b> was selected for drug candidate (DC) status and was subjected to further preclinical evaluation.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents and solvents employed were purchased commercially and used without further purification unless otherwise indicated. Melting points were determined on a Melt-Temp melting point apparatus, model II, and are uncorrected. NMR spectra were recorded on a Varian Mercury Plus 400 MHz instrument. <sup>13</sup>C NMR spectra are assigned with peaks “as observed” with no comment on splitting patterns. Reported spectra may appear to contain superfluous signals due to the existence of rotamers and/or carbon–fluorine coupling. Chemical shifts are reported in parts per million relative to an internal standard of tetramethylsilane in deuterated dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>), deuterated methanol (CD<sub>3</sub>OD), or deuterated chloroform (CDCl<sub>3</sub>). Positive ion fast atom bombardment (FAB) high-resolution mass spectrometry was conducted by Analytical Instrument Group, Inc., Raleigh, NC. All final compounds were purified to ≥95% purity as assayed by analytical HPLC (YMC-Pack Pro 150 × 4.6 mm, 5 μm C18 column, Shimadzu LC-10AT VP system equipped with a Shimadzu SPD-M10A VP diode array detector) at a 1.5 mL/min flow rate with a gradient of 5–95% acetonitrile (containing 0.1% TFA) in 0.1% aqueous TFA for 25 min and a total run time of 27 min. Pharmacokinetic, liver microsome assay, CYP inhibition, MDCK, and <i>K</i><sub>sol</sub> data, reported as average IC<sub>50</sub> (<i>n</i> ≥ 2), were carried out as previously described.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> <i>tert</i>-Butyl 7-Bromo-2,3-dihydrobenz[<i>f</i>][1,4]oxazepine-4(5<i>H</i>)-carboxylate (<b>29</b>)</h3><div class="NLM_p">To a stirred solution of 2-aminoethanol (6.11 g, 100 mmol) in MeOH (60 mL) was added 5-bromosalicylaldehyde (20.1 g, 100 mmol). The reaction mixture was stirred at ambient temperature for 2 h. To this mixture was added sodium borohydride (1.51 g, 40.0 mmol) portionwise with vigorous stirring. After being stirred for an additional 30 min, the reaction mixture was diluted with 6 N NaOH (60 mL). To this mixture was added di-<i>tert</i>-butyl dicarbonate (32.7 g, 150 mmol) slowly. After the reaction mixture was stirred for 30 min, an additional amount of di-<i>tert</i>-butyl dicarbonate (10.9 g, 50.0 mmol) was added, and the reaction mixture was stirred for an additional 30 min. Most of the methanol was removed on a rotary evaporator, and the residual solid was suspended with H<sub>2</sub>O (50 mL). To this suspension was added 1 N HCl slowly with vigorous stirring until the reaction mixture reached pH 4–5. The white precipitates were collected by filtration and washed with H<sub>2</sub>O. The precipitates were then suspended with EtOAc (50 mL) and filtered to provide <b>30</b> (25.8 g, 75%) as a white solid. MS (EI): <i>m</i>/<i>z</i> for C<sub>14</sub>H<sub>20</sub>BrNO<sub>4</sub>, found 346.0 (MH<sup>+</sup>).</div><div class="NLM_p last">A stirred solution of <b>30</b> (17.3 g, 50.0 mmol) and triphenylphosphine (13.6 g, 52.0 mmol) in THF (100 mL) was cooled to 0 °C, and diisopropyl azodicarboxylate (11.1 g, 55.0 mmol) was added slowly. Upon completion of addition, the reaction mixture was stirred at ambient temperature for 30 min and diluted with H<sub>2</sub>O (50 mL) and Et<sub>2</sub>O (50 mL). The separated organic layer was washed with 1 N HCl (50 mL), 1 N NaOH (50 mL), and brine, then dried over anhydrous sodium sulfate, and concentrated on a rotary evaporator. The residue was purified with a short silica gel plug (hexanes/ethyl acetate (20:1)) to give <b>29</b> (15.2 g, 93%) as a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (rotamers are observed) 7.43–7.27 (m, 2H), 6.93–6.88 (m, 1H), 4.44 and 4.36 (s, 2H), 4.03 and 4.02 (d, <i>J</i> = 4.4 Hz, 2H), 3.79 and 3.78 (d, <i>J</i> = 4.4 Hz, 2H), 1.43 (s, 9H). MS (EI): <i>m</i>/<i>z</i> for C<sub>14</sub>H<sub>18</sub>BrNO<sub>3</sub>, found 328.0 (MH<sup>+</sup>).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 4-(<i>tert</i>-Butoxycarbonyl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-7-ylboronic Acid (<b>31</b>)</h3><div class="NLM_p last">A stirred solution of <b>29</b> (10.0 g, 30.5 mmol) and triisopropyl borate (9.1 mL, 40 mmol) in THF (100 mL) was cooled to −78 °C, and a solution of <i>n</i>-butyllithium (25 mL, 40 mmol, 1.6 M in THF) was added dropwise such that the temperature was maintained. Upon completion of addition, the reaction mixture was stirred for an additional 30 min, then quenched with 1 N aqueous HCl (35 mL), and allowed to warm to ambient temperature. The reaction mixture was extracted with EtOAc (100 mL), and the separated organic layer was dried over anhydrous sodium sulfate and concentrated on a rotary evaporator. Hexanes were subsequently added to the crude reaction mixture, which resulted in the formation of a white solid. This slurry was stirred for 1 h at ambient temperature and filtered to afford <b>31</b> (8.6 g, 95%). MS (EI): <i>m</i>/<i>z</i> for C<sub>14</sub>H<sub>20</sub>BNO<sub>3</sub>, found 194.0 (MH<sup>+</sup> – Boc).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 2-Ethyl-4-(methylsulfonyl)benzoic Acid (<b>33</b>)</h3><div class="NLM_p">A stirred solution of 2-bromo-4-(methylsulfonyl)benzoic acid (5.18 g, 18.6 mmol) in THF (40 mL) and MeOH (20 mL) was cooled to 0 °C, and a solution of (trimethylsilyl)diazomethane (12 mL, 24 mmol, 2.0 M in hexanes) was added dropwise such that the temperature was maintained. After being stirred for 2 h, the reaction mixture was concentrated on a rotary evaporator to afford <b>32</b> (5.58 g, quantitative) as a colorless solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.24–8.23 (m, 1H), 7.94–7.92 (m, 2H), 3.99 (s, 3H), 3.09 (s, 3H).</div><div class="NLM_p">A mixture of <b>32</b> (200 mg, 0.683 mmol), ethylboronic acid (55 mg, 0.75 mmol), potassium carbonate (283 mg, 2.05 mmol), Ag<sub>2</sub>O (395 mg, 1.70 mmol), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane (50 mg, 0.068 mmol) in THF (5 mL) was stirred in a sealed tube at 80 °C for 18 h. The reaction mixture was filtered through Celite, and the filtrate was concentrated on a rotary evaporator. The residue was purified by flash chromatography (hexanes/ethyl acetate (4:1)) to give methyl 2-ethyl-4-(methylsulfonyl)benzoate (100 mg, 60%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.99 (d, <i>J</i> = 8.4 Hz, 1H), 7.87 (d, <i>J</i> = 2.0 Hz, 1H), 7.81 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 3.95 (s, 3H), 3.08 (s, 3H), 3.04 (q, <i>J</i> = 7.6 Hz, 2H), 1.28 (t, <i>J</i> = 7.6 Hz, 3H).</div><div class="NLM_p">To a stirred solution of methyl 2-ethyl-4-(methylsulfonyl)benzoate (94 mg, 0.39 mmol) in MeOH (1 mL) and CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added 1 N aqueous NaOH (1 mL), and the resulting mixture was stirred at 45 °C for 2 h. The reaction mixture was cooled to ambient temperature and concentrated on a rotary evaporator. The aqueous residue was acidified with 1 N aqueous HCl to pH 1–2 and extracted with EtOAc (10 mL × 2). The combined organic layers were dried over anhydrous sodium sulfate and concentrated to afford <b>33</b> (83 mg, 94%) as a colorless solid. MS (EI): <i>m</i>/<i>z</i> for C<sub>10</sub>H<sub>12</sub>O<sub>4</sub>S, found 227.0 (MH<sup>–</sup>).</div><div class="NLM_p last">Compound <b>34</b> was prepared from <b>32</b> according to a procedure similar to that described for the synthesis of <b>33</b>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Methyl 4-(Methylsulfonyl)-2-propylbenzoate</h3><div class="NLM_p last">Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.99 (d, <i>J</i> = 8.0 Hz, 1H), 7.84 (d, <i>J</i> = 1.6 Hz, 1H), 7.81 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 3.95 (s, 3H), 3.07 (s, 3H), 2.98 (t, <i>J</i> = 8.0 Hz, 2H), 1.69–1.63 (m, 2H), 0.99 (t, <i>J</i> = 7.6 Hz, 3H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 4-(Methylsulfonyl)-2-propylbenzoic Acid (<b>34</b>)</h3><div class="NLM_p last">MS (EI): <i>m</i>/<i>z</i> for C<sub>11</sub>H<sub>14</sub>O<sub>4</sub>S, found 241.0 (MH<sup>–</sup>).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-(Ethylamino)-4-(methylsulfonyl)benzoic Acid (<b>35</b>)</h3><div class="NLM_p">A solution of <b>32</b> (200 mg, 0.683 mmol), ethylamine (200 μL, excess), xantphos (18 mg, 0.03 mmol), Pd<sub>2</sub>dba<sub>3</sub> (14 mg, 0.015 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (326 mg, 1.00 mmol) in 1,4-dioxane (3 mL) was stirred in a sealed tube at 95 °C for 15 h. The reaction mixture was cooled to ambient temperature and filtered through Celite, and the filtrate was concentrated on a rotary evaporator. The residue was purified by flash chromatography (hexanes/ethyl acetate (4:1)) to afford methyl 2-(ethylamino)-4-(methylsulfonyl)benzoate (39 mg, 22%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.06 (d, <i>J</i> = 8.4 Hz, 1H), 7.88 (br s, 1H), 7.20 (d, <i>J</i> = 2.0 Hz, 1H), 7.04 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 3.90 (s, 3H), 3.33–3.26 (m, 2H), 3.06 (s, 3H), 1.35 (t, <i>J</i> = 7.2 Hz, 3H).</div><div class="NLM_p last">To a stirred solution of methyl 2-(ethylamino)-4-(methylsulfonyl)benzoate (39 mg, 0.15 mmol) in MeOH (1 mL) and CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added 1 N aqueous NaOH (1 mL), and the resulting mixture was stirred at 45 °C for 1 h. The reaction mixture was cooled to ambient temperature and concentrated on a rotary evaporator. The aqueous residue was acidified to pH 4 with HCl and extracted with EtOAc (10 mL × 2). The combined organic layers were dried over anhydrous sodium sulfate and concentrated to afford <b>35</b> (37 mg, quantitative) as a yellow solid. MS (EI): <i>m</i>/<i>z</i> for C<sub>10</sub>H<sub>13</sub>NO<sub>4</sub>S, found 242.0 (MH<sup>–</sup>).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 3-Fluoro-2-methyl-4-(methylsulfonyl)benzoic Acid (<b>37</b>)</h3><div class="NLM_p">To a stirred mixture of 2,3-difluorotoluene (1.9 g, 15 mmol) and Fe (82.7 mg, 1.48 mmol) in chloroform (10 mL) was added bromine (760 μL, 14.8 mmol) slowly at ambient temperature, and the mixture was stirred overnight. Water (10 mL) was added, and the reaction mixture was extracted with Et<sub>2</sub>O (20 mL). The separated organic layer was washed with aqueous sodium thiosulfate and brine, dried over anhydrous sodium sulfate, and concentrated on a rotary evaporator. The residue was purified by Kugelrohr distillation to give 1-bromo-3,4-difluoro-2-methylbenzene (2.49 g, 81%) as a colorless oil.</div><div class="NLM_p">A stirred solution of 1-bromo-3,4-difluoro-2-methylbenzene (2.49 g, 12.0 mmol) in THF (5 mL) was cooled to 0 °C, and a solution of isopropylmagnesium bromide (9.0 mL, 18 mmol, 2 M in THF) was added slowly so that the temperature was maintained. Upon completion of the addition, the resulting stirred mixture was allowed to warm to ambient temperature for 24 h. Carbon dioxide, generated from dry ice, was introduced to the reaction mixture for 10 min, and the resulting mixture was stirred for an additional 30 min. The reaction mixture was quenched with H<sub>2</sub>O (20 mL), and the volatile solvents were removed on a rotary evaporator. The resulting aqueous layer was acidified with concentrated HCl to pH 1–2. The white precipitate that formed was filtered, washed with water and cold hexanes, and dried in vacuo to afford <b>36</b> (1.67 g, 81%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.10 (br s, 1H), 7.72–7.68 (m, 1H), 7.33 (dd, <i>J</i> = 18.4, 8.8 Hz, 1H), 2.48 (s, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>8</sub>H<sub>6</sub>F<sub>2</sub>O<sub>2</sub>, found 171.0 (MH<sup>–</sup>).</div><div class="NLM_p">To a stirred solution of <b>36</b> (700 mg, 4.1 mmol) in DMSO (5 mL) was added NaOH (164 mg, 4.1 mmol), and the mixture was stirred at ambient temperature for 30 min. To this mixture was added sodium thiomethoxide (342 mg, 4.9 mmol), and the resulting mixture was warmed to 55–60 °C for 4 h. The reaction mixture was cooled to 0 °C and quenched with H<sub>2</sub>O (10 mL). The resulting mixture was acidified with concentrated HCl to pH 1–2. The white precipitate was collected by filtration, washed with water, and dried in vacuo to afford 3-fluoro-2-methyl-4-(thiomethyl)benzoic acid (879 mg, quantitative), which was used in the next step without further purification. MS (EI): <i>m</i>/<i>z</i> for C<sub>9</sub>H<sub>9</sub>FO<sub>2</sub>S, found 199.0 (MH<sup>–</sup>).</div><div class="NLM_p last">To a stirred suspension of 3-fluoro-2-methyl-4-(thiomethyl)benzoic acid (879 mg, 4.1 mmol) in acetone (10 mL) and H<sub>2</sub>O (10 mL) were added NaOH (330 mg, 8.3 mmol) and sodium bicarbonate (680 mg, 8.1 mmol). The stirred mixture was cooled to 0 °C, and Oxone (4 g) was added portionwise over 10 min. The reaction was monitored by LC/MS. Upon the completion of the reaction, concentrated HCl was added to acidify the mixture to pH 2–3. The white precipitate that formed was collected by filtration, washed with water, and dried. The precipitate was resuspended in water (10 mL), stirred vigorously at ambient temperature for 1 h, filtered, washed with water and hexanes, and dried in vacuo to afford <b>37</b> (886 mg, 94%) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.74 (br s, 1H), 7.82–7.76 (m, 2H), 3.37 (s, 3H), 2.47 (s, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>9</sub>H<sub>9</sub>FO<sub>4</sub>S, found 231.0 (MH<sup>–</sup>).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Ethyl-3-fluoro-4-(methylsulfonyl)benzoic Acid (<b>39</b>)</h3><div class="NLM_p">To a stirred solution of 2,3-difluorophenylacetic acid (17.2 g, 100 mmol) in THF (150 mL) was added borane–dimethyl sulfide complex solution (75 mL, 150 mmol, 2 M in THF) over the course of 1 h using a dropping funnel. The reaction mixture started to reflux spontaneously. After being stirred for an additional 3 h, it was cooled to 0 °C, and excess MeOH (20 mL) was added carefully to the reaction mixture. The stirred mixture was allowed to warm to ambient temperature for 1 h and then concentrated on a rotary evaporator. The residue was diluted with dichloromethane (100 mL), washed with aqueous sodium bicarbonate (100 mL), dried over anhydrous sodium sulfate, and concentrated on a rotary evaporator to give 2-(2,3-difluorophenyl)ethanol (15.6 g, 99%), which was used in the next step without further purification. GC/MS: <i>m</i>/<i>z</i> for C<sub>8</sub>H<sub>8</sub>F<sub>2</sub>O, found 158 (M<sup>+</sup>).</div><div class="NLM_p">To a stirred solution of 2-(2,3-difluorophenyl)ethanol (15.6 g, 98.6 mmol) and Et<sub>3</sub>N (20.6 mL, 148 mmol) in dichloromethane (100 mL) was added TsCl (20.7 g, 109 mmol). The reaction mixture was stirred for 5 h at ambient temperature and then diluted with dichloromethane (200 mL). The resulting solution was washed with water (100 mL) and brine (100 mL), dried over anhydrous sodium sulfate, and concentrated on a rotary evaporator to afford (2,3-difluorophenyl)ethyl 4-methylbenzenesulfonate (29.6 g, 96%), which was used in the next step without further purification.</div><div class="NLM_p">To a stirred mixture of (2,3-difluorophenyl)ethyl 4-methylbenzenesulfonate (29.6 g, 94.8 mmol) in acetone (150 mL) was added LiBr (42.8 g, 492 mmol), and the reaction was heated to reflux for 3 h. The mixture was cooled to ambient temperature and concentrated on a rotary evaporator. The residue was partitioned with water (200 mL) and hexanes (200 mL). The separated aqueous layer was extracted with hexanes (100 mL). The combined organic layers were then washed with brine, dried over anhydrous sodium sulfate, concentrated on a rotary evaporator, and purified by flash chromatography (hexanes) to give 1-(2-bromoethyl)-2,3-difluorobenzene (19.4 g, 89%). GC/MS: <i>m</i>/<i>z</i> for C<sub>8</sub>H<sub>7</sub>BrF<sub>2</sub>, found 142 (M – Br).</div><div class="NLM_p">To a stirred suspension of Mg (4.26 g, 175 mmol) in Et<sub>2</sub>O (50 mL) was added 1,2-dibromoethane (0.755 mL, 8.76 mmol), and the mixture was allowed to stir for 10 min at ambient temperature. The flask was affixed with a reflux condenser, and a solution of 1-(2-bromoethyl)-2,3-difluorobenzene (19.4 g, 87.6 mmol) and 1,2-dibromoethane (0.755 mL, 8.76 mmol) in Et<sub>2</sub>O (50 mL) was added over 30 min such that the ether warmed to a steady reflux. The stirred reaction was maintained at reflux for 1 h and then allowed to cool to ambient temperature before being further cooled to 0 °C. Aqueous ammonium chloride (50 mL) was carefully added over the course of 1 h to quench the reaction. The resulting mixture was diluted with H<sub>2</sub>O (100 mL), and the separated aqueous layer was extracted with Et<sub>2</sub>O (100 mL). The combined organic layers were washed with brine, dried over anhydrous sodium sulfate, and filtered. Careful distillation of the filtrate gave <b>38</b> (9.5 g, 76%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.01–6.97 (m, 3H), 2.70 (q, <i>J</i> = 7.6 Hz, 2H), 1.23 (t, <i>J</i> = 7.6 Hz, 3H). GC/MS: <i>m</i>/<i>z</i> for C<sub>8</sub>H<sub>8</sub>F<sub>2</sub>, found 142 (M<sup>+</sup>).</div><div class="NLM_p last">Compound <b>39</b> was prepared from compound <b>38</b> according to a procedure similar to that described for the synthesis of compound <b>37</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.73 (br s, 1H), 7.82–7.76 (m, 2H), 3.76 (s, 3H), 2.94 (q, <i>J</i> = 7.2 Hz, 2H), 1.81 (t, <i>J</i> = 7.2 Hz, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>10</sub>H<sub>11</sub>FO<sub>4</sub>S, found 245.0 (MH<sup>–</sup>).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2,2,2-Trifluoro-1-(4-(7-(quinolin-3-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)ethanone (<b>1</b>)</h3><div class="NLM_p">A mixture of <b>29</b> (327 mg, 1.00 mmol), quinolin-3-ylboronic acid (200 mg, 1.15 mmol), potassium carbonate (414 mg, 3.0 mmol), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane (94 mg, 0.12 mmol) in DME (5 mL) was heated to 80 °C for 2 h. The reaction mixture was cooled to ambient temperature and concentrated on a rotary evaporator, and the residue was purified by flash chromatography (hexanes/ethyl acetate (2:1)) to give <b>40</b> (282 mg, 75%) as a white solid. MS (EI): <i>m</i>/<i>z</i> for C<sub>23</sub>H<sub>24</sub>N<sub>2</sub>O<sub>3</sub>, found 377.1 (MH<sup>–</sup>).</div><div class="NLM_p">To a stirred solution of <b>40</b> (282 mg, 0.75 mmol) in 1,4-dioxane (5 mL) was added a solution of HCl (2 mL, 8 mmol, 4 M in 1,4-dioxane), and the resulting mixture was stirred at ambient temperature overnight. The reaction mixture was concentrated on a rotary evaporator to give 7-(quinolin-3-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepine dihydrochloride (259 mg, quantitative), which was used without further purification. 7-(Quinolin-3-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepine (<b>1b</b>) was obtained from basic workup of a sample with aqueous sodium bicarbonate that was extracted with EtOAc (2×). The combined organic layers were dried over anhydrous sodium sulfate and concentrated on a rotary evaporator, and the residue was purified by reverse-phase HPLC (acetonitrile/aqueous ammonium acetate buffer solution, 20–100% gradient) to give <b>1b</b> as a white powder after lyophilization. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.38 (d, <i>J</i> = 2.4 Hz, 1H), 9.04 (s, 1H), 8.23 (d, <i>J</i> = 8.0 Hz, 1H), 8.18 (d, <i>J</i> = 8.4 Hz, 1H), 8.00–7.93 (m, 3H), 7.87–7.85 (m, 1H), 7.36 (d, <i>J</i> = 8.8 Hz, 1H), 4.56 (s, 2H), 4.37–4.35 (m, 2H), 3.69–3.66 (m, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>18</sub>H<sub>16</sub>N<sub>2</sub>O, found 277.0 (MH<sup>+</sup>).</div><div class="NLM_p">A mixture of crude 7-(quinolin-3-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepine dihydrochloride (229 mg, 0.66 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.575 mL, 3.3 mmol), and 4-(2,2,2-trifluoroacetyl)benzoic acid (173 mg, 0.79 mmol) in DMF (5 mL) was treated with <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate (326 mg, 0.86 mmol). After being stirred for 30 min at ambient temperature, the reaction mixture was diluted with saturated sodium bicarbonate (20 mL) and was extracted with EtOAc (30 mLx2). The combined organic layers were dried over anhydrous sodium sulfate and concentrated on a rotary evaporator, and the residue was purified by reverse-phase HPLC (acetonitrile/aqueous ammonium acetate buffer solution, 20–100% gradient) to give <b>1</b> (211 mg, 67%) as a white powder after lyophilization. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 9.27 and 9.10 (s, 1H), 8.66 and 8.38 (s, 1H), 8.09–7.64 (m, 8H), 7.45 and 7.32 (d, <i>J</i> = 7.2 Hz, 2H), 7.16 and 6.98 (s, 1H), 4.93 and 4.53 (s, 2H), 4.32 and 4.22 (br s, 2H), 4.07 and 3.77 (br s, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>27</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub>, found 477.0 (MH<sup>+</sup>).</div><div class="NLM_p last">Compounds <b>1c</b>, <b>2</b>–<b>5</b>, and <b>10</b> were prepared from <b>29</b> and the corresponding boronic acid or 4,4,5,5-tetramethyl-1,3,2-dioxaborolane according to a procedure similar to that described for the synthesis of compound <b>1</b>. Compound <b>1a</b> was prepared from 2,3,4,5-tetrahydro-1,4-benzoxazepine and 4-(2,2,2-trifluoroacetyl)benzoic acid.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2,2,2-Trifluoro-1-(4-(2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)ethanone (<b>1a</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 8.13 and 8.10 (d, <i>J</i> = 8.0 Hz, 2H), 7.51–7.45 (m, 2H), 7.28–7.04 (m, 3H), 7.00–6.97 and 6.61–6.59 (m, 1H), 4.83 and 4.41 (s, 2H), 4.25 and 4.16 (t, <i>J</i> = 8.4 Hz, 2H), 4.04 and 3.75 (t, <i>J</i> = 8.4 Hz, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>18</sub>H<sub>14</sub>F<sub>3</sub>NO<sub>3</sub>, found 350.0 (MH<sup>+</sup>).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Phenyl(7-(quinolin-3-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)methanone (<b>1c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (rotamers are observed) 9.20 and 9.03 (s, 1H), 8.35 and 8.16 (s, 1H), 8.14 (d, <i>J</i> = 8.8 Hz, 1H), 7.91–8.31 (m, 1H), 7.76–7.58 (m, 3H), 7.52–7.37 (m, 5H), 7.23–7.19 (m, 1H), 6.93 (s, 1H), 4.93 and 4.55 (s, 2H), 4.31 and 4.19 (br s, 2H), 4.10–3.87 (br s, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>, found 381.0 (MH<sup>+</sup>).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2,2,2-Trifluoro-1-(4-(7-(naphthalen-2-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)ethanone (<b>2</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (rotamers are observed) 8.20 and 8.14 (d, <i>J</i> = 7.6 Hz, 2H), 7.93–7.74 (m, 4H), 7.63 and 7.61 (d, <i>J</i> = 2.4 Hz, 1H), 7.58–7.48 (m, 5H), 7.20 and 7.17 (d, <i>J</i> = 3.6 Hz, 1H), 6.91 (br s, 1H), 4.94 and 4.50 (s, 2H), 4.31 and 4.21 (t, <i>J</i> = 4.0 Hz, 2H), 4.10 and 3.80 (t, <i>J</i> = 4.0 Hz, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>28</sub>H<sub>20</sub>F<sub>3</sub>NO<sub>3</sub>, found 476.0 (MH<sup>+</sup>).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2,2,2-Trifluoro-1-(4-(7-phenyl-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)ethanone (<b>3</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 7.72–7.66 (m, 5H), 7.53 and 7.51 (d, <i>J</i> = 2.4 Hz, 1H), 7.46–7.28 (m, 5H), 7.11–7.05 (m, 1H), 4.85 and 4.48 (s, 2H), 4.26 amd 4.16 (br s, 2H), 4.02 and 3.74 (br s, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>24</sub>H<sub>18</sub>F<sub>3</sub>NO<sub>3</sub>, found 426.0 (MH<sup>+</sup>).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2,2,2-Trifluoro-1-(4-(7-(pyridin-3-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)ethanone (<b>4</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 8.95 and 8.87 (s, 1H), 8.70 and 8.52 (br s, 1H), 8.07–8.03 (m, 1H), 7.79–7.26 (m, 6H), 7.11–7.06 (m, 1H), 6.94–6.90 (m, 1H), 4.86 and 4.73 (s, 2H), 4.26 and 4.18 (br s, 2H), 4.00 and 3.72 (br s, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>23</sub>H<sub>17</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub>, found 427.0 (MH<sup>+</sup>).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-(3-(4-(4-(2,2,2-Trifluoroacetyl)benzoyl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-7-yl)phenyl)acetamide (<b>5</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 10.06 and 10.02 (s, 1H), 7.85 and 7.83 (s, 1H), 7.73–7.64 (m, 3H), 7.60 and 7.58 (s, 1H), 7.47–7.06 (m, 5H), 7.30 and 6.71 (br s, 1H), 4.84 and 4.48 (s, 2H), 4.27 and 4.16 (br s, 2H), 4.02 and 3.74 (br s, 2H), 2.07 (s, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>26</sub>H<sub>21</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub>, found 483.0 (MH<sup>+</sup>).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-(4-(7-(1<i>H</i>-Pyrazol-4-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)-2,2,2-trifluoroethanone (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 12.92 (s, 1H), 8.18–7.58 (m, 5H), 7.46–7.41 (m, 2H), 7.29–6.95 (m, 2H), 4.80 and 4.40 (s, 2H), 4.19 and 4.11 (br s, 2H), 4.00 and 3.71 (br s, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>21</sub>H<sub>16</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>, found 416.0 (MH<sup>+</sup>).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-(4-(7-(1<i>H</i>-Indazol-6-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)-2,2,2-trifluoroethanone (<b>6</b>)</h3><div class="NLM_p">A stirred mixture of <b>31</b> (293 mg, 1.0 mmol), 6-bromo-1<i>H</i>-indazole (197 mg, 1.0 mmol), triethylamine (348 μL, 2.5 mmol), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane (82 mg, 0.10 mmol) in DME (5 mL) and H<sub>2</sub>O (1 mL) was heated to 90 °C for 4 h. The reaction mixture was cooled to ambient temperature, concentrated on a rotary evaporator, and purified by flash chromatography (hexanes/ethyl acetate (1:1)) to give <b>41</b> (288 mg, 79%). MS (EI): <i>m</i>/<i>z</i> for C<sub>21</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>, found 366.0 (MH<sup>+</sup>).</div><div class="NLM_p">To a solution of <b>41</b> (288 mg, 0.79 mmol) in 1,4-dioxane (5 mL) was added a solution of HCl (2 mL, 8 mmol, 4 M in 1,4-dioxane) and the resulting mixture was stirred at ambient temperature for overnight. The reaction mixture was concentrated on a rotary evaporator to give 7-(1<i>H</i>-indazol-6-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepine dihydrochloride (269 mg, quant.) which was used in the next step without further purification.</div><div class="NLM_p">A mixture of crude 7-(1<i>H</i>-indazol-6-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepine dihydrochloride (269 mg, 0.79 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.688 mL, 3.9 mmol) and 4-(2,2,2-trifluoroacetyl)benzoic acid (207 mg, 0.95 mmol) in DMF (5 mL) was treated with <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate (390 mg, 1.03 mmol). After stirring for 30 min at ambient temperature, the reaction mixture was diluted with saturated sodium bicarbonate (20 mL) and the aqueous layer was extracted with EtOAc (30 mL × 2). The combined organic layers were dried over anhydrous sodium sulfate and concentrated on a rotary evaporator, and the residue was purified by reverse phase HPLC (acetonitrile/aqueous ammonium acetate buffer solution; 20–100% gradient) to give <b>6</b> (272 mg, 74%) as a white powder after lyophilization. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 13.13 (s, 1H), 8.10 (s, 1H), 7.85–7.51 (m, 7H), 7.43–7.32 (m, 2H), 7.18–7.08 (m, 1H), 4.89 and 4.53 (d, <i>J</i> = 11.2 Hz, 2H), 4.28 and 4.17 (br s, 2H), 4.04 and 3.76 (br s, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>, found 466.0 (MH<sup>+</sup>).</div><div class="NLM_p last">Compounds <b>7, 11–28</b> were prepared according to a similar procedure as described for the synthesis of compound <b>6</b>. Compound <b>8</b> was prepared from 7-(1<i>H</i>-indazol-6-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepine dihydrochloride and 4-acetylbenzoic acid.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-(4-(7-(1<i>H</i>-Indazol-5-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)-2,2,2-trifluoroethanone (<b>7</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 13.12 and 13.08 (s, 1H), 8.08 and 8.07 (s, 2H), 7.83–7.49 (m, 6H), 7.43–7.14 (m, 2H), 7.11–6.91 (m, 1H), 4.88 and 4.52 (d, <i>J</i> = 11.2 Hz, 2H), 4.30–4.27 and 4.16–4.14 (m, 2H), 4.05–4.00 and 3.74–3.70 (m, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>, found 466.0 (MH<sup>+</sup>).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-(4-(7-(1<i>H</i>-Indazol-6-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)ethanone (<b>8</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 13.14 and 13.11 (s, 1H), 8.09 and 8.08 (s, 1H), 8.06 (d, <i>J</i> = 7.6 Hz, 2H), 7.85–7.38 (m, 6H), 7.22–6.91 (m, 2H), 4.89 and 4.55 (s, 2H), 4.31 and 4.16 (br s, 2H), 4.04 and 3.73 (br s, 2H), 2.61 (s, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>, found 412.0 (MH<sup>+</sup>).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-(4-(7-(1-Methyl-<i>H</i>-indazol-6-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)ethanone (<b>9</b>)</h3><div class="NLM_p last">To a stirred solution of <b>8</b> (41 mg, 0.1 mmol) in DMF (2 mL) was added K<sub>2</sub>CO<sub>3</sub> (42 mg, 0.3 mmol) and iodomethane (0.1 mL, 1.6 mmol). The reaction mixture was stirred at ambient temperature for overnight. The crude mixture was directly purified by reverse phase HPLC (acetonitrile/aqueous ammonium acetate buffer solution; 20–100% gradient) to give <b>9</b> (24 mg, 54%) as a white powder after lyophilization. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 8.06–8.00 (m, 3H), 7.92–7.40 (m, 6H), 7.26–6.97 (m, 2H), 4.91 and 4.55 (s, 2H), 4.31 and 4.17 (br s, 2H), 4.12 and 4.08 (s, 3H), 4.06 and 3.74 (br s, 2H), 2.61 (s, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>26</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>, found 426.0 (MH<sup>+</sup>).</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-(4-(7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)-2,2,2-trifluoroethanone (<b>11</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 12.51 and 12.43 (s, 1H), 8.26 and 8.25 (s, 1H), 7.90–7.43 (m, 8H), 7.35–7.30 (m, 1H), 7.10–7.06 and 6.76–6.74 (m, 1H), 4.86 and 4.52 (br s, 2H), 4.26 and 4.16 (br s, 2H), 4.03 and 3.75 (br s, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>: 466.0 (MH<sup>+</sup>).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2,2,2-Trifluoro-1-(4-(7-(2-methyl-1<i>H</i>-benz[<i>d</i>]imidazol-6-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)phenyl)ethanone (<b>12</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 12.30 (br s, 1H), 8.10 and 7.81 (br s, 1H), 7.71–7.65 (m, 4H), 7.57–7.42 (m, 3H), 7.33–6.74 (m, 2H), 4.86 and 4.52 (br s, 2H), 4.25 and 4.15 (br s, 2H), 4.04 and 3.75 (br s, 2H), 2.55 (s, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>26</sub>H<sub>20</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>, found 480.0 (MH<sup>+</sup>).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(4-(trifluoromethyl)phenyl)methanone (<b>13</b>) (HCl Salt)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 9.49 and 9.45 (s, 1H), 8.03–7.62 (m, 8H), 7.49–6.96 (m, 2H), 4.91 and 4.58 (s, 2H), 4.33 and 4.19 (br s, 2H), 4.05 and 3.74 (br s, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>24</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>, found 438.0 (MH<sup>+</sup>).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-(7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)benzenesulfonamide (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 12.53 (br s, 1H), 8.26 (s, 1H), 7.91–7.46 (m, 10H), 7.30–6.81 (m, 2H), 4.88 and 4.56 (s, 2H), 4.28 and 4.16 (br s, 2H), 4.04 and 3.73 (br s, 2H). MS (EI): <i>m</i>/<i>z</i> for C<sub>23</sub>H<sub>20</sub>N<sub>4</sub>O<sub>4</sub>S, found 449.0 (MH<sup>+</sup>).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 4-(7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3,4,5-tetrahydrobenz[<i>f</i>][1,4]oxazepin-4-ylcarbonyl)-<i>N</i>-methylbenzenesulfonamide (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 12.51 and 12.42 (s, 1H), 8.25 (br s, 1H), 7.93–7.47 (m, 9H), 7.31–6.76 (m, 2H), 4.88 and 4.53 (s, 2H), 4.27 and 4.16 (br s, 2H), 4.05 and 3.73 (br s, 2H), 2.45–2.35 (m, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>24</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>S, found 463.0 (MH<sup>+</sup>).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(4-methylsulfonyl)phenyl)methanone (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 12.52 and 12.44 (s, 1H), 8.25 and 8.24 (s, 1H), 8.02–7.90 (m, 2H), 7.74–7.49 (m, 6H), 7.29–6.85 (m, 2H), 4.88 and 4.53 (s, 2H), 4.28 and 4.16 (br s, 2H), 4.05 and 3.72 (br s, 2H), 3.27 (br s, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>24</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>S, found 448.0 (MH<sup>+</sup>).</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(4-ethylsulfonyl)phenyl)methanone (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.14–7.56 (m, 4H), 7.55–7.41 (m, 4H), 7.23 (s, 1H), 7.15 (d, <i>J</i> = 8.4 Hz, 1H), 6.33 (d, <i>J</i> = 2.0 Hz, 1H), 4.91 and 4.42 (s, 2H), 4.26–3.78 (m, 4H), 3.28 (q, <i>J</i> = 7.6 Hz, 2H), 2.12 and 2.02 (s, 1H), 1.38 (t, <i>J</i> = 7.6 Hz, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>S, found 462.0 (MH<sup>+</sup>).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(2-methyl-4-(methylsulfonyl)phenyl)methanone (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.11–7.80 (m, 4H), 7.54–7.38 (m, 3H), 7.28–7.14 (m, 2H), 6.29 (s, 1H), 4.39–4.10 (m, 6H), 3.21 (s, 3H), 2.12 (s, 1H), 2.02 (s, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>S, found 462.0 (MH<sup>+</sup>).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(2-ethyl-4-(methylsulfonyl)phenyl)methanone (<b>19</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (rotamers are observed) 8.10 (s, 1H), 8.03–7.79 (m, 3H), 7.53 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.43 (dd, <i>J</i> = 8.8, 1.6 Hz, 1H), 7.33 (d, <i>J</i> = 7.6 Hz, 1H), 7.26 (s, 1H), 7.15 (d, <i>J</i> = 8.4 Hz, 1H), 6.29 (d, <i>J</i> = 2.4 Hz, 1H), 4.38–4.20 (m, 6H), 3.21 (s, 3H), 2.54–2.44 and 2.29–2.20 (m, 2H), 2.12 (br s, 1H), 1.14 (t, <i>J</i> = 7.6 Hz, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>26</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub>S, found 476.0 (MH<sup>+</sup>).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(4-(methylsulfonyl)-2-propylphenyl)methanone (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (rotamers are observed) 8.11 (br s, 1H), 7.99 (s, 1H), 7.97 (d, <i>J</i> = 2.0 Hz, 1H), 7.81 (dd, <i>J</i> = 18.8, 10.0 Hz, 1H), 7.53 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.42 (dd, <i>J</i> = 8.8, 1.6 Hz, 1H), 7.32 (d, <i>J</i> = 8.0 Hz, 1H), 7.27 (s, 1H), 7.15 (d, <i>J</i> = 8.0 Hz, 1H), 6.29 (d, <i>J</i> = 2.4 Hz, 1H), 4.38 (d, <i>J</i> = 15.6 Hz, 1H), 4.25 (d, <i>J</i> = 14.8 Hz, 1H), 4.23 (br s, 4H), 3.21 (s, 3H), 2.45–2.37 (m 1H), 2.24–2.16 (m, 1H), 2.12 (s, 1H), 1.70–1.61 (m 1H), 1.50–1.43 (m, 1H), 0.89 and 0.86 (t, <i>J</i> = 7.2 Hz, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>27</sub>H<sub>27</sub>N<sub>3</sub>O<sub>4</sub>S, found 490.0 (MH<sup>+</sup>).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(2-(ethylamino)-4-(methylsulfonyl)phenyl)methanone (<b>21</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.10 (s, 1H), 7.80 (d, <i>J</i> = 8.0 Hz, 1H), 7.52 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.44–7.39 (m, 3H), 7.25–7.23 (m, 2H), 7.13 (d, <i>J</i> = 8.4 Hz, 1H), 6.47 (s, 1H), 4.46 (br s, 2H), 4.24–4.18 (m, 5H), 3.19 (s, 3H), 2.94 (br s, 2H), 2.12 (s, 1H), 0.99 (t, <i>J</i> = 6.8 Hz, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>26</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub>S, found 491.0 (MH<sup>+</sup>).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(2-chloro-4-(methylsulfonyl)phenyl)methanone (<b>22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.22 (s, 1H), 8.18 (d, <i>J</i> = 1.6 Hz, 1H), 8.04 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.81 (d, <i>J</i> = 8.4 Hz, 1H), 7.53 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.45 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 7.36 (d, <i>J</i> = 8.0 Hz, 1H), 7.23 (s, 1H), 7.16 (d, <i>J</i> = 8.4 Hz, 1H), 6.35 (d, <i>J</i> = 2.4 Hz, 1H), 4.45 (d, <i>J</i> = 15.6 Hz, 1H), 4.42–4.32 (m, 2H), 4.25 (d, <i>J</i> = 15.6 Hz, 1H), 4.16–4.05 (m, 2H), 3.24 (s, 3H), 2.11 (s, 1H). MS (EI): <i>m</i>/<i>z</i> for C<sub>24</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>S, found 482.0 (MH<sup>+</sup>).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(2-bromo-4-(methylsulfonyl)phenyl)methanone (<b>23</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.34 (d, <i>J</i> = 1.6 Hz, 1H), 8.10 (d, <i>J</i> = 1.6 Hz, 1H), 8.08 (s, 1H), 7.80 (d, <i>J</i> = 8.0 Hz, 1H), 7.54 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.42 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.35 (d, <i>J</i> = 8.0 Hz, 1H), 7.22 (s, 1H), 7.16 (d, <i>J</i> = 8.4 Hz, 1H), 6.35 (s, 1H), 4.44 (d, <i>J</i> = 15.6 Hz, 1H), 4.37–4.32 (m, 2H), 4.26 (d, <i>J</i> = 15.6 Hz, 1H), 4.19–4.08 (m, 2H), 3.23 (s, 3H), 2.12 (s, 1H). MS (EI): <i>m</i>/<i>z</i> for C<sub>24</sub>H<sub>20</sub>BrN<sub>3</sub>O<sub>4</sub>S, found 526.0, 528.0 (MH<sup>+</sup>).</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(3-methyl-4-(methylsulfonyl)phenyl)methanone (<b>24</b>) (HCl Salt)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 9.55 and 9.53 (s, 1H), 8.03–7.78 (m, 4H), 7.64–7.49 (m, 2H), 7.46 and 7.37 (d, <i>J</i> = 8.8 Hz, 1H), 7.31–7.02 (m, 3H), 4.90 and 4.56 (s, 2H), 4.34 and 4.18 (br s, 2H), 4.04 and 3.74 (br s, 2H), 3.25 and 3.17 (s, 3H), 2.65 and 2.46 (s, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>S, found 462.0 (MH<sup>+</sup>).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(3-fluoro-2-methyl-4-(methylsulfonyl)phenyl)methanone (<b>25</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 12.49 and 12.00 (br s, 1H), 8.25 (d, <i>J</i> = 8.4 Hz, 1H), 7.83–7.49 (m, 5H), 7.30–6.77 (m, 3H), 4.98–4.85 (m, 1H), 4.53–4.36 (m, 1H), 4.36–3.57 (m, 4H), 3.34 (s, 3H, overlapping with H<sub>2</sub>O), 2.13 and 1.78 (d, <i>J</i> = 2.4 Hz, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>4</sub>S, found 480.0 (MH<sup>+</sup>).</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (7-(1<i>H</i>-Benz[<i>d</i>]imidazol-6-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(2-ethyl-3-fluoro-4-(methylsulfonyl)phenyl)methanone (<b>26</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 12.48 and 12.39 (br s, 1H), 8.24 (d, <i>J</i> = 8.0 Hz, 1H), 7.79–7.51 (m, 5H), 7.30–6.79 (m, 3H), 5.03 and 4.83 (d, <i>J</i> = 15.2 Hz, 1H), 4.49 and 4.41 (d, <i>J</i> = 15.6 Hz, 1H), 4.34–3.59 (m, 4H), 3.36 (s, 3H, overlapping with H<sub>2</sub>O), 2.69–2.04 (m, 2H), 1.10 and 0.99 (t, <i>J</i> = 7.6 Hz, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>26</sub>H<sub>242</sub>FN<sub>3</sub>O<sub>4</sub>S, found 494.0 (MH<sup>+</sup>).</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (7-(6-Aminopyridin-3-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(4-(methylsulfonyl)phenyl)methanone (<b>27</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 8.23 (br s, 1H), 8.04–7.97 (m, 2H), 7.70–7.64 (m, 2H), 7.56 and 6.72 (s, 1H), 7.50–7.40 (m, 2H), 7.05 and 7.01 (d, <i>J</i> = 8.8 Hz, 1H), 6.53 and 6.46 (d, <i>J</i> = 8.8 Hz, 1H), 6.05 (s, 2H), 4.84 and 4.47 (s, 2H), 4.24 and 4.12 (br s, 2H), 4.03 and 3.70 (br s, 2H), 3.28 and 3.26 (s, 3H). MS (EI): <i>m</i>/<i>z</i> for C<sub>22</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>S, found 424.0 (MH<sup>+</sup>).</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (7-(6-Aminopyridin-3-yl)-2,3-dihydrobenz[<i>f</i>][1,4]oxazepin-4(5<i>H</i>)-yl)(3-fluoro-2-methyl-4-(methylsulfonyl)phenyl)methanone (<b>28</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (rotamers are observed) 8.24 and 8.03 (d, <i>J</i> = 2.4 Hz, 1H), 7.77 and 7.72 (t, <i>J</i> = 7.6 Hz, 1H), 7.71–7.39 (m, 2H), 7.57 and 6.63 (d, <i>J</i> = 2.4 Hz, 1H), 7.28 and 7.19 (d, <i>J</i> = 7.6 Hz, 1H), 7.04 and 7.02 (d, <i>J</i> = 8.0 Hz, 1H), 6.52 and 6.46 (d, <i>J</i> = 8.8 Hz, 1H), 6.05 (br s, 2H), 4.93–4.31 (m, 2H), 4.28–3.56 (m, 4H), 3.37 and 3.34 (s, 3H), 2.12 and 1.77 (d, <i>J</i> = 1.6 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.3, 167.2, 166.6, 166.6, 158.9, 158.9, 158.4, 158.4, 157.4, 157.2, 155.9, 155.8, 145.4, 145.1, 145.1, 144.0, 143.9, 135.0, 134.7, 132.9, 132.8, 129.4, 129.2, 128.2, 128.2, 128.1, 128.0, 127.0, 126.9, 126.8, 125.9, 125.6, 125.4, 123.6, 123.5, 123.3, 123.1, 122.8, 122.0, 122.0, 121.9, 121.9, 121.2, 120.7, 107.8, 107.8, 70.9, 70.8, 51.1, 51.1, 47.4, 46.5, 43.5, 43.5, 43.5, 43.4, 11.0, 10.9, 10.7, 10.6. IR (KBr pellet): 1623, 1487, 1457, 1423, 1385, 1314, 1269, 1226, 1193, 1144, 1133, 1054, 1031, 962, 821, 768 cm<sup>–1</sup>. Mp: 204–205 °C. MS (EI): <i>m</i>/<i>z</i> for C<sub>23</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>4</sub>S, 456.0 (MH<sup>+</sup>). High-resolution MS (FAB MS using glycerol as the matrix): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>4</sub>S 456.13878, found 456.13943.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> mTOR ELISA Assay</h3><div class="NLM_p last">The measurement of mTOR enzyme activity was performed in an ELISA format following the phosphorylation of 4E-BP1 protein. All experiments were performed in the 384-well format. Generally, 0.5 μL of DMSO containing varying concentrations of the test compound was mixed with 15 μL of the enzyme solution. Kinase reactions were initiated with the addition of 15 μL of a solution containing the substrate. The assay conditions were as follows: 0.2 nM mTOR, 10 μM ATP, and 50 nM NHis-tagged 4E-BP1 in 20 mM Hepes, pH 7.2, 1 mM DTT, 50 mM NaCl, 10 mM MnCl<sub>2</sub>, 0.02 mg/mL BSA, 0.01% CHAPS, 50 mM β-glycerophophate. Following an incubation of 120 min at ambient temperature, 20 μL of the reaction mixture was transferred to a Ni-chelate-coated 384-well plate. The binding step of the 4E-BP1 protein proceeded for 60 min, followed by washing four times each with 50 μL of Tris-buffered saline solution (TBS). Anti-phospho-4E-BP1 rabbit immunoglobulin G (IgG; 20 μL, 1:5000) in 5% BSA–TBST (0.2% Tween-20 in TBS) was added, and the reaction mixuture was further incubated for 60 min. Incubation with a secondary horseradish peroxidase (HRP)-tagged anti-IgG was similarly performed after the primary antibody was washed off (four washes of 50 μL). Following the final wash step with TBST, 20 μL of SuperSignal ELISA Femto (Pierce Biotechnology, 37075) was added and the luminescence measured using an EnVision plate reader. Data are reported as the mean (<i>n</i> ≥ 2).</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> PI3Kα Biochemical Assay</h3><div class="NLM_p last">PI3Kα activity is measured as the percentage of ATP consumed following the kinase reaction using luciferase–luciferin-coupled chemiluminescence. Reactions were conducted in 384-well white, medium-binding microtiter plates (Greiner). Kinase reactions were initiated by combining test compounds, ATP, substrate (PIP2), and kinase in a 20 μL volume in a buffer solution. The standard PI3Kα assay buffer is composed of 50 mM Tris, pH 7.5, 1 mM EGTA, 10 mM MgCl<sub>2</sub>, 1 mM DTT, and 0.03% CHAPS. The standard assay concentrations for enzyme, ATP, and substrate are 1.5 nM, 1 μM, and 10 μM, respectively. The reaction mixture was incubated at ambient temperature for approximately 2 h. Following the kinase reaction, a 10 μL aliquot of luciferase–luciferin mix (Promega Kinase-Glo) was added and the chemiluminescence signal measured using a Victor2 plate reader (Perkin-Elmer). Total ATP consumption was limited to 40–60%, and the IC<sub>50</sub> values of the control compounds correlated well with literature references. Data are reported as the mean (<i>n</i> ≥ 2).</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> pS6 (S240/244) ELISA</h3><div class="NLM_p last">PC-3 cells (ATCC) were seeded onto 96-well plates (Corning, 3904) in DMEM (Cellgro) containing 10% FBS (Cellgro), 1% NEAA (Cellgro), and 1% penicillin–streptomycin (Cellgro) at 8 × 10<sup>3</sup> cells per well. The cells were incubated at 37 °C and 5% CO<sub>2</sub> for 48 h, and the growth medium was replaced with serum-free DMEM. Serial dilutions of the test compound in 0.3% DMSO (vehicle) were added to the cells and incubated for 3 h. To fix the cells, medium was removed and 100 μL/well of 4% formaldehyde (Sigma) in TBS was added to each well at ambient temperature for 30 min. The cells were washed three times with 200 μL of TBST and quenched with 100 μL of 0.6% H<sub>2</sub>O<sub>2</sub> (VWR International) in TBST for 30 min at ambient temperature. The plates were washed three times with 200 μL of TBST and blocked with 100 μL of 5% BSA (Jackson ImmunoResearch) in TBST for 1 h at ambient temperature. Anti-pS6 (S240/244) antibody (Cell Signaling Technology, 2215) or anti-total-S6 antibody (Cell Signaling Technology, 2217) was diluted 1:500 in 5% BSA in TBST. A 50 μL volume of either primary antibody solution was added to the plate to detect pS6 or total S6. After incubation overnight at 4 °C, the plates were washed four times with 200 μL of TBST. Goat antirabbit secondary antibody (Jackson ImmunoResearch) was diluted at 1:15000 in 5% BSA in TBST. A 100 μL volume of antibody solution was added to each well and incubated for 1 h at ambient temperature. The plates were washed three times with 200 μL of TBST and two times with 200 μL of TBS. Chemiluminescent substrate (SuperSignal Elisa Femto) was prepared at rt. A 100 μL volume of chemiluminescent substrate per well was added, and then the plate was shaken for 1 min. Luminescence was read immediately on a Wallac plate reader at a wavelength of 560 nm. After normalization of the pS6 signal to a total S6 signal, IC<sub>50</sub> values were determined relative to the DMSO-treated control. Data are reported as the mean (<i>n</i> ≥ 2).</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> pAKT (S473) ELISA</h3><div class="NLM_p last">PC-3 cells (ATCC) were seeded onto 96-well plates (Corning, 3904) in DMEM (Cellgro, 10-013-CV) containing 10% FBS (Cellgro, 35-016-CV), 1% NEAA (Cellgro, 25-025-CI), and 1% penicillin–streptomycin (Cellgro, 30-002-CI) at 8 × 10<sup>3</sup> cells per well. The cells were incubated at 37 °C and 5% CO<sub>2</sub> for 48 h, and the growth medium was replaced with serum-free DMEM. Serial dilutions of the test compound in 0.3% DMSO (vehicle) were added to the cells and incubated for 2 h and 50 min. The cells were then stimulated for 10 min with 20 ng/mL EGF (US Biologicals, E3374-07A)) for PC-3 or with 1.2 μg/mL Long R<sup>3</sup> IGF-1 (Sigma, I1271) for MCF-7. To fix the cells, medium was removed and 100 μL/well of 4% formaldehyde (Sigma, F8775) in TBS (20 mM Tris, 500 mM NaCl) was added to each well at ambient temperature for 30 min. The cells were washed three times with 200 μL of TBS containing 0.1% Tween 20 (Bio-Rad, 170-6351) (TBST) and quenched with 100 μL of 0.6% H<sub>2</sub>O<sub>2</sub> (VWR International, VW3742-1) in TBST for 30 min at rt. The plates were washed three times with 200 μL of TBST and blocked with 100 μL of 5% BSA (Jackson ImmunoResearch, 001-000-173) in TBST for 1 h at rt. Anti-pAKT (S473) antibody (Cell Signaling Technology, 4058) or anti-total-AKT antibody (Cell Signaling Technology, 9272) was diluted 1:400 or 1:500, respectively, in 5% BSA in TBST. A 50 μL volume of either primary antibody solution was added to the plate to detect pAKT (S473) or total AKT. After incubation overnight at 4 °C, the plates were washed four times with 200 μL of TBST. Goat antirabbit secondary antibody (Jackson ImmunoResearch, 111-035-003) was diluted at 1:15000 in 5% BSA in TBST. A 100 μL volume of antibody solution was added to each well and incubated for 1 h at ambient temperature. The plates were washed three times with 200 μL of TBST and two times with 200 μL of TBS. Chemiluminescent substrate (SuperSignal Elisa Femto) was prepared at rt. A 100 μL volume of chemiluminescent substrate per well was added, and then the plate was shaken for 1 min. Luminescence was read immediately on a Wallac plate reader at a wavelength of 560 nm. After normalization of the pAKT signal to a total AKT signal, IC<sub>50</sub> values were determined relative to the DMSO-treated control. Data are reported as the mean (<i>n</i> ≥ 2).</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> In Vivo Pharmacokinetic Studies</h3><div class="NLM_p last">Pharmacokinetic studies of <b>28</b> were determined in female athymic nude mice, female CD rats, male beagle dogs, and male cynomolgus monkeys. Compound <b>28</b> was administered intravenously and by oral gavage at 10 mg/kg as a solution formulated in EPW (5% ethanol/45% PEG400/water + 1:2 HCl (m/m)) to mice, 3 mg/kg as a solution formulated in EPW (5% ethanol/45% PEG400/water + 1:2 HCl (m/m)) to CD rats and male beagle dogs, and 3 mg/kg as a solution formulated in EPW (5% ethanol/45% PEG400/water + 1:1.5 HCl (m/m)) to male cynomolgus monkeys. The plasma levels of <b>28</b> were monitored over a 24 h period.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> In Vivo Pharmacodynamic Studies</h3><div id="sec4_45_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> PC-3 Prostate Adenocarcinoma Model</h4><div class="NLM_p last">PC-3 human prostate adenocarcinoma cells were cultured in vitro in DMEM (Mediatech) supplemented with 20% fetal bovine serum (Hyclone), penicillin–streptomycin, and nonessential amino acids at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere. On day 0, cells were harvested by trypsinization, and 3 × 10<sup>6</sup> cells (passages 10–14, >95% viability) in 0.1 mL of ice-cold Hank’s balanced salt solution were implanted subcutaneously into the hindflank of 5–8 week old male nude mice. When the tumors reached 200–500 mg in size, the mice were administered a single dose of <b>28</b>. Scheduled takedown was at 4 h after a single dose. PC-3 tumor lysate was pooled for each group. Phosphor-AKT (S473), phosphor-AKT (T308), phosphor-p70S6K (T389), phosphor-S6 (S240/244), and phosphor-4E-BP1 (T37/46) levels were analyzed by Western immunoblotting and normalized to α-tubulin. α-Tubulin levels were analyzed by Western immunoblotting from the same membrane as the p-S6 and p-4E-BP1 blots.</div></div><div id="sec4_45_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> MCF-7 Breast Adenocarcinama Model</h4><div class="NLM_p last">MCF-7 human mammary adenocarcinoma cells were cultured in vitro in DMEM (Cellgro) supplemented with 10% fetal bovine serum (Cellgro), penicillin–streptomycin, and nonessential amino acids at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere. On day 0, cells were harvested by trypsinization, and 5 × 10<sup>6</sup> cells in 0.1 mL of a solution made of 50% cold Hank’s balanced salt solution with 50% growth factor reduced matrigel (Becton Dickinson) were implanted subcutaneously into the hindflank of 5–8 week old female nude mice. When the tumors reached 40–150 mg in size, the mice were administered a single dose of <b>28</b>. Scheduled takedown was at 4 h after a single dose. MCF-7 tumor lysate was pooled for each group. Phosphor-AKT (S473), phosphor-AKT (T308), phosphor-p70S6K (T389), phosphor-S6 (S240/244), and phosphor-4E-BP1 (T37/46) levels were analyzed by Western immunoblotting and normalized to α-tubulin. α-Tubulin levels were analyzed by Western immunoblotting from the same membrane as the p-S6 and p-4E-BP1 blots.</div></div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Antitumor (MCF-7 Model) Efficacy Studies</h3><div class="NLM_p last">Female athymic nude mice (NCr) 5–8 weeks of age and weighing approximately 20–25 g were used. Prior to initiation of study, the animals were allowed to acclimate for a minimum of 48 h. During these studies, the animals were provided food and water ad libitum and housed in a room conditioned at 70–75 °F and 60% relative humidity. A 12 h light and 12 h dark cycle was maintained with automatic timers. MCF-7 tumors were established subcutaneously and staged when the average tumor mass reached 100–200 mg. Compound <b>28</b> was orally administered as a solution/fine suspension in water (with a 1:1 molar ratio of 1 N HCl) qd at 50 and 100 mg/kg for 14 days. Tumor mass was determined by measuring perpendicular diameters with a caliper, using the following formula: tumor mass (mg) = [tumor volume = length (mm) × width<sup>2</sup> (mm<sup>2</sup>)]/2. During the period of study, tumor masses were determined twice weekly and body masses were recorded daily. All animals were examined daily for compound-induced or tumor-related deaths.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm3007933" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40757" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40757" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Byung Gyu Kim</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1a78636f747d7d636f2d287173775a7d777b7376347975773a706d767f7b72635a6f697c347f7e6f"><span class="__cf_email__" data-cfemail="02607b776c65657b773530696b6f42656f636b6e2c616d6f">[email protected]</span> <span class="__cf_email__" data-cfemail="6f0518030a0e07162f1a1c09410a0b1a">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James W. Leahy</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#57352e223930302e2260653c3e3a17303a363e3b7934383a773d203b32363f2e1722243179323322"><span class="__cf_email__" data-cfemail="f19388849f96968884c6c39a989cb1969c90989ddf929e9c">[email protected]</span> <span class="__cf_email__" data-cfemail="6208150e07030a1b221711044c070617">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig S. Takeuchi</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles M. Blazey</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sunghoon Ma</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henry W. B. Johnson</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neel K. Anand</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arlyn Arcalas</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tae Gon Baik</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chris A. Buhr</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonah Cannoy</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sergey Epshteyn</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anagha Joshi</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine Lara</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew S. Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Longcheng Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John M. Nuss</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naing Aay</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ron Aoyama</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Foster</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jae Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabelle Lehoux</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Narsimha Munagala</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arthur Plonowski</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sharmila Rajan</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Woolfrey</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyoko Yamaguchi</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Lamb</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicole Miller</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery, Exelixis, 169 Harbor
Way, South San Francisco, California 94083, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2982e4941-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71373" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71373" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Siamak Dailami for analytical support, Annapurna Sapre and Eric Brooks for conducting the biochemical assay, Jing Ping Yang, Peter Kim, Qiang Wu, Torsten Trowe, Suzanne Crawley, Keith Calkins, Eun Ok Kim, Suresh Selvaraj, and Loan Hoang for executing cell-based assays, Lory Tan, John Bui, Kendra Kim, Arturo Picones, Jing Wang, Shineal Patel, and Xiang Wu for collecting the reported ADME data, and Atulkumar Ramaiya, Scott Womble, Michael F. Yakes, Joshua Tanguay, and Scott Lam for obtaining PK and conducting PD/efficacy studies.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i61" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i61"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i62" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i62"> Abbreviations Used</h2><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">Akt</td><td class="NLM_def"><p class="first last">v-akt murine thymoma viral oncogene homologue 1</p></td></tr><tr><td class="NLM_term">DNA-PK</td><td class="NLM_def"><p class="first last">DNA-activated protein kinase</p></td></tr><tr><td class="NLM_term">ATM</td><td class="NLM_def"><p class="first last">ataxia telangiectasia mutated kinase</p></td></tr><tr><td class="NLM_term">4E-BP1</td><td class="NLM_def"><p class="first last">eukaryotic translationa initiation factor 4E binding protein</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsom</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05053" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05053" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Bjornsti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, P. J.</span><span> </span><span class="NLM_article-title">The TOR Pathway: A Target for Cancer Therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1038%2Fnrc1362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=15122205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFSlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=335-348&author=M.+A.+Bjornstiauthor=P.+J.+Houghton&title=The+TOR+Pathway%3A+A+Target+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The TOR pathway: a target for cancer therapy</span></div><div class="casAuthors">Bjornsti, Mary-Ann; Houghton, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">335-348</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rapamycin, a macrocyclic lactone, is a highly specific inhibitor of the Ser/threonine protein kinase target of rapamycin (TOR).  Although it is clear that TOR controls initiation of protein translation, recent results indicate that TOR is a central controller, integrating a plethora of signalling pathways that respond to growth factors and nutritional status.  In addn. to the role of rapamycin as an immune suppressant, emerging data indicate that genetic and metabolic changes accompanying malignant transformation might cause hypersensitivity to TOR inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqivgUxs8RJPLVg90H21EOLACvtfcHk0lgu9hJ4cRXrow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFSlu7Y%253D&md5=40cc8442a8f8f8c19f776af5d8ed3772</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc1362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1362%26sid%3Dliteratum%253Aachs%26aulast%3DBjornsti%26aufirst%3DM.%2BA.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520TOR%2520Pathway%253A%2520A%2520Target%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D335%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the Role of mTOR in Cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+Role+of+mTOR+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520Role%2520of%2520mTOR%2520in%2520Cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">mTOR as a Target for Cancer Therapy</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=339-359&author=P.+J.+Houghtonauthor=S.+Huang&title=mTOR+as+a+Target+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DmTOR%2520as%2520a%2520Target%2520for%2520Cancer%2520Therapy%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2004%26volume%3D279%26spage%3D339%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Inoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradetti, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, K. L.</span><span> </span><span class="NLM_article-title">Dysregulation of the TSC-mTOR Pathway in Human Disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1038%2Fng1494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=15624019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFChsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=19-24&author=K.+Inokiauthor=M.+N.+Corradettiauthor=K.+L.+Guan&title=Dysregulation+of+the+TSC-mTOR+Pathway+in+Human+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulation of the TSC-mTOR pathway in human disease</span></div><div class="casAuthors">Inoki, Ken; Corradetti, Michael N.; Guan, Kun-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-24</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) has a central role in the regulation of cell growth. mTOR receives input from multiple signaling pathways, including growth factors and nutrients, to stimulate protein synthesis by phosphorylating key translation regulators such as ribosomal S6 kinase and eukaryote initiation factor 4E binding protein 1.  High levels of dysregulated mTOR activity are assocd. with several hamartoma syndromes, including tuberous sclerosis complex, the PTEN-related hamartoma syndromes and Peutz-Jeghers syndrome.  These disorders are all caused by mutations in tumor-suppressor genes that neg. regulate mTOR.  Here we discuss the emerging evidence for a functional relationship between the mTOR signaling pathway and several genetic diseases, and we present evidence supporting a model in which dysregulation of mTOR may be a common mol. basis, not only for hamartoma syndromes, but also for other cellular hypertrophic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcM0DjY6r9LVg90H21EOLACvtfcHk0lgu9hJ4cRXrow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFChsL3M&md5=7cc3c4b4f1b02265816de0737a078fc7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fng1494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1494%26sid%3Dliteratum%253Aachs%26aulast%3DInoki%26aufirst%3DK.%26aulast%3DCorradetti%26aufirst%3DM.%2BN.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26atitle%3DDysregulation%2520of%2520the%2520TSC-mTOR%2520Pathway%2520in%2520Human%2520Disease%26jtitle%3DNat.%2520Genet.%26date%3D2005%26volume%3D37%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Jiang, Y. −P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballou, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, R. Z.</span><span> </span><span class="NLM_article-title">Rapamycin-Insensitive Regulation of 4E-BP1 in Regenerating Rat Liver</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">10943</span><span class="NLM_x">–</span> <span class="NLM_lpage">10951</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=10943-10951&author=Y.+%E2%88%92P.+Jiangauthor=L.+M.+Ballouauthor=R.+Z.+Lin&title=Rapamycin-Insensitive+Regulation+of+4E-BP1+in+Regenerating+Rat+Liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%2B%25E2%2588%2592P.%26aulast%3DBallou%26aufirst%3DL.%2BM.%26aulast%3DLin%26aufirst%3DR.%2BZ.%26atitle%3DRapamycin-Insensitive%2520Regulation%2520of%25204E-BP1%2520in%2520Regenerating%2520Rat%2520Liver%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D10943%26epage%3D10951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Boylan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruppuso, P. A.</span><span> </span><span class="NLM_article-title">Ribosomal Protein S6 Phosphorylation and Function during Late Gestation Liver Development in the Rat</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">44457</span><span class="NLM_x">–</span> <span class="NLM_lpage">44463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=44457-44463&author=J.+M.+Boylanauthor=P.+Anandauthor=P.+A.+Gruppuso&title=Ribosomal+Protein+S6+Phosphorylation+and+Function+during+Late+Gestation+Liver+Development+in+the+Rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoylan%26aufirst%3DJ.%2BM.%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DGruppuso%26aufirst%3DP.%2BA.%26atitle%3DRibosomal%2520Protein%2520S6%2520Phosphorylation%2520and%2520Function%2520during%2520Late%2520Gestation%2520Liver%2520Development%2520in%2520the%2520Rat%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D44457%26epage%3D44463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">An ATP Competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-Resistant Functions of mTORC1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">–</span> <span class="NLM_lpage">8032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8023-8032&author=C.+C.+Thoreenauthor=S.+A.+Kangauthor=J.+W.+Changauthor=Q.+Liuauthor=J.+Zhangauthor=Y.+Gaoauthor=L.+J.+Reichlingauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=An+ATP+Competitive+Mammalian+Target+of+Rapamycin+Inhibitor+Reveals+Rapamycin-Resistant+Functions+of+mTORC1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DAn%2520ATP%2520Competitive%2520Mammalian%2520Target%2520of%2520Rapamycin%2520Inhibitor%2520Reveals%2520Rapamycin-Resistant%2520Functions%2520of%2520mTORC1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8023%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outpurs of mTORC1 and mTORC2</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=371-383&author=M.+E.+Feldmanauthor=B.+Apselauthor=A.+Uotilaauthor=R.+Loewithauthor=Z.+A.+Knightauthor=D.+Ruggeroauthor=K.+M.+Shokat&title=Active-Site+Inhibitors+of+mTOR+Target+Rapamycin-Resistant+Outpurs+of+mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DUotila%26aufirst%3DA.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DActive-Site%2520Inhibitors%2520of%2520mTOR%2520Target%2520Rapamycin-Resistant%2520Outpurs%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D371%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Finger, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blenis, J.</span><span> </span><span class="NLM_article-title">Mammalian Cell Size Is Controlled by mTOR and Its Downstream Targets S6K1 and 4EBP1/eIF4E</span> <span class="citation_source-journal">Gene Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1472</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=1472-1487&author=D.+C.+Fingerauthor=S.+Salamaauthor=C.+Tsouauthor=E.+Harlowauthor=J.+Blenis&title=Mammalian+Cell+Size+Is+Controlled+by+mTOR+and+Its+Downstream+Targets+S6K1+and+4EBP1%2FeIF4E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinger%26aufirst%3DD.%2BC.%26aulast%3DSalama%26aufirst%3DS.%26aulast%3DTsou%26aufirst%3DC.%26aulast%3DHarlow%26aufirst%3DE.%26aulast%3DBlenis%26aufirst%3DJ.%26atitle%3DMammalian%2520Cell%2520Size%2520Is%2520Controlled%2520by%2520mTOR%2520and%2520Its%2520Downstream%2520Targets%2520S6K1%2520and%25204EBP1%252FeIF4E%26jtitle%3DGene%2520Dev.%26date%3D2002%26volume%3D16%26spage%3D1472%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Finger, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tee, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheatham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blenis, J.</span><span> </span><span class="NLM_article-title">mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eurkaryotic Translation Initiation Factor 4E</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1128%2FMCB.24.1.200-216.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=14673156" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=200-216&author=D.+C.+Fingerauthor=C.+J.+Richardsonauthor=A.+R.+Teeauthor=L.+Cheathamauthor=C.+Tsouauthor=J.+Blenis&title=mTOR+Controls+Cell+Cycle+Progression+through+Its+Cell+Growth+Effectors+S6K1+and+4E-BP1%2FEurkaryotic+Translation+Initiation+Factor+4E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.1.200-216.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.1.200-216.2004%26sid%3Dliteratum%253Aachs%26aulast%3DFinger%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DC.%2BJ.%26aulast%3DTee%26aufirst%3DA.%2BR.%26aulast%3DCheatham%26aufirst%3DL.%26aulast%3DTsou%26aufirst%3DC.%26aulast%3DBlenis%26aufirst%3DJ.%26atitle%3DmTOR%2520Controls%2520Cell%2520Cycle%2520Progression%2520through%2520Its%2520Cell%2520Growth%2520Effectors%2520S6K1%2520and%25204E-BP1%252FEurkaryotic%2520Translation%2520Initiation%2520Factor%25204E%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D200%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagley, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markhard, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=159-168&author=D.+D.+Sarbassovauthor=S.+M.+Aliauthor=S.+Senguptaauthor=J.+H.+Sheenauthor=P.+P.+Hsuauthor=A.+F.+Bagleyauthor=A.+L.+Markhardauthor=D.+M.+Sabatini&title=Prolonged+Rapamycin+Treatment+Inhibits+mTORC2+Assembly+and+Akt%2FPKB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DSheen%26aufirst%3DJ.%2BH.%26aulast%3DHsu%26aufirst%3DP.%2BP.%26aulast%3DBagley%26aufirst%3DA.%2BF.%26aulast%3DMarkhard%26aufirst%3DA.%2BL.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DProlonged%2520Rapamycin%2520Treatment%2520Inhibits%2520mTORC2%2520Assembly%2520and%2520Akt%252FPKB%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D22%26spage%3D159%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Choo, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blenis, J.</span><span> </span><span class="NLM_article-title">Rapamycin Differentially Inhibits S6Ks and 4E-BP1 To Mediate Cell-Type-Specific Repression of mRNA Translation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">17414</span><span class="NLM_x">–</span> <span class="NLM_lpage">17419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17414-17419&author=A.+Y.+Chooauthor=S.+O.+Yoonauthor=S.+G.+Kimauthor=P.+P.+Rouxauthor=J.+Blenis&title=Rapamycin+Differentially+Inhibits+S6Ks+and+4E-BP1+To+Mediate+Cell-Type-Specific+Repression+of+mRNA+Translation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DA.%2BY.%26aulast%3DYoon%26aufirst%3DS.%2BO.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DRoux%26aufirst%3DP.%2BP.%26aulast%3DBlenis%26aufirst%3DJ.%26atitle%3DRapamycin%2520Differentially%2520Inhibits%2520S6Ks%2520and%25204E-BP1%2520To%2520Mediate%2520Cell-Type-Specific%2520Repression%2520of%2520mRNA%2520Translation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D17414%26epage%3D17419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">The Pharmacology of mTOR Inhibition</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1126%2Fscisignal.267pe24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=19318623" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=1-6&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=The+Pharmacology+of+mTOR+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.267pe24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.267pe24%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DThe%2520Pharmacology%2520of%2520mTOR%2520Inhibition%26jtitle%3DSci.%2520Signaling%26date%3D2009%26volume%3D2%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">PI 3-Kinase Related Kinases: “Big” Players in Stress-Induced Signaling Pathways</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=883-887&author=R.+T.+Abraham&title=PI+3-Kinase+Related+Kinases%3A+%E2%80%9CBig%E2%80%9D+Players+in+Stress-Induced+Signaling+Pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DPI%25203-Kinase%2520Related%2520Kinases%253A%2520%25E2%2580%259CBig%25E2%2580%259D%2520Players%2520in%2520Stress-Induced%2520Signaling%2520Pathways%26jtitle%3DDNA%2520Repair%26date%3D2004%26volume%3D3%26spage%3D883%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamburini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viguie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ifrah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyfus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouscary, D.</span><span> </span><span class="NLM_article-title">PI-103, a Dual Inhibitor of Class IA Phosphatidylinositide 3-Kinase and mTOR, Has Antileukemic Activity in AML</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1698</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1698-1706&author=S.+Parkauthor=N.+Chapuisauthor=V.+Bardetauthor=J.+Tamburiniauthor=N.+Gallayauthor=L.+Willemsauthor=Z.+A.+Knightauthor=K.+M.+Shokatauthor=N.+Azarauthor=F.+Viguieauthor=N.+Ifrahauthor=F.+Dreyfusauthor=P.+Mayeuxauthor=C.+Lacombeauthor=D.+Bouscary&title=PI-103%2C+a+Dual+Inhibitor+of+Class+IA+Phosphatidylinositide+3-Kinase+and+mTOR%2C+Has+Antileukemic+Activity+in+AML"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%26aulast%3DChapuis%26aufirst%3DN.%26aulast%3DBardet%26aufirst%3DV.%26aulast%3DTamburini%26aufirst%3DJ.%26aulast%3DGallay%26aufirst%3DN.%26aulast%3DWillems%26aufirst%3DL.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DAzar%26aufirst%3DN.%26aulast%3DViguie%26aufirst%3DF.%26aulast%3DIfrah%26aufirst%3DN.%26aulast%3DDreyfus%26aufirst%3DF.%26aulast%3DMayeux%26aufirst%3DP.%26aulast%3DLacombe%26aufirst%3DC.%26aulast%3DBouscary%26aufirst%3DD.%26atitle%3DPI-103%252C%2520a%2520Dual%2520Inhibitor%2520of%2520Class%2520IA%2520Phosphatidylinositide%25203-Kinase%2520and%2520mTOR%252C%2520Has%2520Antileukemic%2520Activity%2520in%2520AML%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D1698%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Serra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaltriti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, P. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botero, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llonch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atzori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosimo, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span> </span><span class="NLM_article-title">NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">8022</span><span class="NLM_x">–</span> <span class="NLM_lpage">8030</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1158%2F0008-5472.CAN-08-1385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=18829560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2msLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=8022-8030&author=V.+Serraauthor=B.+Markmanauthor=M.+Scaltritiauthor=P.+J.+A.+Eichhornauthor=V.+Valeroauthor=M.+Guzmanauthor=M.+L.+Boteroauthor=E.+Llonchauthor=F.+Atzoriauthor=S.+D.+Cosimoauthor=M.+Mairaauthor=C.+Carcia-Echeverriaauthor=J.+L.+Parraauthor=J.+Arribasauthor=J.+Baselga&title=NVP-BEZ235%2C+a+Dual+PI3K%2FmTOR+Inhibitor%2C+Prevents+PI3K+Signaling+and+Inhibits+the+Growth+of+Cancer+Cells+with+Activating+PI3K+Mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations</span></div><div class="casAuthors">Serra, Violeta; Markman, Ben; Scaltriti, Maurizio; Eichhorn, Pieter J. A.; Valero, Vanesa; Guzman, Marta; Botero, Maria Luisa; Llonch, Elisabeth; Atzori, Francesco; Di Cosimo, Serena; Maira, Michel; Garcia-Echeverria, Carlos; Parra, Josep Lluis; Arribas, Joaquin; Baselga, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8022-8030</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) pathway deregulation is a common event in human cancer, either through inactivation of the tumor suppressor phosphatase and tensin homolog deleted from chromosome 10 or activating mutations of p110-α.  These hotspot mutations result in oncogenic activity of the enzyme and contribute to therapeutic resistance to the anti-HER2 antibody trastuzumab.  The PI3K pathway is, therefore, an attractive target for cancer therapy.  We have studied NVP-BEZ235, a dual inhibitor of the PI3K and the downstream mammalian target of rapamycin (mTOR).  NVP-BEZ235 inhibited the activation of the downstream effectors Akt, S6 ribosomal protein, and 4EBP1 in breast cancer cells.  The antiproliferative activity of NVP-BEZ235 was superior to the allosteric selective mTOR complex inhibitor everolimus in a panel of 21 cancer cell lines of different origin and mutation status.  The described Akt activation due to mTOR inhibition was prevented by higher doses of NVP-BEZ235.  NVP-BEZ235 reversed the hyperactivation of the PI3K/mTOR pathway caused by the oncogenic mutations of p110-α, E545K, and H1047R, and inhibited the proliferation of HER2-amplified BT474 cells exogenously expressing these mutations that render them resistant to trastuzumab.  In trastuzumab-resistant BT474 H1047R breast cancer xenografts, NVP-BEZ235 inhibited PI3K signaling and had potent antitumor activity.  In treated animals, there was complete inhibition of PI3K signaling in the skin at pharmacol. active doses, suggesting that skin may serve as surrogate tissue for pharmacodynamic studies.  In summary, NVP-BEZ235 inhibits the PI3K/mTOR axis and results in antiproliferative and antitumoral activity in cancer cells with both wild-type and mutated p110-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlC_vqzWMDk7Vg90H21EOLACvtfcHk0lhuJRdj-Cuzdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2msLrK&md5=b5d08e989c1b619e3c0ee9437002afd7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-1385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-1385%26sid%3Dliteratum%253Aachs%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DMarkman%26aufirst%3DB.%26aulast%3DScaltriti%26aufirst%3DM.%26aulast%3DEichhorn%26aufirst%3DP.%2BJ.%2BA.%26aulast%3DValero%26aufirst%3DV.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DBotero%26aufirst%3DM.%2BL.%26aulast%3DLlonch%26aufirst%3DE.%26aulast%3DAtzori%26aufirst%3DF.%26aulast%3DCosimo%26aufirst%3DS.%2BD.%26aulast%3DMaira%26aufirst%3DM.%26aulast%3DCarcia-Echeverria%26aufirst%3DC.%26aulast%3DParra%26aufirst%3DJ.%2BL.%26aulast%3DArribas%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DNVP-BEZ235%252C%2520a%2520Dual%2520PI3K%252FmTOR%2520Inhibitor%252C%2520Prevents%2520PI3K%2520Signaling%2520and%2520Inhibits%2520the%2520Growth%2520of%2520Cancer%2520Cells%2520with%2520Activating%2520PI3K%2520Mutations%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D8022%26epage%3D8030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span> </span><span class="NLM_article-title">Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7579</span><span class="NLM_x">–</span> <span class="NLM_lpage">7587</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2009327" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Ort7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7579-7587&author=D.+P.+Sutherlinauthor=L.+Baoauthor=M.+Berryauthor=G.+Castanedoauthor=I.+Chuckowreeauthor=J.+Dostonauthor=A.+Folkesauthor=L.+Freidmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Murrayauthor=J.+Nonomiyaauthor=J.+Pangauthor=N.+Peggauthor=W.+W.+Priorauthor=L.+Rougeauthor=L.+Salphatiauthor=D.+Sampathauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=B.+Weiauthor=C.+Wiesmannauthor=P.+Wuauthor=B.+Zhuauthor=A.+Olivero&title=Discovery+of+a+Potent%2C+Selective%2C+and+Orally+Available+Class+I+Phosphatidylinositol+3-Kinase+%28PI3K%29%2FMammalian+Target+of+Rapamycin+%28mTOR%29+Kinase+Inhibitor+%28GDC-0980%29+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer</span></div><div class="casAuthors">Sutherlin, Daniel P.; Bao, Linda; Berry, Megan; Castanedo, Georgette; Chuckowree, Irina; Dotson, Jenna; Folks, Adrian; Friedman, Lori; Goldsmith, Richard; Gunzner, Janet; Heffron, Timothy; Lesnick, John; Lewis, Cristina; Mathieu, Simon; Murray, Jeremy; Nonomiya, Jim; Pang, Jodie; Pegg, Niel; Prior, Wei Wei; Rouge, Lionel; Salphati, Laurent; Sampath, Deepak; Tian, Qingping; Tsui, Vickie; Wan, Nan Chi; Wang, Shumei; Wei, Bin Qing; Wiesmann, Christian; Wu, Ping; Zhu, Bing-Yan; Olivero, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7579-7587</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of 2 (GDC-0980, I), a class I PI3K and mTOR kinase inhibitor for oncol. indications, is described. mTOR inhibition was added to the class I PI3K inhibitor 1 (GDC-0941) scaffold primarily through the substitution of the indazole in 1 for a 2-aminopyrimidine.  This substitution also increased the microsomal stability and the free fraction of compds. as evidenced through a pairwise comparison of mols. that were otherwise identical.  Highlighted in detail are analogs of an advanced compd. 4 that were designed to improve soly., resulting in 2.  This compd., is potent across PI3K class I isoforms with IC50s of 5, 27, 7, and 14 nM for PI3Kα, β, δ, and γ, resp., inhibits mTOR with a Ki of 17 nM yet is highly selective vs. a large panel of kinases including others in the PIKK family.  On the basis of the cell potency, low clearance in mouse, and high free fraction, 2 demonstrated significant efficacy in mouse xenografts when dosed as low as 1 mg/kg orally and is currently in phase I clin. trials for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-3-5KDI509bVg90H21EOLACvtfcHk0lhuJRdj-Cuzdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Ort7%252FJ&md5=ba7ede710885b51fffa63977fc64d3f5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm2009327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2009327%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDoston%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFreidman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPegg%26aufirst%3DN.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DRouge%26aufirst%3DL.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DOlivero%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520Class%2520I%2520Phosphatidylinositol%25203-Kinase%2520%2528PI3K%2529%252FMammalian%2520Target%2520of%2520Rapamycin%2520%2528mTOR%2529%2520Kinase%2520Inhibitor%2520%2528GDC-0980%2529%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7579%26epage%3D7587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarpong, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershner, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span> </span><span class="NLM_article-title">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900028r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=39-43&author=S.+D.+Knightauthor=N.+D.+Adamsauthor=J.+L.+Burgessauthor=A.+M.+Chaudhariauthor=M.+G.+Darcyauthor=C.+A.+Donatelliauthor=J.+I.+Luengoauthor=K.+A.+Newlanderauthor=C.+A.+Parrishauthor=L.+Ridgersauthor=M.+A.+Sarpongauthor=S.+J.+Schmidtauthor=G.+S.+Van+Allerauthor=J.+D.+Carsonauthor=M.+A.+Diamondauthor=P.+A.+Elkinsauthor=C.+M.+Gardinerauthor=E.+Carverauthor=S.+A.+Gilbertauthor=R.+R.+Gontarekauthor=J.+R.+Jacksonauthor=K.+L.+Kershnerauthor=L.+Luoauthor=K.+Ragaauthor=C.+S.+Sherkauthor=C.+Sungauthor=D.+Suttonauthor=P.+J.+Tumminoauthor=R.+J.+Wegrzynauthor=K.+R.+Augerauthor=D.+Dhanak&title=Discovery+of+GSK2126458%2C+a+Highly+Potent+Inhibitor+of+PI3K+and+the+Mammalian+Target+of+Rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span></div><div class="casAuthors">Knight, Steven D.; Adams, Nicholas D.; Burgess, Joelle L.; Chaudhari, Amita M.; Darcy, Michael G.; Donatelli, Carla A.; Luengo, Juan I.; Newlander, Ken A.; Parrish, Cynthia A.; Ridgers, Lance H.; Sarpong, Martha A.; Schmidt, Stanley J.; Van Aller, Glenn S.; Carson, Jeffrey D.; Diamond, Melody A.; Elkins, Patricia A.; Gardiner, Christine M.; Garver, Eric; Gilbert, Seth A.; Gontarek, Richard R.; Jackson, Jeffrey R.; Kershner, Kevin L.; Luo, Lusong; Raha, Kaushik; Sherk, Christian S.; Sung, Chiu-Mei; Sutton, David; Tummino, Peter J.; Wegrzyn, Ronald J.; Auger, Kurt R.; Dhanak, Dashyant</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-43</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase α (PI3Kα) is a crit. regulator of cell growth and transformation, and its signaling pathway is the most commonly mutated pathway in human cancers.  The mammalian target of rapamycin (mTOR), a class IV PI3K protein kinase, is also a central regulator of cell growth, and mTOR inhibitors are believed to augment the antiproliferative efficacy of PI3K/AKT pathway inhibition. 2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide (GSK2126458, 1 (I)) has been identified as a highly potent, orally bioavailable inhibitor of PI3Kα and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.  Compd. 1 is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBH6_ywCnjCrVg90H21EOLACvtfcHk0lhuJRdj-Cuzdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D&md5=72fcca85702dba95529ac03281e0bdbc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml900028r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900028r%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DRidgers%26aufirst%3DL.%26aulast%3DSarpong%26aufirst%3DM.%2BA.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DDiamond%26aufirst%3DM.%2BA.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26aulast%3DCarver%26aufirst%3DE.%26aulast%3DGilbert%26aufirst%3DS.%2BA.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKershner%26aufirst%3DK.%2BL.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DRaga%26aufirst%3DK.%26aulast%3DSherk%26aufirst%3DC.%2BS.%26aulast%3DSung%26aufirst%3DC.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DWegrzyn%26aufirst%3DR.%2BJ.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520GSK2126458%252C%2520a%2520Highly%2520Potent%2520Inhibitor%2520of%2520PI3K%2520and%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D39%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Garcia-Martinez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">412</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=412&publication_year=2009&pages=29-42&author=J.+M.+Garcia-Martinezauthor=J.+Moranauthor=R.+G.+Clarkeauthor=A.+Grayauthor=S.+C.+Cosulichauthor=C.+M.+Chrestaauthor=D.+R.+Alessi&title=Ku-0063794+Is+a+Specific+Inhibitor+of+the+Mammalian+Target+of+Rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Martinez%26aufirst%3DJ.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DR.%2BG.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DCosulich%26aufirst%3DS.%2BC.%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKu-0063794%2520Is%2520a%2520Specific%2520Inhibitor%2520of%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%2520%2528mTOR%2529%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D412%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Biochemical, Cellular, and in Vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6232</span><span class="NLM_x">–</span> <span class="NLM_lpage">6240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6232-6240&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Shiauthor=W.+Zhangauthor=J.+Lucasauthor=B.+Shorauthor=J.+Kimauthor=J.+Verheijenauthor=K.+Curranauthor=D.+J.+Malwitzauthor=D.+C.+Coleauthor=J.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=P.+Nowakauthor=A.+Zask&title=Biochemical%2C+Cellular%2C+and+in+Vivo+Activity+of+Novel+ATP-Competitive+and+Selective+Inhibitors+of+the+Mammalian+Target+of+Rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DShor%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520Cellular%252C%2520and%2520in%2520Vivo%2520Activity%2520of%2520Novel%2520ATP-Competitive%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6232%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchlow, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, M.</span><span> </span><span class="NLM_article-title">AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with in Vitro and in Vivo Antitumor Activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=288-298&author=C.+M.+Chrestaauthor=B.+R.+Daviesauthor=I.+Hicksonauthor=T.+Hardingauthor=S.+Cosulichauthor=S.+E.+Critchlowauthor=J.+P.+Vincentauthor=R.+Ellsonauthor=D.+Jonesauthor=P.+Siniauthor=D.+Jamesauthor=Z.+Howardauthor=P.+Dudleyauthor=G.+Hughesauthor=L.+Smithauthor=S.+Maguireauthor=M.+Hummersoneauthor=K.+Malaguauthor=K.+Menearauthor=R.+Jenkinsauthor=M.+Jacobsenauthor=G.+C.+M.+Smithauthor=S.+Guichardauthor=M.+Pass&title=AZD8055+Is+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+ATP-Competitive+Mammalian+Target+of+Rapamycin+Kinase+Inhibitor+with+in+Vitro+and+in+Vivo+Antitumor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DHarding%26aufirst%3DT.%26aulast%3DCosulich%26aufirst%3DS.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DEllson%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DSini%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DZ.%26aulast%3DDudley%26aufirst%3DP.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DMaguire%26aufirst%3DS.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DJenkins%26aufirst%3DR.%26aulast%3DJacobsen%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DPass%26aufirst%3DM.%26atitle%3DAZD8055%2520Is%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520ATP-Competitive%2520Mammalian%2520Target%2520of%2520Rapamycin%2520Kinase%2520Inhibitor%2520with%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Antitumor%2520Activity%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D288%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fundo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presnot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torode, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, K. G.</span><span> </span><span class="NLM_article-title">Identification and Optimization of Novel and Selective Small Molecular Weight Kinase Inhibitors of mTOR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5898</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5898-5901&author=K.+A.+Menearauthor=S.+Gomezauthor=K.+Malaguauthor=C.+Baileyauthor=K.+Blackburnauthor=X.+Cockcroftauthor=S.+Ewenauthor=A.+Fundoauthor=A.+L.+Gallauthor=G.+Hermannauthor=L.+Sebastianauthor=M.+Sunoseauthor=T.+Presnotauthor=E.+Torodeauthor=I.+Hicksonauthor=N.+M.+Martinauthor=G.+C.+M.+Smithauthor=K.+G.+Pike&title=Identification+and+Optimization+of+Novel+and+Selective+Small+Molecular+Weight+Kinase+Inhibitors+of+mTOR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DBlackburn%26aufirst%3DK.%26aulast%3DCockcroft%26aufirst%3DX.%26aulast%3DEwen%26aufirst%3DS.%26aulast%3DFundo%26aufirst%3DA.%26aulast%3DGall%26aufirst%3DA.%2BL.%26aulast%3DHermann%26aufirst%3DG.%26aulast%3DSebastian%26aufirst%3DL.%26aulast%3DSunose%26aufirst%3DM.%26aulast%3DPresnot%26aufirst%3DT.%26aulast%3DTorode%26aufirst%3DE.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DPike%26aufirst%3DK.%2BG.%26atitle%3DIdentification%2520and%2520Optimization%2520of%2520Novel%2520and%2520Selective%2520Small%2520Molecular%2520Weight%2520Kinase%2520Inhibitors%2520of%2520mTOR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5898%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefever, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Discovery of 4-Morpholino-6-aryl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">8010</span><span class="NLM_x">–</span> <span class="NLM_lpage">8024</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9013828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=8010-8024&author=J.+C.+Verheijenauthor=D.+J.+Richardauthor=K.+Curranauthor=J.+Kaplanauthor=M.+Lefeverauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=W.+G.+Zhangauthor=J.+Lucasauthor=I.+Hollanderauthor=A.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yuauthor=A.+Zask&title=Discovery+of+4-Morpholino-6-aryl-1H-pyrazolo%5B3%2C4-d%5Dpyrimidines+as+Highly+Potent+and+Selective+ATP-Competitive+Inhibitors+of+the+Mammalian+Target+of+Rapamycin+%28mTOR%29%3A+Optimization+of+the+6-Aryl+Substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9013828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9013828%26sid%3Dliteratum%253Aachs%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DLefever%26aufirst%3DM.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAyral-Kaloustian%26aufirst%3DA.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25204-Morpholino-6-aryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520Highly%2520Potent%2520and%2520Selective%2520ATP-Competitive%2520Inhibitors%2520of%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%2520%2528mTOR%2529%253A%2520Optimization%2520of%2520the%25206-Aryl%2520Substituent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D8010%26epage%3D8024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[<i>h</i>][1,6]naphthyridin-2(1<i>H</i>)-one (Torin2) as a Potent, Selective, and Orally Available Mammalian Target of Rapamycin (mTOR) Inhibitor for Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1473</span><span class="NLM_x">–</span> <span class="NLM_lpage">1480</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101520v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1473-1480&author=Q.+Liuauthor=J.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=W.+Hurauthor=T.+Ahmedauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+of+9-%286-Aminopyridin-3-yl%29-1-%283-%28trifluoromethyl%29phenyl%29benzo%5Bh%5D%5B1%2C6%5Dnaphthyridin-2%281H%29-one+%28Torin2%29+as+a+Potent%2C+Selective%2C+and+Orally+Available+Mammalian+Target+of+Rapamycin+%28mTOR%29+Inhibitor+for+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm101520v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101520v%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25209-%25286-Aminopyridin-3-yl%2529-1-%25283-%2528trifluoromethyl%2529phenyl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2520%2528Torin2%2529%2520as%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520Mammalian%2520Target%2520of%2520Rapamycin%2520%2528mTOR%2529%2520Inhibitor%2520for%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1473%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Mortensen, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin-Ninkovic, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevlin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khmbatta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisonette, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fultz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankar, S.</span><span> </span><span class="NLM_article-title">Discovery and SAR Exploration of a Novel Series of Imidazo[4,5-<i>b</i>]pyrazin-2-ones as Potent and Selective mTOR Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6793</span><span class="NLM_x">–</span> <span class="NLM_lpage">6799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1016%2Fj.bmcl.2011.09.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=21978683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6793-6799&author=D.+S.+Mortensenauthor=S.+M.+Perrin-Ninkovicauthor=R.+Harrisauthor=B.+G.+S.+Leeauthor=G.+Shevlinauthor=M.+Hickmanauthor=G.+Khmbattaauthor=R.+R.+Bisonetteauthor=K.+E.+Fultzauthor=S.+Sankar&title=Discovery+and+SAR+Exploration+of+a+Novel+Series+of+Imidazo%5B4%2C5-b%5Dpyrazin-2-ones+as+Potent+and+Selective+mTOR+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors</span></div><div class="casAuthors">Mortensen, Deborah S.; Perrin-Ninkovic, Sophie M.; Harris, Roy; Lee, Branden G. S.; Shevlin, Graziella; Hickman, Matt; Khambatta, Gody; Bisonette, Rene R.; Fultz, Kimberly E.; Sankar, Sabita</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6793-6799</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report here the discovery of a novel series of selective mTOR kinase inhibitors.  A series of imidazo[4,5-b]pyrazin-2-ones, represented by screening hit 1, was developed into lead compds. with excellent mTOR potency and exquisite kinase selectivity.  Potent compds. from this series show >1000-fold selectivity over the related PI3Kα lipid kinase.  Further, compds. such as 2 achieve mTOR pathway inhibition, blocking both mTORC1 and mTORC2 signaling, in PC3 cancer cells as measured by inhibition of pS6 and pAkt (S473).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWly4sBJXgerVg90H21EOLACvtfcHk0lh6Cxvvm43IfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr3P&md5=d422a7d505c1032951547d997ac2e033</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.035%26sid%3Dliteratum%253Aachs%26aulast%3DMortensen%26aufirst%3DD.%2BS.%26aulast%3DPerrin-Ninkovic%26aufirst%3DS.%2BM.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DB.%2BG.%2BS.%26aulast%3DShevlin%26aufirst%3DG.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DKhmbatta%26aufirst%3DG.%26aulast%3DBisonette%26aufirst%3DR.%2BR.%26aulast%3DFultz%26aufirst%3DK.%2BE.%26aulast%3DSankar%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520SAR%2520Exploration%2520of%2520a%2520Novel%2520Series%2520of%2520Imidazo%255B4%252C5-b%255Dpyrazin-2-ones%2520as%2520Potent%2520and%2520Selective%2520mTOR%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6793%26epage%3D6799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robarge, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Potent, Selective, and Orally Bioavailable Inhibitors of Mammalian Target of Rapamycin (mTOR) Kinase Based on a Quaternary Substituted Dihydrofuropyrimidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3426</span><span class="NLM_x">–</span> <span class="NLM_lpage">3435</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200215y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3426-3435&author=F.+Cohenauthor=P.+Bergeronauthor=E.+Blackwoodauthor=K.+K.+Bowmanauthor=H.+Chenauthor=A.+G.+DiPasqualeauthor=J.+A.+Eplerauthor=M.+F.+T.+Koehlerauthor=K.+Lauauthor=C.+Lewisauthor=L.+Liuauthor=C.+Q.+Lyauthor=S.+Malekauthor=J.+Nonomiyaauthor=D.+F.+Ortwineauthor=Z.+Peiauthor=K.+D.+Robargeauthor=S.+Siderisauthor=L.+Trinhauthor=T.+Truongauthor=J.+Wuauthor=X.+Zhaoauthor=J.+P.+Lyssikatos&title=Potent%2C+Selective%2C+and+Orally+Bioavailable+Inhibitors+of+Mammalian+Target+of+Rapamycin+%28mTOR%29+Kinase+Based+on+a+Quaternary+Substituted+Dihydrofuropyrimidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm200215y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200215y%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DEpler%26aufirst%3DJ.%2BA.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DRobarge%26aufirst%3DK.%2BD.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTrinh%26aufirst%3DL.%26aulast%3DTruong%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3DPotent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Inhibitors%2520of%2520Mammalian%2520Target%2520of%2520Rapamycin%2520%2528mTOR%2529%2520Kinase%2520Based%2520on%2520a%2520Quaternary%2520Substituted%2520Dihydrofuropyrimidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3426%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Maira, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chène, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Echeverría, C.</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maira%2C+S.-M.%3B+Stauffer%2C+F.%3B+Brueggen%2C+J.%3B+Furet%2C+P.%3B+Schnell%2C+C.%3B+Fritsch%2C+C.%3B+Brachmann%2C+S.%3B+Ch%C3%A8ne%2C+P.%3B+De+Pover%2C+A.%3B+Schoemaker%2C+K.%3B+Fabbro%2C+D.%3B+Gabriel%2C+D.%3B+Simonen%2C+M.%3B+Murphy%2C+L.%3B+Finan%2C+P.%3B+Sellers%2C+W.%3B+Garc%C3%ADa-Echeverr%C3%ADa%2C+C.Mol.+Cancer+Ther.+2008%2C+7%2C+1851%E2%80%931863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0lg2O_YV9IiD6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.-M.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DCh%25C3%25A8ne%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarc%25C3%25ADa-Echeverr%25C3%25ADa%26aufirst%3DC.%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><div class="note"><p class="first last">For an example of the use of PC3 cells to evaluate mTOR activity, see:</p></div><span class="NLM_contrib-group">Dan, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, A. S.</span><span> </span><span class="NLM_article-title">Regulation of Mammalian Target of Rapamycin Activity in PTEN-Inactive Prostate Cancer Cells by I κB Kinase α</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">6263</span><span class="NLM_x">–</span> <span class="NLM_lpage">6269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6263-6269&author=H.+C.+Danauthor=M.+Adliauthor=A.+S.+Baldwin&title=Regulation+of+Mammalian+Target+of+Rapamycin+Activity+in+PTEN-Inactive+Prostate+Cancer+Cells+by+I+%CE%BAB+Kinase+%CE%B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDan%26aufirst%3DH.%2BC.%26aulast%3DAdli%26aufirst%3DM.%26aulast%3DBaldwin%26aufirst%3DA.%2BS.%26atitle%3DRegulation%2520of%2520Mammalian%2520Target%2520of%2520Rapamycin%2520Activity%2520in%2520PTEN-Inactive%2520Prostate%2520Cancer%2520Cells%2520by%2520I%2520%25CE%25BAB%2520Kinase%2520%25CE%25B1%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6263%26epage%3D6269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Anand, N. K.; Arcalas, A.; Blazey, C. M.; Buhr, C. A.; Cannoy, J.; Ephsteyn, S.; Johnson, H. W.B.; Joshi, A.; Kim, B. G.; Leahy, J. W.; Lee, M. S.; Ma, S.; Mac, M. B.; Nuss, J. M.; Takeuchi, C. S.; Wang, L.; Wang, Y.</span><span> </span><span class="NLM_article-title">Benzoxazepin-4-(5<i>H</i>)-yl Derivatives and Their Use To Treat Cancer</span>. PCT Int Appl. WO2010118208A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=N.+K.+Anand&author=A.+Arcalas&author=C.+M.+Blazey&author=C.+A.+Buhr&author=J.+Cannoy&author=S.+Ephsteyn&author=H.+W.B.+Johnson&author=A.+Joshi&author=B.+G.+Kim&author=J.+W.+Leahy&author=M.+S.+Lee&author=S.+Ma&author=M.+B.+Mac&author=J.+M.+Nuss&author=C.+S.+Takeuchi&author=L.+Wang&author=Y.+Wang&title=Benzoxazepin-4-%285H%29-yl+Derivatives+and+Their+Use+To+Treat+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DN.%2BK.%26atitle%3DBenzoxazepin-4-%25285H%2529-yl%2520Derivatives%2520and%2520Their%2520Use%2520To%2520Treat%2520Cancer%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><div class="note"><p class="first last">For an example of the use of this straightforward method for the analysis of the kinetics of enzyme reactions, see:</p></div><span class="NLM_contrib-group">Krohn, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, J. M.</span><span> </span><span class="NLM_article-title">Interpreting Enzyme and Receptor Kinetics: Keeping It Simple, but Not Too Simple</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1016%2FS0969-8051%2803%2900132-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=14698785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWisrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=819-826&author=K.+A.+Krohnauthor=J.+M.+Link&title=Interpreting+Enzyme+and+Receptor+Kinetics%3A+Keeping+It+Simple%2C+but+Not+Too+Simple"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple</span></div><div class="casAuthors">Krohn, Kenneth A.; Link, Jeanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">819-826</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The hyperbolic parabola is commonly used to summarize kinetics for enzyme reactions and receptor binding kinetics.  Depending on the exptl. conditions, certain assumptions are valid but others might be violated so that the parameters used to fit this hyperbolic function, the max. asymptote and the equil. const., require different interpretations.  The first topic of this review compares enzyme-induced transformations and receptor binding in terms of the appropriate assumptions.  The second topic considers the complication of adding a competitive inhibitor as an enzyme substrate or a receptor ligand and the subtleties of inferring the equil. dissocn. const. from the concn. of inhibitor (for example unlabeled drug) that leads to the midpoint, IC50, of an inhibition curve.  Receptor binding may be measured directly by a concn. assay or as a pharmacodynamic response variable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3yoMxChxIPrVg90H21EOLACvtfcHk0lg2O_YV9IiD6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWisrfJ&md5=d62f241658499c5d6d5d6ca1e056ed06</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2803%2900132-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252803%252900132-X%26sid%3Dliteratum%253Aachs%26aulast%3DKrohn%26aufirst%3DK.%2BA.%26aulast%3DLink%26aufirst%3DJ.%2BM.%26atitle%3DInterpreting%2520Enzyme%2520and%2520Receptor%2520Kinetics%253A%2520Keeping%2520It%2520Simple%252C%2520but%2520Not%2520Too%2520Simple%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D819%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><div class="note"><p class="first last">For an example of the use of MCF7 cells to evaluate mTOR activity, see:</p></div><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span> </span><span class="NLM_article-title">mTOR, a Novel Target in Breast Cancer: The Effect of CCI-779, an mTOR Inhibitor, in Preclinical Models of Breast Cancer</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=249-258&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Discafaniauthor=W.-G.+Zhangauthor=J.+Skotnickiauthor=P.+Frostauthor=J.+J.+Gibbons&title=mTOR%2C+a+Novel+Target+in+Breast+Cancer%3A+The+Effect+of+CCI-779%2C+an+mTOR+Inhibitor%2C+in+Preclinical+Models+of+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26atitle%3DmTOR%252C%2520a%2520Novel%2520Target%2520in%2520Breast%2520Cancer%253A%2520The%2520Effect%2520of%2520CCI-779%252C%2520an%2520mTOR%2520Inhibitor%252C%2520in%2520Preclinical%2520Models%2520of%2520Breast%2520Cancer%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2001%26volume%3D8%26spage%3D249%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Huckle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M.</span><span> </span><span class="NLM_article-title">The Preparation of Some 2,3-Dihydro-1,4-benzoxazepin-5(4<i>H</i>)-ones and Related Compounds</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span><span class="NLM_x">–</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1039%2Fjr9650001137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADyaF2MXltFKltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1965&pages=1137-1141&author=D.+Huckleauthor=I.+M.+Lockhartauthor=M.+Wright&title=The+Preparation+of+Some+2%2C3-Dihydro-1%2C4-benzoxazepin-5%284H%29-ones+and+Related+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The preparation of some 2,3-dihydro-1,4-benzoxazepin-5(4H) ones and related compounds</span></div><div class="casAuthors">Huckle, D.; Lockhart, I. M.; Wright, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">1137-41</span>CODEN:
                <span class="NLM_cas:coden">JCSOA9</span>;
        ISSN:<span class="NLM_cas:issn">0368-1769</span>.
    </div><div class="casAbstract">The action of hydrazoic acid on 4-chromanone leads to the formation of 2,3-dihydro-1,4-benzoxazepin-5(4H)-one (I, R = R1 = H).  The syntheses of other I are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1tvJvmirqHrVg90H21EOLACvtfcHk0liF4OZiuWCvPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXltFKltA%253D%253D&md5=a7fe414f08b210a06a1f5535296707c8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2Fjr9650001137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9650001137%26sid%3Dliteratum%253Aachs%26aulast%3DHuckle%26aufirst%3DD.%26aulast%3DLockhart%26aufirst%3DI.%2BM.%26aulast%3DWright%26aufirst%3DM.%26atitle%3DThe%2520Preparation%2520of%2520Some%25202%252C3-Dihydro-1%252C4-benzoxazepin-5%25284H%2529-ones%2520and%2520Related%2520Compounds%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1965%26spage%3D1137%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Vernier, J. M.; Ripka, W.; May, J.; Bounaud, P.; O’Connor, P.; Hopkins, S.; Burkel, H.</span><span> </span><span class="NLM_article-title">Antitumor Hedgehog Signaling Inhibitors</span>. PCT Int Appl. WO2011014888A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+M.+Vernier&author=W.+Ripka&author=J.+May&author=P.+Bounaud&author=P.+O%E2%80%99Connor&author=S.+Hopkins&author=H.+Burkel&title=Antitumor+Hedgehog+Signaling+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVernier%26aufirst%3DJ.%2BM.%26atitle%3DAntitumor%2520Hedgehog%2520Signaling%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Zou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falck, J. R.</span><span> </span><span class="NLM_article-title">Ag(I)-Promoted Suzuki–Miyaura Cross-Couplings of <i>n</i>-Alkylboronic Acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">7213</span><span class="NLM_x">–</span> <span class="NLM_lpage">7215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=7213-7215&author=G.+Zouauthor=Y.+K.+Reddyauthor=J.+R.+Falck&title=Ag%28I%29-Promoted+Suzuki%E2%80%93Miyaura+Cross-Couplings+of+n-Alkylboronic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DG.%26aulast%3DReddy%26aufirst%3DY.%2BK.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26atitle%3DAg%2528I%2529-Promoted%2520Suzuki%25E2%2580%2593Miyaura%2520Cross-Couplings%2520of%2520n-Alkylboronic%2520Acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D7213%26epage%3D7215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, J. M.</span><span> </span><span class="NLM_article-title">Pd-Catalyzed <i>N</i>-Arylation of Heteroarylamines</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3481</span><span class="NLM_x">–</span> <span class="NLM_lpage">3484</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0265923" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1Omur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=3481-3484&author=J.+Yinauthor=M.+M.+Zhaoauthor=M.+A.+Huffmanauthor=J.+M.+McNamara&title=Pd-Catalyzed+N-Arylation+of+Heteroarylamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-Catalyzed N-Arylation of Heteroarylamines</span></div><div class="casAuthors">Yin, Jingjun; Zhao, Matthew M.; Huffman, Mark A.; McNamara, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3481-3484</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed N-(hetero)arylation of a no. of heteroarylamines including 2-aminopyridines, 2-aminothiazoles, and their analogs has been realized using Xantphos as the ligand.  Weak bases such as Cs2CO3, Na2CO3, and K3PO4 were used in most cases to allow for the introduction of functional groups.  Choice of the base and solvent was crit. for the success of these reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpto0A1OmazwbVg90H21EOLACvtfcHk0liF4OZiuWCvPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1Omur8%253D&md5=95f39b69250ce41d7c97d66ecc7f1ae8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fol0265923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0265923%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DM.%2BM.%26aulast%3DHuffman%26aufirst%3DM.%2BA.%26aulast%3DMcNamara%26aufirst%3DJ.%2BM.%26atitle%3DPd-Catalyzed%2520N-Arylation%2520of%2520Heteroarylamines%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D3481%26epage%3D3484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ibrahim, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, H. W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolfrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banica, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heald, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattheakis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipway, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, G.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of Potent and Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1368</span><span class="NLM_x">–</span> <span class="NLM_lpage">1381</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201533b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1368-1381&author=M.+A.+Ibrahimauthor=H.+W.+B.+Johnsonauthor=J.+W.+Jeongauthor=G.+L.+Lewisauthor=X.+Shiauthor=R.+T.+Noguchiauthor=M.+Williamsauthor=J.+W.+Leahyauthor=J.+M.+Nussauthor=J.+Woolfreyauthor=M.+Banicaauthor=F.+Bentzienauthor=Y.-C.+Chouauthor=A.+Gibsonauthor=N.+Healdauthor=P.+Lambauthor=L.+Mattheakisauthor=D.+Matthewsauthor=A.+Shipwayauthor=X.+Wuauthor=W.+Zhangauthor=S.+Zhouauthor=G.+Shankar&title=Discovery+of+a+Novel+Class+of+Potent+and+Orally+Bioavailable+Sphingosine+1-Phosphate+Receptor+1+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm201533b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201533b%26sid%3Dliteratum%253Aachs%26aulast%3DIbrahim%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DH.%2BW.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BW.%26aulast%3DLewis%26aufirst%3DG.%2BL.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DNoguchi%26aufirst%3DR.%2BT.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DLeahy%26aufirst%3DJ.%2BW.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DWoolfrey%26aufirst%3DJ.%26aulast%3DBanica%26aufirst%3DM.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DChou%26aufirst%3DY.-C.%26aulast%3DGibson%26aufirst%3DA.%26aulast%3DHeald%26aufirst%3DN.%26aulast%3DLamb%26aufirst%3DP.%26aulast%3DMattheakis%26aufirst%3DL.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DShipway%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DShankar%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Orally%2520Bioavailable%2520Sphingosine%25201-Phosphate%2520Receptor%25201%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1368%26epage%3D1381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Leahy, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhr, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, H. W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannoy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heald, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougheed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plonowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeber, O.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase γ Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5467</span><span class="NLM_x">–</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300403a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5467-5482&author=J.+W.+Leahyauthor=C.+A.+Buhrauthor=H.+W.+B.+Johnsonauthor=B.+G.+Kimauthor=T.+Baikauthor=J.+Cannoyauthor=T.+P.+Forsythauthor=J.+W.+Jeongauthor=M.+S.+Leeauthor=S.+Maauthor=K.+Nosonauthor=L.+Wangauthor=M.+Williamsauthor=J.+M.+Nussauthor=E.+Brooksauthor=P.+Fosterauthor=L.+Goonauthor=N.+Healdauthor=C.+Holstauthor=C.+Jaegerauthor=S.+Lamauthor=J.+Lougheedauthor=L.+Nguyenauthor=A.+Plonowskiauthor=J.+Songauthor=T.+Stoutauthor=X.+Wuauthor=M.+F.+Yakesauthor=P.+Yuauthor=W.+Zhangauthor=P.+Lambauthor=O.+Raeber&title=Discovery+of+a+Novel+Series+of+Potent+and+Orally+Bioavailable+Phosphoinositide+3-Kinase+%CE%B3+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm300403a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300403a%26sid%3Dliteratum%253Aachs%26aulast%3DLeahy%26aufirst%3DJ.%2BW.%26aulast%3DBuhr%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DH.%2BW.%2BB.%26aulast%3DKim%26aufirst%3DB.%2BG.%26aulast%3DBaik%26aufirst%3DT.%26aulast%3DCannoy%26aufirst%3DJ.%26aulast%3DForsyth%26aufirst%3DT.%2BP.%26aulast%3DJeong%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DNoson%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DBrooks%26aufirst%3DE.%26aulast%3DFoster%26aufirst%3DP.%26aulast%3DGoon%26aufirst%3DL.%26aulast%3DHeald%26aufirst%3DN.%26aulast%3DHolst%26aufirst%3DC.%26aulast%3DJaeger%26aufirst%3DC.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DLougheed%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DPlonowski%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DStout%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYakes%26aufirst%3DM.%2BF.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLamb%26aufirst%3DP.%26aulast%3DRaeber%26aufirst%3DO.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Series%2520of%2520Potent%2520and%2520Orally%2520Bioavailable%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5467%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 37 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Aurélie Claraz, Thibaut Courant, <span class="NLM_string-name hlFld-ContribAuthor">Géraldine Masson</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemical Intramolecular Oxytrifluoromethylation of N-Tethered Alkenyl Alcohols: Synthesis of Functionalized Morpholines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (4)
                                     , 1580-1584. <a href="https://doi.org/10.1021/acs.orglett.0c00176" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00176%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DElectrochemical%252BIntramolecular%252BOxytrifluoromethylation%252Bof%252BN-Tethered%252BAlkenyl%252BAlcohols%25253A%252BSynthesis%252Bof%252BFunctionalized%252BMorpholines%26aulast%3DClaraz%26aufirst%3DAur%25C3%25A9lie%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13012020%26date%3D04022020%26volume%3D22%26issue%3D4%26spage%3D1580%26epage%3D1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yong Chen, Xue Yuan, Wanhua Zhang, Minghai Tang, Li Zheng, Fang Wang, Wei Yan, Shengyong Yang, Yuquan Wei, Jun He, <span class="NLM_string-name hlFld-ContribAuthor">Lijuan Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1577-1592. <a href="https://doi.org/10.1021/acs.jmedchem.8b01825" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01825%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BDual%252BHistone%252BDeacetylase%252Band%252BMammalian%252BTarget%252Bof%252BRapamycin%252BTarget%252BInhibitors%252Bas%252Ba%252BPromising%252BStrategy%252Bfor%252BCancer%252BTherapy%26aulast%3DChen%26aufirst%3DYong%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D22112018%26date%3D24012019%26date%3D10012019%26volume%3D62%26issue%3D3%26spage%3D1577%26epage%3D1592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingxiang  Guo</span>, <span class="hlFld-ContribAuthor ">Chenhua  Yu</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongtao  Li</span>, <span class="hlFld-ContribAuthor ">Tianqi  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi  Huang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Yao  Li</span>, <span class="hlFld-ContribAuthor ">Zhongxiang  Qin</span>, <span class="hlFld-ContribAuthor ">Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Ruifang  Gao</span>, <span class="hlFld-ContribAuthor ">Yongwei  Nie</span>, <span class="hlFld-ContribAuthor ">Yakun  Ma</span>, <span class="hlFld-ContribAuthor ">Yi  Shi</span>, <span class="hlFld-ContribAuthor ">Jianyu  Zheng</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>, <span class="hlFld-ContribAuthor ">Yan  Fan</span>, and <span class="hlFld-ContribAuthor ">Rong  Xiang</span>  . </span><span class="cited-content_cbyCitation_article-title">Highly Selective, Potent, and Oral mTOR Inhibitor for Treatment of Cancer as Autophagy Inducer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 881-904. <a href="https://doi.org/10.1021/acs.jmedchem.7b01402" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01402%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BSelective%25252C%252BPotent%25252C%252Band%252BOral%252BmTOR%252BInhibitor%252Bfor%252BTreatment%252Bof%252BCancer%252Bas%252BAutophagy%252BInducer%26aulast%3DGuo%26aufirst%3DQingxiang%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D21092017%26date%3D27012018%26date%3D08022018%26date%3D08012018%26volume%3D61%26issue%3D3%26spage%3D881%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> James W.    Leahy </span><span class="hlFld-ContribAuthor "> Sriram    Naganathan </span><span class="hlFld-ContribAuthor "> Denise L.    Andersen </span><span class="hlFld-ContribAuthor "> Neil G.    Andersen </span><span class="hlFld-ContribAuthor "> Stephen    Lau </span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, Process Development, and Scale-Up of a Benzoxazepine-Containing mTor Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 249-285. <a href="https://doi.org/10.1021/bk-2018-1307.ch009" title="DOI URL">https://doi.org/10.1021/bk-2018-1307.ch009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2018-1307.ch009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2018-1307.ch009%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%25252C%252BProcess%252BDevelopment%25252C%252Band%252BScale-Up%252Bof%252Ba%252BBenzoxazepine-Containing%252BmTor%252BInhibitor%26aulast%3DLeahy%26aufirst%3DJames%2BW.%26date%3D2018%26date%3D2018%26spage%3D249%26epage%3D285%26atitle%3DComplete%252BAccounts%252Bof%252BIntegrated%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BExamples%252Bfrom%252Bthe%252BPharmaceutical%252BIndustry%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2018%26date%3D2018%26volume%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shweta  Bisht</span> and <span class="hlFld-ContribAuthor ">Rama Krishna  Peddinti</span>  . </span><span class="cited-content_cbyCitation_article-title">FeCl3-Mediated Domino Reaction of Benzoxazinones with Aroylmethylidene Malonates: Synthesis to Functionalized Pyrrolobenzoxazines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (24)
                                     , 13617-13625. <a href="https://doi.org/10.1021/acs.joc.7b02207" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02207%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFeCl3-Mediated%252BDomino%252BReaction%252Bof%252BBenzoxazinones%252Bwith%252BAroylmethylidene%252BMalonates%25253A%252BSynthesis%252Bto%252BFunctionalized%252BPyrrolobenzoxazines%26aulast%3DBisht%26aufirst%3DShweta%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D01092017%26date%3D21112017%26date%3D15122017%26volume%3D82%26issue%3D24%26spage%3D13617%26epage%3D13625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Li</span>, <span class="hlFld-ContribAuthor ">Jiang-Ping  Meng</span>, <span class="hlFld-ContribAuthor ">Jie  Lei</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhu  Chen</span>, <span class="hlFld-ContribAuthor ">Dian-Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Jin  Zhang</span>, and <span class="hlFld-ContribAuthor ">Zhi-Gang  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Fused Oxazepino-isoquinoline Scaffolds via an Ugi, Followed by an Intramolecular Cyclization. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2017,</strong> <em>19 </em>
                                    (5)
                                     , 324-330. <a href="https://doi.org/10.1021/acscombsci.7b00002" title="DOI URL">https://doi.org/10.1021/acscombsci.7b00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.7b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.7b00002%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DEfficient%252BSynthesis%252Bof%252BFused%252BOxazepino-isoquinoline%252BScaffolds%252Bvia%252Ban%252BUgi%25252C%252BFollowed%252Bby%252Ban%252BIntramolecular%252BCyclization%26aulast%3DLi%26aufirst%3DYong%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03012017%26date%3D06032017%26date%3D16032017%26date%3D08052017%26date%3D08032017%26volume%3D19%26issue%3D5%26spage%3D324%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandan Kumar  Shahi</span>, <span class="hlFld-ContribAuthor ">Aditya  Bhattacharyya</span>, <span class="hlFld-ContribAuthor ">Yerramsetti  Nanaji</span>, and <span class="hlFld-ContribAuthor ">Manas K.  Ghorai</span>  . </span><span class="cited-content_cbyCitation_article-title">A Stereoselective Route to Tetrahydrobenzoxazepines and Tetrahydrobenzodiazepines via Ring-Opening and Aza-Michael Addition of Activated Aziridines with 2-Hydroxyphenyl and 2-Aminophenyl Acrylates. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (1)
                                     , 37-47. <a href="https://doi.org/10.1021/acs.joc.6b01919" title="DOI URL">https://doi.org/10.1021/acs.joc.6b01919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b01919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b01919%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BStereoselective%252BRoute%252Bto%252BTetrahydrobenzoxazepines%252Band%252BTetrahydrobenzodiazepines%252Bvia%252BRing-Opening%252Band%252BAza-Michael%252BAddition%252Bof%252BActivated%252BAziridines%252Bwith%252B2-Hydroxyphenyl%252Band%252B2-Aminophenyl%252BAcrylates%26aulast%3DShahi%26aufirst%3DChandan%2BKumar%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D05082016%26date%3D17102016%26date%3D06012017%26date%3D05102016%26volume%3D82%26issue%3D1%26spage%3D37%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sriram  Naganathan</span>, <span class="hlFld-ContribAuthor ">Denise L.  Andersen</span>, <span class="hlFld-ContribAuthor ">Neil G.  Andersen</span>, <span class="hlFld-ContribAuthor ">Stephen  Lau</span>, <span class="hlFld-ContribAuthor ">Anders  Lohse</span>, and <span class="hlFld-ContribAuthor ">Mads Detlef  Sørensen</span>  . </span><span class="cited-content_cbyCitation_article-title">Process Development and Scale-Up of a Benzoxazepine-Containing Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2015,</strong> <em>19 </em>
                                    (7)
                                     , 721-734. <a href="https://doi.org/10.1021/acs.oprd.5b00037" title="DOI URL">https://doi.org/10.1021/acs.oprd.5b00037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.5b00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.5b00037%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BDevelopment%252Band%252BScale-Up%252Bof%252Ba%252BBenzoxazepine-Containing%252BKinase%252BInhibitor%26aulast%3DNaganathan%26aufirst%3DSriram%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D03022015%26date%3D15052015%26date%3D17072015%26date%3D29042015%26volume%3D19%26issue%3D7%26spage%3D721%26epage%3D734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanjib  Das</span>, <span class="hlFld-ContribAuthor ">Rajabrata  Bhuyan</span>, <span class="hlFld-ContribAuthor ">Achintya Mohan  Goswami</span>, <span class="hlFld-ContribAuthor ">Tanima  Saha</span>. </span><span class="cited-content_cbyCitation_article-title">Kinome analyses of Candida albicans, C. parapsilosis and C. tropicalis enable novel kinases as therapeutic drug targets in candidiasis. </span><span class="cited-content_cbyCitation_journal-name">Gene</span><span> <strong>2021,</strong> <em>780 </em>, 145530. <a href="https://doi.org/10.1016/j.gene.2021.145530" title="DOI URL">https://doi.org/10.1016/j.gene.2021.145530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gene.2021.145530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gene.2021.145530%26sid%3Dliteratum%253Aachs%26jtitle%3DGene%26atitle%3DKinome%252Banalyses%252Bof%252BCandida%252Balbicans%25252C%252BC.%252Bparapsilosis%252Band%252BC.%252Btropicalis%252Benable%252Bnovel%252Bkinases%252Bas%252Btherapeutic%252Bdrug%252Btargets%252Bin%252Bcandidiasis%26aulast%3DDas%26aufirst%3DSanjib%26date%3D2021%26volume%3D780%26spage%3D145530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fengqin  Wang</span>, <span class="hlFld-ContribAuthor ">Hanzhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhigang  Cheng</span>, . </span><span class="cited-content_cbyCitation_article-title">EPHA2 Promotes the Invasion and Migration of Human Tongue Squamous Cell Carcinoma Cal-27 Cells by Enhancing AKT/mTOR Signaling Pathway. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2021,</strong> <em>2021 </em>, 1-13. <a href="https://doi.org/10.1155/2021/4219690" title="DOI URL">https://doi.org/10.1155/2021/4219690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2021/4219690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2021%2F4219690%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DEPHA2%252BPromotes%252Bthe%252BInvasion%252Band%252BMigration%252Bof%252BHuman%252BTongue%252BSquamous%252BCell%252BCarcinoma%252BCal-27%252BCells%252Bby%252BEnhancing%252BAKT%25252FmTOR%252BSignaling%252BPathway%26aulast%3DWang%26aufirst%3DFengqin%26date%3D2021%26volume%3D2021%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongyan  Yang</span>, <span class="hlFld-ContribAuthor ">Haixia  Wang</span>, <span class="hlFld-ContribAuthor ">Zhijin  Fan</span>, <span class="hlFld-ContribAuthor ">Zhengming  Li</span>, <span class="hlFld-ContribAuthor ">Shuang  Zhou</span>, <span class="hlFld-ContribAuthor ">Zesheng  Hao</span>, <span class="hlFld-ContribAuthor ">You  Lv</span>, <span class="hlFld-ContribAuthor ">Tatiana A.  Kalinina</span>, <span class="hlFld-ContribAuthor ">Tatiana V.  Glukhareva</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antifungal activity of (E)-3-acyl-5-(methoxyimino)-1,5-dihydrobenzo[e][1,2]oxazepin-4(3H)-one analogues. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>25 </em>
                                    (1)
                                     , 159-169. <a href="https://doi.org/10.1007/s11030-020-10035-z" title="DOI URL">https://doi.org/10.1007/s11030-020-10035-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10035-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10035-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantifungal%252Bactivity%252Bof%252B%252528E%252529-3-acyl-5-%252528methoxyimino%252529-1%25252C5-dihydrobenzo%25255Be%25255D%25255B1%25252C2%25255Doxazepin-4%2525283H%252529-one%252Banalogues%26aulast%3DYang%26aufirst%3DDongyan%26date%3D2021%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D159%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaopeng  Peng</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Sun</span>, <span class="hlFld-ContribAuthor ">Peihua  Kuang</span>, <span class="hlFld-ContribAuthor ">Jianjun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112831. <a href="https://doi.org/10.1016/j.ejmech.2020.112831" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112831</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112831%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bon%252BHDAC%252Binhibitors%252Bwith%252Bdual%252Btargeting%252Bcapabilities%252Bfor%252Bcancer%252Btreatment%26aulast%3DPeng%26aufirst%3DXiaopeng%26date%3D2020%26volume%3D208%26spage%3D112831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amrita  Ghosh</span>, <span class="hlFld-ContribAuthor ">Shital K.  Chattopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-mediated Synthesis of Medium Ring-sized Heterocyclic Compounds. </span><span class="cited-content_cbyCitation_journal-name">Current Microwave Chemistry</span><span> <strong>2020,</strong> <em>7 </em>
                                    (2)
                                     , 123-144. <a href="https://doi.org/10.2174/2213335607666200226101602" title="DOI URL">https://doi.org/10.2174/2213335607666200226101602</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/2213335607666200226101602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F2213335607666200226101602%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Microwave%2520Chemistry%26atitle%3DMicrowave-mediated%252BSynthesis%252Bof%252BMedium%252BRing-sized%252BHeterocyclic%252BCompounds%26aulast%3DGhosh%26aufirst%3DAmrita%26date%3D2020%26volume%3D7%26issue%3D2%26spage%3D123%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian  Xu</span>, <span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112391. <a href="https://doi.org/10.1016/j.ejmech.2020.112391" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112391%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BmTOR%252Bfor%252Bfighting%252Bdiseases%25253A%252BA%252Brevisited%252Breview%252Bof%252BmTOR%252Binhibitors%26aulast%3DXu%26aufirst%3DTian%26date%3D2020%26volume%3D199%26spage%3D112391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyeongmin  Kim</span>, <span class="hlFld-ContribAuthor ">Songyeon  Choi</span>, <span class="hlFld-ContribAuthor ">Myeounghoon  Cha</span>, <span class="hlFld-ContribAuthor ">Bae Hwan  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of mTOR inhibitors on neuropathic pain revealed by optical imaging of the insular cortex in rats. </span><span class="cited-content_cbyCitation_journal-name">Brain Research</span><span> <strong>2020,</strong> <em>1733 </em>, 146720. <a href="https://doi.org/10.1016/j.brainres.2020.146720" title="DOI URL">https://doi.org/10.1016/j.brainres.2020.146720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainres.2020.146720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainres.2020.146720%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%26atitle%3DEffects%252Bof%252BmTOR%252Binhibitors%252Bon%252Bneuropathic%252Bpain%252Brevealed%252Bby%252Boptical%252Bimaging%252Bof%252Bthe%252Binsular%252Bcortex%252Bin%252Brats%26aulast%3DKim%26aufirst%3DKyeongmin%26date%3D2020%26volume%3D1733%26spage%3D146720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Pinna</span>, <span class="hlFld-ContribAuthor ">Andrea  Basso</span>, <span class="hlFld-ContribAuthor ">Chiara  Lambruschini</span>, <span class="hlFld-ContribAuthor ">Lisa  Moni</span>, <span class="hlFld-ContribAuthor ">Renata  Riva</span>, <span class="hlFld-ContribAuthor ">Valeria  Rocca</span>, <span class="hlFld-ContribAuthor ">Luca  Banfi</span>. </span><span class="cited-content_cbyCitation_article-title">Stereodivergent access to all four stereoisomers of chiral tetrahydrobenzo[
              f
              ][1,4]oxazepines, through highly diastereoselective multicomponent Ugi–Joullié reaction. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 965-972. <a href="https://doi.org/10.1039/C9RA10689H" title="DOI URL">https://doi.org/10.1039/C9RA10689H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA10689H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA10689H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DStereodivergent%252Baccess%252Bto%252Ball%252Bfour%252Bstereoisomers%252Bof%252Bchiral%252Btetrahydrobenzo%25255B%252Bf%252B%25255D%25255B1%25252C4%25255Doxazepines%25252C%252Bthrough%252Bhighly%252Bdiastereoselective%252Bmulticomponent%252BUgi%2525E2%252580%252593Joulli%2525C3%2525A9%252Breaction%26aulast%3DPinna%26aufirst%3DAlessandro%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D2%26spage%3D965%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Songyeon  Choi</span>, <span class="hlFld-ContribAuthor ">Kyeongmin  Kim</span>, <span class="hlFld-ContribAuthor ">Myeounghoon  Cha</span>, <span class="hlFld-ContribAuthor ">Minjee  Kim</span>, <span class="hlFld-ContribAuthor ">Bae Hwan  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">mTOR signaling intervention by Torin1 and XL388 in the insular cortex alleviates neuropathic pain. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience Letters</span><span> <strong>2020,</strong> <em>718 </em>, 134742. <a href="https://doi.org/10.1016/j.neulet.2020.134742" title="DOI URL">https://doi.org/10.1016/j.neulet.2020.134742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neulet.2020.134742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neulet.2020.134742%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520Letters%26atitle%3DmTOR%252Bsignaling%252Bintervention%252Bby%252BTorin1%252Band%252BXL388%252Bin%252Bthe%252Binsular%252Bcortex%252Balleviates%252Bneuropathic%252Bpain%26aulast%3DChoi%26aufirst%3DSongyeon%26date%3D2020%26volume%3D718%26spage%3D134742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul  Tyagi</span>, <span class="hlFld-ContribAuthor ">Mostafa A.  Elfawal</span>, <span class="hlFld-ContribAuthor ">Scott A.  Wildman</span>, <span class="hlFld-ContribAuthor ">Jon  Helander</span>, <span class="hlFld-ContribAuthor ">Christina A.  Bulman</span>, <span class="hlFld-ContribAuthor ">Judy  Sakanari</span>, <span class="hlFld-ContribAuthor ">Bruce A.  Rosa</span>, <span class="hlFld-ContribAuthor ">Paul J.  Brindley</span>, <span class="hlFld-ContribAuthor ">James W.  Janetka</span>, <span class="hlFld-ContribAuthor ">Raffi V.  Aroian</span>, <span class="hlFld-ContribAuthor ">Makedonka  Mitreva</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of small molecule enzyme inhibitors as broad-spectrum anthelmintics. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-45548-7" title="DOI URL">https://doi.org/10.1038/s41598-019-45548-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-45548-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-45548-7%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DIdentification%252Bof%252Bsmall%252Bmolecule%252Benzyme%252Binhibitors%252Bas%252Bbroad-spectrum%252Banthelmintics%26aulast%3DTyagi%26aufirst%3DRahul%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed S.  Abdel‐Maksoud</span>, <span class="hlFld-ContribAuthor ">Mohammed I.  El‐Gamal</span>, <span class="hlFld-ContribAuthor ">Dalia Reyane  Benhalilou</span>, <span class="hlFld-ContribAuthor ">Sandy  Ashraf</span>, <span class="hlFld-ContribAuthor ">Shatha Abdulghaffar  Mohammed</span>, <span class="hlFld-ContribAuthor ">Chang‐Hyun  Oh</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (2)
                                     , 631-664. <a href="https://doi.org/10.1002/med.21535" title="DOI URL">https://doi.org/10.1002/med.21535</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21535%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMechanistic%25252Fmammalian%252Btarget%252Bof%252Brapamycin%25253A%252BRecent%252Bpathological%252Baspects%252Band%252Binhibitors%26aulast%3DAbdel%25E2%2580%2590Maksoud%26aufirst%3DMohammed%2BS.%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D2%26spage%3D631%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta Érica  Saidel</span>, <span class="hlFld-ContribAuthor ">Karen C.  dos Santos</span>, <span class="hlFld-ContribAuthor ">Luís F.P.  Nagano</span>, <span class="hlFld-ContribAuthor ">Carlos Alberto  Montanari</span>, <span class="hlFld-ContribAuthor ">Andrei  Leitão</span>. </span><span class="cited-content_cbyCitation_article-title">Novel anti-prostate cancer scaffold identified by the combination of in silico and cell-based assays targeting the PI3K-AKT-mTOR pathway. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (17)
                                     , 4001-4006. <a href="https://doi.org/10.1016/j.bmcl.2017.07.061" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.061%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Banti-prostate%252Bcancer%252Bscaffold%252Bidentified%252Bby%252Bthe%252Bcombination%252Bof%252Bin%252Bsilico%252Band%252Bcell-based%252Bassays%252Btargeting%252Bthe%252BPI3K-AKT-mTOR%252Bpathway%26aulast%3DSaidel%26aufirst%3DMarta%2B%25C3%2589rica%26date%3D2017%26volume%3D27%26issue%3D17%26spage%3D4001%26epage%3D4006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zuquan  Xiong</span>, <span class="hlFld-ContribAuthor ">Yiwen  Zang</span>, <span class="hlFld-ContribAuthor ">Shan  Zhong</span>, <span class="hlFld-ContribAuthor ">Lujia  Zou</span>, <span class="hlFld-ContribAuthor ">Yishuo  Wu</span>, <span class="hlFld-ContribAuthor ">Shenghua  Liu</span>, <span class="hlFld-ContribAuthor ">Zujun  Fang</span>, <span class="hlFld-ContribAuthor ">Zhoujun  Shen</span>, <span class="hlFld-ContribAuthor ">Qiang  Ding</span>, <span class="hlFld-ContribAuthor ">Shanwen  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (18)
                                     , 30151-30161. <a href="https://doi.org/10.18632/oncotarget.15620" title="DOI URL">https://doi.org/10.18632/oncotarget.15620</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.15620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.15620%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DThe%252Bpreclinical%252Bassessment%252Bof%252BXL388%25252C%252Ba%252BmTOR%252Bkinase%252Binhibitor%25252C%252Bas%252Ba%252Bpromising%252Banti-renal%252Bcell%252Bcarcinoma%252Bagent%26aulast%3DXiong%26aufirst%3DZuquan%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D18%26spage%3D30151%26epage%3D30161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Xu</span>, <span class="hlFld-ContribAuthor ">Yong  Li</span>, <span class="hlFld-ContribAuthor ">Jiang-Ping  Meng</span>, <span class="hlFld-ContribAuthor ">Jie  Lei</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhu  Chen</span>, <span class="hlFld-ContribAuthor ">Dian-Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhi-Gang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient microwave-assisted synthesis of fused benzoxazepine–isoquinoline derivatives via an Ugi reaction/tautomerization/intramolecular SNAr reaction sequence. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (16)
                                     , 1640-1643. <a href="https://doi.org/10.1016/j.tetlet.2017.03.036" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.03.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.03.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.03.036%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DEfficient%252Bmicrowave-assisted%252Bsynthesis%252Bof%252Bfused%252Bbenzoxazepine%2525E2%252580%252593isoquinoline%252Bderivatives%252Bvia%252Ban%252BUgi%252Breaction%25252Ftautomerization%25252Fintramolecular%252BSNAr%252Breaction%252Bsequence%26aulast%3DXu%26aufirst%3DJia%26date%3D2017%26volume%3D58%26issue%3D16%26spage%3D1640%26epage%3D1643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Azam  Roohi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Hojjat-Farsangi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in targeting mTOR signaling pathway using small molecule inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Targeting</span><span> <strong>2017,</strong> <em>25 </em>
                                    (3)
                                     , 189-201. <a href="https://doi.org/10.1080/1061186X.2016.1236112" title="DOI URL">https://doi.org/10.1080/1061186X.2016.1236112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1061186X.2016.1236112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1061186X.2016.1236112%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Targeting%26atitle%3DRecent%252Badvances%252Bin%252Btargeting%252BmTOR%252Bsignaling%252Bpathway%252Busing%252Bsmall%252Bmolecule%252Binhibitors%26aulast%3DRoohi%26aufirst%3DAzam%26date%3D2017%26date%3D2016%26volume%3D25%26issue%3D3%26spage%3D189%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beibei  Mao</span>, <span class="hlFld-ContribAuthor ">Shanyun  Gao</span>, <span class="hlFld-ContribAuthor ">Yiran  Weng</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>, <span class="hlFld-ContribAuthor ">Lihe  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of imidazo[1,2- b ]pyridazine derivatives as mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>129 </em>, 135-150. <a href="https://doi.org/10.1016/j.ejmech.2017.02.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.02.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.02.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bimidazo%25255B1%25252C2-%252Bb%252B%25255Dpyridazine%252Bderivatives%252Bas%252BmTOR%252Binhibitors%26aulast%3DMao%26aufirst%3DBeibei%26date%3D2017%26volume%3D129%26spage%3D135%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei Shi  Ong</span>, <span class="hlFld-ContribAuthor ">Louis Z.  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Dai</span>, <span class="hlFld-ContribAuthor ">Sheng Hsuan  Tseng</span>, <span class="hlFld-ContribAuthor ">Shang Jun  Loo</span>, <span class="hlFld-ContribAuthor ">Gautam  Sethi</span>. </span><span class="cited-content_cbyCitation_article-title">Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2016,</strong> <em>7 </em><a href="https://doi.org/10.3389/fphar.2016.00395" title="DOI URL">https://doi.org/10.3389/fphar.2016.00395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2016.00395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2016.00395%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DJudicious%252BToggling%252Bof%252BmTOR%252BActivity%252Bto%252BCombat%252BInsulin%252BResistance%252Band%252BCancer%25253A%252BCurrent%252BEvidence%252Band%252BPerspectives%26aulast%3DOng%26aufirst%3DPei%2BShi%26date%3D2016%26date%3D2016%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Yang</span>, <span class="hlFld-ContribAuthor ">Simin  Yang</span>, <span class="hlFld-ContribAuthor ">Shanshan  Zhou</span>, <span class="hlFld-ContribAuthor ">Dongbo  Lu</span>, <span class="hlFld-ContribAuthor ">Liyan  Ji</span>, <span class="hlFld-ContribAuthor ">Zhongjun  Li</span>, <span class="hlFld-ContribAuthor ">Siwang  Yu</span>, <span class="hlFld-ContribAuthor ">Xiangbao  Meng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>122 </em>, 488-496. <a href="https://doi.org/10.1016/j.ejmech.2016.07.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Banti-cancer%252Bevaluation%252Bof%252Bbenzenesulfonamide%252Bderivatives%252Bas%252Bpotent%252Btubulin-targeting%252Bagents%26aulast%3DYang%26aufirst%3DJun%26date%3D2016%26volume%3D122%26spage%3D488%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun-Rong  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiao-zhong  Zhou</span>, <span class="hlFld-ContribAuthor ">Lun-qing  Zhu</span>, <span class="hlFld-ContribAuthor ">Chen  Yao</span>, <span class="hlFld-ContribAuthor ">Jian-Feng  Fang</span>, <span class="hlFld-ContribAuthor ">Feng  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiong-Wei  Deng</span>, <span class="hlFld-ContribAuthor ">Yun-Qing  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (31)
                                     , 49527-49538. <a href="https://doi.org/10.18632/oncotarget.10389" title="DOI URL">https://doi.org/10.18632/oncotarget.10389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.10389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.10389%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DThe%252Banti-cancer%252Bactivity%252Bof%252Bthe%252BmTORC1%25252F2%252Bdual%252Binhibitor%252BXL388%252Bin%252Bpreclinical%252Bosteosarcoma%252Bmodels%26aulast%3DZhu%26aufirst%3DYun-Rong%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D31%26spage%3D49527%26epage%3D49538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohsine  Driowya</span>, <span class="hlFld-ContribAuthor ">Aziza  Saber</span>, <span class="hlFld-ContribAuthor ">Hamid  Marzag</span>, <span class="hlFld-ContribAuthor ">Luc  Demange</span>, <span class="hlFld-ContribAuthor ">Khalid  Bougrin</span>, <span class="hlFld-ContribAuthor ">Rachid  Benhida</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-Assisted Syntheses of Bioactive Seven-Membered, Macro-Sized Heterocycles and Their Fused Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (8)
                                     , 1032. <a href="https://doi.org/10.3390/molecules21081032" title="DOI URL">https://doi.org/10.3390/molecules21081032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21081032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21081032%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMicrowave-Assisted%252BSyntheses%252Bof%252BBioactive%252BSeven-Membered%25252C%252BMacro-Sized%252BHeterocycles%252Band%252BTheir%252BFused%252BDerivatives%26aulast%3DDriowya%26aufirst%3DMohsine%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D8%26spage%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Udit  Chaube</span>, <span class="hlFld-ContribAuthor ">Dhara  Chhatbar</span>, <span class="hlFld-ContribAuthor ">Hardik  Bhatt</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 864-874. <a href="https://doi.org/10.1016/j.bmcl.2015.12.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3D-QSAR%25252C%252Bmolecular%252Bdynamics%252Bsimulations%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252Bbenzoxazepine%252Bmoiety%252Bas%252BmTOR%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252Blung%252Bcancer%26aulast%3DChaube%26aufirst%3DUdit%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D864%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Parrino</span>, <span class="hlFld-ContribAuthor ">Cristina  Ciancimino</span>, <span class="hlFld-ContribAuthor ">Anna  Carbone</span>, <span class="hlFld-ContribAuthor ">Virginia  Spanò</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>, <span class="hlFld-ContribAuthor ">Girolamo  Cirrincione</span>, <span class="hlFld-ContribAuthor ">Patrizia  Diana</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of isoindolo[1,4]benzoxazinone and isoindolo[1,5]benzoxazepine: two new ring systems of pharmaceutical interest. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (39)
                                     , 7332-7338. <a href="https://doi.org/10.1016/j.tet.2015.04.083" title="DOI URL">https://doi.org/10.1016/j.tet.2015.04.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.04.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.04.083%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bisoindolo%25255B1%25252C4%25255Dbenzoxazinone%252Band%252Bisoindolo%25255B1%25252C5%25255Dbenzoxazepine%25253A%252Btwo%252Bnew%252Bring%252Bsystems%252Bof%252Bpharmaceutical%252Binterest%26aulast%3DParrino%26aufirst%3DBarbara%26date%3D2015%26volume%3D71%26issue%3D39%26spage%3D7332%26epage%3D7338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alonso  Heredia</span>, <span class="hlFld-ContribAuthor ">Nhut  Le</span>, <span class="hlFld-ContribAuthor ">Ronald B.  Gartenhaus</span>, <span class="hlFld-ContribAuthor ">Edward  Sausville</span>, <span class="hlFld-ContribAuthor ">Sandra  Medina-Moreno</span>, <span class="hlFld-ContribAuthor ">Juan C.  Zapata</span>, <span class="hlFld-ContribAuthor ">Charles  Davis</span>, <span class="hlFld-ContribAuthor ">Robert C.  Gallo</span>, <span class="hlFld-ContribAuthor ">Robert R.  Redfield</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2015,</strong> <em>112 </em>
                                    (30)
                                     , 9412-9417. <a href="https://doi.org/10.1073/pnas.1511144112" title="DOI URL">https://doi.org/10.1073/pnas.1511144112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1511144112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1511144112%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DTargeting%252Bof%252BmTOR%252Bcatalytic%252Bsite%252Binhibits%252Bmultiple%252Bsteps%252Bof%252Bthe%252BHIV-1%252Blifecycle%252Band%252Bsuppresses%252BHIV-1%252Bviremia%252Bin%252Bhumanized%252Bmice%26aulast%3DHeredia%26aufirst%3DAlonso%26date%3D2015%26date%3D2015%26volume%3D112%26issue%3D30%26spage%3D9412%26epage%3D9417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Analia  Azaro</span>, <span class="hlFld-ContribAuthor ">Jordi  Rodon</span>, <span class="hlFld-ContribAuthor ">Antonio  Calles</span>, <span class="hlFld-ContribAuthor ">Irene  Braña</span>, <span class="hlFld-ContribAuthor ">Manuel  Hidalgo</span>, <span class="hlFld-ContribAuthor ">Pedro P.  Lopez-Casas</span>, <span class="hlFld-ContribAuthor ">Manuel  Munoz</span>, <span class="hlFld-ContribAuthor ">Paul  Westwood</span>, <span class="hlFld-ContribAuthor ">Joel  Miller</span>, <span class="hlFld-ContribAuthor ">Brian A.  Moser</span>, <span class="hlFld-ContribAuthor ">Ute  Ohnmacht</span>, <span class="hlFld-ContribAuthor ">William  Bumgardner</span>, <span class="hlFld-ContribAuthor ">Karim A.  Benhadji</span>, <span class="hlFld-ContribAuthor ">Emiliano  Calvo</span>. </span><span class="cited-content_cbyCitation_article-title">A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2015,</strong> <em>33 </em>
                                    (3)
                                     , 710-719. <a href="https://doi.org/10.1007/s10637-015-0241-7" title="DOI URL">https://doi.org/10.1007/s10637-015-0241-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-015-0241-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-015-0241-7%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DA%252Bfirst-in-human%252Bphase%252BI%252Btrial%252Bof%252BLY2780301%25252C%252Ba%252Bdual%252Bp70%252BS6%252Bkinase%252Band%252BAkt%252BInhibitor%25252C%252Bin%252Bpatients%252Bwith%252Badvanced%252Bor%252Bmetastatic%252Bcancer%26aulast%3DAzaro%26aufirst%3DAnalia%26date%3D2015%26date%3D2015%26volume%3D33%26issue%3D3%26spage%3D710%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barreddi  Chiranjeevi</span>, <span class="hlFld-ContribAuthor ">Botla  Vinayak</span>, <span class="hlFld-ContribAuthor ">Thupakula  Parsharamulu</span>, <span class="hlFld-ContribAuthor ">Vemulapalli S.  PhaniBabu</span>, <span class="hlFld-ContribAuthor ">Bharatam  Jagadeesh</span>, <span class="hlFld-ContribAuthor ">Balasubramanian  Sridhar</span>, <span class="hlFld-ContribAuthor ">Malapaka  Chandrasekharam</span>. </span><span class="cited-content_cbyCitation_article-title">Iron(III)-Catalyzed C-H Functionalization:
              ortho
              -Benzoyloxylation of
              N
              ,
              N
              -Dialkylanilines and Its Application to 1,4-Benzoxazepines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (35)
                                     , 7839-7849. <a href="https://doi.org/10.1002/ejoc.201402751" title="DOI URL">https://doi.org/10.1002/ejoc.201402751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201402751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201402751%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIron%252528III%252529-Catalyzed%252BC-H%252BFunctionalization%25253A%252Bortho%252B-Benzoyloxylation%252Bof%252BN%252B%25252C%252BN%252B-Dialkylanilines%252Band%252BIts%252BApplication%252Bto%252B1%25252C4-Benzoxazepines%26aulast%3DChiranjeevi%26aufirst%3DBarreddi%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D35%26spage%3D7839%26epage%3D7849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdellah  Messoussi</span>, <span class="hlFld-ContribAuthor ">Lucile  Peyronnet</span>, <span class="hlFld-ContribAuthor ">Clémence  Feneyrolles</span>, <span class="hlFld-ContribAuthor ">Gwénaël  Chevé</span>, <span class="hlFld-ContribAuthor ">Khalid  Bougrin</span>, <span class="hlFld-ContribAuthor ">Aziz  Yasri</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Elucidation of the DFG-Asp in and DFG-Asp out States of TAM Kinases and Insight into the Selectivity of Their Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (10)
                                     , 16223-16239. <a href="https://doi.org/10.3390/molecules191016223" title="DOI URL">https://doi.org/10.3390/molecules191016223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules191016223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules191016223%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructural%252BElucidation%252Bof%252Bthe%252BDFG-Asp%252Bin%252Band%252BDFG-Asp%252Bout%252BStates%252Bof%252BTAM%252BKinases%252Band%252BInsight%252Binto%252Bthe%252BSelectivity%252Bof%252BTheir%252BInhibitors%26aulast%3DMessoussi%26aufirst%3DAbdellah%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D10%26spage%3D16223%26epage%3D16239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John H.  Ryan</span>, <span class="hlFld-ContribAuthor ">Jason A.  Smith</span>, <span class="hlFld-ContribAuthor ">Christopher  Hyland</span>, <span class="hlFld-ContribAuthor ">Adam G.  Meyer</span>, <span class="hlFld-ContribAuthor ">Charlotte C.  Williams</span>, <span class="hlFld-ContribAuthor ">Alex C.  Bissember</span>, <span class="hlFld-ContribAuthor ">Jeremy  Just</span>. </span><span class="cited-content_cbyCitation_article-title">Seven-Membered Rings. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 521-571. <a href="https://doi.org/10.1016/B978-0-08-100017-5.00016-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-100017-5.00016-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100017-5.00016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100017-5.00016-9%26sid%3Dliteratum%253Aachs%26atitle%3DSeven-Membered%252BRings%26aulast%3DRyan%26aufirst%3DJohn%2BH.%26date%3D2014%26spage%3D521%26epage%3D571%26pub%3DElsevier%26date%3D2014%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shashi  Pandey</span>, <span class="hlFld-ContribAuthor ">S. Vinod  Kumar</span>, <span class="hlFld-ContribAuthor ">Ruchir  Kant</span>, <span class="hlFld-ContribAuthor ">Prem M. S.  Chauhan</span>. </span><span class="cited-content_cbyCitation_article-title">Base mediated 7-exo-dig intramolecular cyclization of Ugi–propargyl precursors: a highly efficient and regioselective synthetic approach toward diverse 1,4-benzoxazepine-5(2H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (29)
                                     , 5346-5350. <a href="https://doi.org/10.1039/C4OB00793J" title="DOI URL">https://doi.org/10.1039/C4OB00793J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB00793J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB00793J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DBase%252Bmediated%252B7-exo-dig%252Bintramolecular%252Bcyclization%252Bof%252BUgi%2525E2%252580%252593propargyl%252Bprecursors%25253A%252Ba%252Bhighly%252Befficient%252Band%252Bregioselective%252Bsynthetic%252Bapproach%252Btoward%252Bdiverse%252B1%25252C4-benzoxazepine-5%2525282H%252529-ones%26aulast%3DPandey%26aufirst%3DShashi%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D29%26spage%3D5346%26epage%3D5350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Lichuan  Lin</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, <span class="hlFld-ContribAuthor ">Kirk D.  Robarge</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>. </span><span class="cited-content_cbyCitation_article-title">A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (18)
                                     , 5097-5104. <a href="https://doi.org/10.1016/j.bmcl.2013.07.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.07.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.07.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bhit%252Bto%252Blead%252Bdiscovery%252Bof%252Bnovel%252BN-methylated%252Bimidazolo-%25252C%252Bpyrrolo-%25252C%252Band%252Bpyrazolo-pyrimidines%252Bas%252Bpotent%252Band%252Bselective%252BmTOR%252Binhibitors%26aulast%3DLee%26aufirst%3DWendy%26date%3D2013%26volume%3D23%26issue%3D18%26spage%3D5097%26epage%3D5104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Literature examples of dual PI3K/mTOR and selective ATP-competitive mTOR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Early benzoxazepine derivatives of HTS hit <b>1</b>. Note 1: average IC<sub>50</sub> (<i>n</i> ≥ 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Proposed binding orientation of BEZ235 in PI3Kγ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E8Z">1E8Z</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (B) Potential binding orientation of <b>1</b> where benzoxazepine oxygen forms a hinge region hydrogen bond. (C) Potential binding orientation of <b>1</b> where quinoline nitrogen forms a hinge region hydrogen bond.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Pharmacokinetic profile of <b>28</b> in dogs. Compound <b>28</b> was dosed at 3 mg/kg in male beagles. Data are reported as the mean ± SD (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. IC<sub>50</sub> for <b>28</b> as a function of the ATP concentration. Error bars represent the standard error of the mean on four IC<sub>50</sub> values at each ATP concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition (%) of phosphorylation of p70S6K, S6, 4E-BP1, and AKT in PC-3 xenograft tumors and exposure data after a single oral dose (100 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibition (%) of phosphorylation of p70S6K, S6, 4E-BP1, and AKT in MCF-7 xenograft tumors and exposure data after a single oral dose (100 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. In vivo efficacy of <b>28</b> in MCF-7 xenograft tumors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-aminoethanol, NaBH<sub>4</sub>, MeOH, Boc<sub>2</sub>O; (b) (Ph)<sub>3</sub>P, DIAD, THF, (c) <i>n</i>-BuLi, THF, triisopropyl borate, −78 °C, HCl.</p></p></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (TMS)CHN<sub>2</sub>, THF/MeOH (2:1), 0 °C; (b) RB(OH)<sub>2</sub>, [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane, K<sub>2</sub>CO<sub>3</sub>, Ag<sub>2</sub>O, THF, 85 °C; (c) MeOH, 1 N NaOH, 45 °C; (d) ethylamine, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 95 °C; (e) CH<sub>2</sub>Cl<sub>2</sub>/MeOH (1:1), 1 N NaOH, 45 °C.</p></p></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Fe, Br<sub>2</sub>, CHCl<sub>3</sub>; (b) <sup>i</sup>PrMgCl, THF, CO<sub>2</sub>; (c) NaSCH<sub>3</sub>, DMF, Oxone, NaOH, NaHCO<sub>3</sub>, acetone/H<sub>2</sub>O (1:1), 0 °C.</p></p></figure><figure data-id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BH<sub>3</sub>–SMe<sub>2</sub>, THF; (b) TsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, LiBr, acetone; (c) Mg, Et<sub>2</sub>O, BrCH<sub>2</sub>CH<sub>2</sub>Br, aqueous NH<sub>4</sub>Cl; (d) Fe, Br<sub>2</sub>, CHCl<sub>3</sub>; (e) <sup>i</sup>PrMgCl, THF, CO<sub>2</sub>; (f) NaSCH<sub>3</sub>, DMF, Oxone, NaOH, NaHCO<sub>3</sub>, acetone/H<sub>2</sub>O (1:1), 0 °C.</p></p></figure><figure data-id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) quinolin-3-ylboronic acid, [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane, triethylamine, 1,4-dioxane, H<sub>2</sub>O, 85 °C; (b) 4 N HCl, 1,4-dioxane, rt; (c) <i>N</i>,<i>N</i>-diisopropylethylamine, HATU, DMF, 4-(2,2,2-trifluoroacetyl)benzoic acid, rt.</p></p></figure><figure data-id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/medium/jm-2012-007933_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3007933/production/images/large/jm-2012-007933_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007933&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 6-bromo-1<i>H</i>-indazole, 1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane, triethylamine, 1,4-dioxane, H<sub>2</sub>O, 85 °C; (b) 4 N HCl, 1,4-dioxane, rt; (c) <i>N</i>,<i>N</i>-diisopropylethylamine, HATU, DMF, 4-(2,2,2-trifluoroacetyl)benzoic acid, rt.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76614" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76614" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Bjornsti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, P. J.</span><span> </span><span class="NLM_article-title">The TOR Pathway: A Target for Cancer Therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1038%2Fnrc1362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=15122205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFSlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=335-348&author=M.+A.+Bjornstiauthor=P.+J.+Houghton&title=The+TOR+Pathway%3A+A+Target+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The TOR pathway: a target for cancer therapy</span></div><div class="casAuthors">Bjornsti, Mary-Ann; Houghton, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">335-348</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rapamycin, a macrocyclic lactone, is a highly specific inhibitor of the Ser/threonine protein kinase target of rapamycin (TOR).  Although it is clear that TOR controls initiation of protein translation, recent results indicate that TOR is a central controller, integrating a plethora of signalling pathways that respond to growth factors and nutritional status.  In addn. to the role of rapamycin as an immune suppressant, emerging data indicate that genetic and metabolic changes accompanying malignant transformation might cause hypersensitivity to TOR inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqivgUxs8RJPLVg90H21EOLACvtfcHk0ljf0spg22fNyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFSlu7Y%253D&md5=40cc8442a8f8f8c19f776af5d8ed3772</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc1362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1362%26sid%3Dliteratum%253Aachs%26aulast%3DBjornsti%26aufirst%3DM.%2BA.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520TOR%2520Pathway%253A%2520A%2520Target%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D335%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the Role of mTOR in Cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+Role+of+mTOR+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520Role%2520of%2520mTOR%2520in%2520Cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">mTOR as a Target for Cancer Therapy</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=339-359&author=P.+J.+Houghtonauthor=S.+Huang&title=mTOR+as+a+Target+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DmTOR%2520as%2520a%2520Target%2520for%2520Cancer%2520Therapy%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2004%26volume%3D279%26spage%3D339%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Inoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradetti, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, K. L.</span><span> </span><span class="NLM_article-title">Dysregulation of the TSC-mTOR Pathway in Human Disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1038%2Fng1494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=15624019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFChsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=19-24&author=K.+Inokiauthor=M.+N.+Corradettiauthor=K.+L.+Guan&title=Dysregulation+of+the+TSC-mTOR+Pathway+in+Human+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulation of the TSC-mTOR pathway in human disease</span></div><div class="casAuthors">Inoki, Ken; Corradetti, Michael N.; Guan, Kun-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-24</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) has a central role in the regulation of cell growth. mTOR receives input from multiple signaling pathways, including growth factors and nutrients, to stimulate protein synthesis by phosphorylating key translation regulators such as ribosomal S6 kinase and eukaryote initiation factor 4E binding protein 1.  High levels of dysregulated mTOR activity are assocd. with several hamartoma syndromes, including tuberous sclerosis complex, the PTEN-related hamartoma syndromes and Peutz-Jeghers syndrome.  These disorders are all caused by mutations in tumor-suppressor genes that neg. regulate mTOR.  Here we discuss the emerging evidence for a functional relationship between the mTOR signaling pathway and several genetic diseases, and we present evidence supporting a model in which dysregulation of mTOR may be a common mol. basis, not only for hamartoma syndromes, but also for other cellular hypertrophic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcM0DjY6r9LVg90H21EOLACvtfcHk0ljf0spg22fNyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFChsL3M&md5=7cc3c4b4f1b02265816de0737a078fc7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fng1494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1494%26sid%3Dliteratum%253Aachs%26aulast%3DInoki%26aufirst%3DK.%26aulast%3DCorradetti%26aufirst%3DM.%2BN.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26atitle%3DDysregulation%2520of%2520the%2520TSC-mTOR%2520Pathway%2520in%2520Human%2520Disease%26jtitle%3DNat.%2520Genet.%26date%3D2005%26volume%3D37%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Jiang, Y. −P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballou, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, R. Z.</span><span> </span><span class="NLM_article-title">Rapamycin-Insensitive Regulation of 4E-BP1 in Regenerating Rat Liver</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">10943</span><span class="NLM_x">–</span> <span class="NLM_lpage">10951</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=10943-10951&author=Y.+%E2%88%92P.+Jiangauthor=L.+M.+Ballouauthor=R.+Z.+Lin&title=Rapamycin-Insensitive+Regulation+of+4E-BP1+in+Regenerating+Rat+Liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%2B%25E2%2588%2592P.%26aulast%3DBallou%26aufirst%3DL.%2BM.%26aulast%3DLin%26aufirst%3DR.%2BZ.%26atitle%3DRapamycin-Insensitive%2520Regulation%2520of%25204E-BP1%2520in%2520Regenerating%2520Rat%2520Liver%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D10943%26epage%3D10951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Boylan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruppuso, P. A.</span><span> </span><span class="NLM_article-title">Ribosomal Protein S6 Phosphorylation and Function during Late Gestation Liver Development in the Rat</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">44457</span><span class="NLM_x">–</span> <span class="NLM_lpage">44463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=44457-44463&author=J.+M.+Boylanauthor=P.+Anandauthor=P.+A.+Gruppuso&title=Ribosomal+Protein+S6+Phosphorylation+and+Function+during+Late+Gestation+Liver+Development+in+the+Rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoylan%26aufirst%3DJ.%2BM.%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DGruppuso%26aufirst%3DP.%2BA.%26atitle%3DRibosomal%2520Protein%2520S6%2520Phosphorylation%2520and%2520Function%2520during%2520Late%2520Gestation%2520Liver%2520Development%2520in%2520the%2520Rat%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D44457%26epage%3D44463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">An ATP Competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-Resistant Functions of mTORC1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">–</span> <span class="NLM_lpage">8032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8023-8032&author=C.+C.+Thoreenauthor=S.+A.+Kangauthor=J.+W.+Changauthor=Q.+Liuauthor=J.+Zhangauthor=Y.+Gaoauthor=L.+J.+Reichlingauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=An+ATP+Competitive+Mammalian+Target+of+Rapamycin+Inhibitor+Reveals+Rapamycin-Resistant+Functions+of+mTORC1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DAn%2520ATP%2520Competitive%2520Mammalian%2520Target%2520of%2520Rapamycin%2520Inhibitor%2520Reveals%2520Rapamycin-Resistant%2520Functions%2520of%2520mTORC1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8023%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outpurs of mTORC1 and mTORC2</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=371-383&author=M.+E.+Feldmanauthor=B.+Apselauthor=A.+Uotilaauthor=R.+Loewithauthor=Z.+A.+Knightauthor=D.+Ruggeroauthor=K.+M.+Shokat&title=Active-Site+Inhibitors+of+mTOR+Target+Rapamycin-Resistant+Outpurs+of+mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DUotila%26aufirst%3DA.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DActive-Site%2520Inhibitors%2520of%2520mTOR%2520Target%2520Rapamycin-Resistant%2520Outpurs%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D371%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Finger, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blenis, J.</span><span> </span><span class="NLM_article-title">Mammalian Cell Size Is Controlled by mTOR and Its Downstream Targets S6K1 and 4EBP1/eIF4E</span> <span class="citation_source-journal">Gene Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1472</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=1472-1487&author=D.+C.+Fingerauthor=S.+Salamaauthor=C.+Tsouauthor=E.+Harlowauthor=J.+Blenis&title=Mammalian+Cell+Size+Is+Controlled+by+mTOR+and+Its+Downstream+Targets+S6K1+and+4EBP1%2FeIF4E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinger%26aufirst%3DD.%2BC.%26aulast%3DSalama%26aufirst%3DS.%26aulast%3DTsou%26aufirst%3DC.%26aulast%3DHarlow%26aufirst%3DE.%26aulast%3DBlenis%26aufirst%3DJ.%26atitle%3DMammalian%2520Cell%2520Size%2520Is%2520Controlled%2520by%2520mTOR%2520and%2520Its%2520Downstream%2520Targets%2520S6K1%2520and%25204EBP1%252FeIF4E%26jtitle%3DGene%2520Dev.%26date%3D2002%26volume%3D16%26spage%3D1472%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Finger, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tee, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheatham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blenis, J.</span><span> </span><span class="NLM_article-title">mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eurkaryotic Translation Initiation Factor 4E</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1128%2FMCB.24.1.200-216.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=14673156" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=200-216&author=D.+C.+Fingerauthor=C.+J.+Richardsonauthor=A.+R.+Teeauthor=L.+Cheathamauthor=C.+Tsouauthor=J.+Blenis&title=mTOR+Controls+Cell+Cycle+Progression+through+Its+Cell+Growth+Effectors+S6K1+and+4E-BP1%2FEurkaryotic+Translation+Initiation+Factor+4E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.1.200-216.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.1.200-216.2004%26sid%3Dliteratum%253Aachs%26aulast%3DFinger%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DC.%2BJ.%26aulast%3DTee%26aufirst%3DA.%2BR.%26aulast%3DCheatham%26aufirst%3DL.%26aulast%3DTsou%26aufirst%3DC.%26aulast%3DBlenis%26aufirst%3DJ.%26atitle%3DmTOR%2520Controls%2520Cell%2520Cycle%2520Progression%2520through%2520Its%2520Cell%2520Growth%2520Effectors%2520S6K1%2520and%25204E-BP1%252FEurkaryotic%2520Translation%2520Initiation%2520Factor%25204E%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D200%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagley, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markhard, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=159-168&author=D.+D.+Sarbassovauthor=S.+M.+Aliauthor=S.+Senguptaauthor=J.+H.+Sheenauthor=P.+P.+Hsuauthor=A.+F.+Bagleyauthor=A.+L.+Markhardauthor=D.+M.+Sabatini&title=Prolonged+Rapamycin+Treatment+Inhibits+mTORC2+Assembly+and+Akt%2FPKB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DSheen%26aufirst%3DJ.%2BH.%26aulast%3DHsu%26aufirst%3DP.%2BP.%26aulast%3DBagley%26aufirst%3DA.%2BF.%26aulast%3DMarkhard%26aufirst%3DA.%2BL.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DProlonged%2520Rapamycin%2520Treatment%2520Inhibits%2520mTORC2%2520Assembly%2520and%2520Akt%252FPKB%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D22%26spage%3D159%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Choo, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blenis, J.</span><span> </span><span class="NLM_article-title">Rapamycin Differentially Inhibits S6Ks and 4E-BP1 To Mediate Cell-Type-Specific Repression of mRNA Translation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">17414</span><span class="NLM_x">–</span> <span class="NLM_lpage">17419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17414-17419&author=A.+Y.+Chooauthor=S.+O.+Yoonauthor=S.+G.+Kimauthor=P.+P.+Rouxauthor=J.+Blenis&title=Rapamycin+Differentially+Inhibits+S6Ks+and+4E-BP1+To+Mediate+Cell-Type-Specific+Repression+of+mRNA+Translation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DA.%2BY.%26aulast%3DYoon%26aufirst%3DS.%2BO.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DRoux%26aufirst%3DP.%2BP.%26aulast%3DBlenis%26aufirst%3DJ.%26atitle%3DRapamycin%2520Differentially%2520Inhibits%2520S6Ks%2520and%25204E-BP1%2520To%2520Mediate%2520Cell-Type-Specific%2520Repression%2520of%2520mRNA%2520Translation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D17414%26epage%3D17419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">The Pharmacology of mTOR Inhibition</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1126%2Fscisignal.267pe24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=19318623" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=1-6&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=The+Pharmacology+of+mTOR+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.267pe24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.267pe24%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DThe%2520Pharmacology%2520of%2520mTOR%2520Inhibition%26jtitle%3DSci.%2520Signaling%26date%3D2009%26volume%3D2%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">PI 3-Kinase Related Kinases: “Big” Players in Stress-Induced Signaling Pathways</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=883-887&author=R.+T.+Abraham&title=PI+3-Kinase+Related+Kinases%3A+%E2%80%9CBig%E2%80%9D+Players+in+Stress-Induced+Signaling+Pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DPI%25203-Kinase%2520Related%2520Kinases%253A%2520%25E2%2580%259CBig%25E2%2580%259D%2520Players%2520in%2520Stress-Induced%2520Signaling%2520Pathways%26jtitle%3DDNA%2520Repair%26date%3D2004%26volume%3D3%26spage%3D883%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamburini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viguie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ifrah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyfus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouscary, D.</span><span> </span><span class="NLM_article-title">PI-103, a Dual Inhibitor of Class IA Phosphatidylinositide 3-Kinase and mTOR, Has Antileukemic Activity in AML</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1698</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1698-1706&author=S.+Parkauthor=N.+Chapuisauthor=V.+Bardetauthor=J.+Tamburiniauthor=N.+Gallayauthor=L.+Willemsauthor=Z.+A.+Knightauthor=K.+M.+Shokatauthor=N.+Azarauthor=F.+Viguieauthor=N.+Ifrahauthor=F.+Dreyfusauthor=P.+Mayeuxauthor=C.+Lacombeauthor=D.+Bouscary&title=PI-103%2C+a+Dual+Inhibitor+of+Class+IA+Phosphatidylinositide+3-Kinase+and+mTOR%2C+Has+Antileukemic+Activity+in+AML"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%26aulast%3DChapuis%26aufirst%3DN.%26aulast%3DBardet%26aufirst%3DV.%26aulast%3DTamburini%26aufirst%3DJ.%26aulast%3DGallay%26aufirst%3DN.%26aulast%3DWillems%26aufirst%3DL.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DAzar%26aufirst%3DN.%26aulast%3DViguie%26aufirst%3DF.%26aulast%3DIfrah%26aufirst%3DN.%26aulast%3DDreyfus%26aufirst%3DF.%26aulast%3DMayeux%26aufirst%3DP.%26aulast%3DLacombe%26aufirst%3DC.%26aulast%3DBouscary%26aufirst%3DD.%26atitle%3DPI-103%252C%2520a%2520Dual%2520Inhibitor%2520of%2520Class%2520IA%2520Phosphatidylinositide%25203-Kinase%2520and%2520mTOR%252C%2520Has%2520Antileukemic%2520Activity%2520in%2520AML%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D1698%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Serra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaltriti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, P. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botero, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llonch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atzori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosimo, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span> </span><span class="NLM_article-title">NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">8022</span><span class="NLM_x">–</span> <span class="NLM_lpage">8030</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1158%2F0008-5472.CAN-08-1385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=18829560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2msLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=8022-8030&author=V.+Serraauthor=B.+Markmanauthor=M.+Scaltritiauthor=P.+J.+A.+Eichhornauthor=V.+Valeroauthor=M.+Guzmanauthor=M.+L.+Boteroauthor=E.+Llonchauthor=F.+Atzoriauthor=S.+D.+Cosimoauthor=M.+Mairaauthor=C.+Carcia-Echeverriaauthor=J.+L.+Parraauthor=J.+Arribasauthor=J.+Baselga&title=NVP-BEZ235%2C+a+Dual+PI3K%2FmTOR+Inhibitor%2C+Prevents+PI3K+Signaling+and+Inhibits+the+Growth+of+Cancer+Cells+with+Activating+PI3K+Mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations</span></div><div class="casAuthors">Serra, Violeta; Markman, Ben; Scaltriti, Maurizio; Eichhorn, Pieter J. A.; Valero, Vanesa; Guzman, Marta; Botero, Maria Luisa; Llonch, Elisabeth; Atzori, Francesco; Di Cosimo, Serena; Maira, Michel; Garcia-Echeverria, Carlos; Parra, Josep Lluis; Arribas, Joaquin; Baselga, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8022-8030</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) pathway deregulation is a common event in human cancer, either through inactivation of the tumor suppressor phosphatase and tensin homolog deleted from chromosome 10 or activating mutations of p110-α.  These hotspot mutations result in oncogenic activity of the enzyme and contribute to therapeutic resistance to the anti-HER2 antibody trastuzumab.  The PI3K pathway is, therefore, an attractive target for cancer therapy.  We have studied NVP-BEZ235, a dual inhibitor of the PI3K and the downstream mammalian target of rapamycin (mTOR).  NVP-BEZ235 inhibited the activation of the downstream effectors Akt, S6 ribosomal protein, and 4EBP1 in breast cancer cells.  The antiproliferative activity of NVP-BEZ235 was superior to the allosteric selective mTOR complex inhibitor everolimus in a panel of 21 cancer cell lines of different origin and mutation status.  The described Akt activation due to mTOR inhibition was prevented by higher doses of NVP-BEZ235.  NVP-BEZ235 reversed the hyperactivation of the PI3K/mTOR pathway caused by the oncogenic mutations of p110-α, E545K, and H1047R, and inhibited the proliferation of HER2-amplified BT474 cells exogenously expressing these mutations that render them resistant to trastuzumab.  In trastuzumab-resistant BT474 H1047R breast cancer xenografts, NVP-BEZ235 inhibited PI3K signaling and had potent antitumor activity.  In treated animals, there was complete inhibition of PI3K signaling in the skin at pharmacol. active doses, suggesting that skin may serve as surrogate tissue for pharmacodynamic studies.  In summary, NVP-BEZ235 inhibits the PI3K/mTOR axis and results in antiproliferative and antitumoral activity in cancer cells with both wild-type and mutated p110-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlC_vqzWMDk7Vg90H21EOLACvtfcHk0liaxZEO7rTfSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2msLrK&md5=b5d08e989c1b619e3c0ee9437002afd7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-1385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-1385%26sid%3Dliteratum%253Aachs%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DMarkman%26aufirst%3DB.%26aulast%3DScaltriti%26aufirst%3DM.%26aulast%3DEichhorn%26aufirst%3DP.%2BJ.%2BA.%26aulast%3DValero%26aufirst%3DV.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DBotero%26aufirst%3DM.%2BL.%26aulast%3DLlonch%26aufirst%3DE.%26aulast%3DAtzori%26aufirst%3DF.%26aulast%3DCosimo%26aufirst%3DS.%2BD.%26aulast%3DMaira%26aufirst%3DM.%26aulast%3DCarcia-Echeverria%26aufirst%3DC.%26aulast%3DParra%26aufirst%3DJ.%2BL.%26aulast%3DArribas%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DNVP-BEZ235%252C%2520a%2520Dual%2520PI3K%252FmTOR%2520Inhibitor%252C%2520Prevents%2520PI3K%2520Signaling%2520and%2520Inhibits%2520the%2520Growth%2520of%2520Cancer%2520Cells%2520with%2520Activating%2520PI3K%2520Mutations%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D8022%26epage%3D8030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span> </span><span class="NLM_article-title">Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7579</span><span class="NLM_x">–</span> <span class="NLM_lpage">7587</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2009327" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Ort7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7579-7587&author=D.+P.+Sutherlinauthor=L.+Baoauthor=M.+Berryauthor=G.+Castanedoauthor=I.+Chuckowreeauthor=J.+Dostonauthor=A.+Folkesauthor=L.+Freidmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Murrayauthor=J.+Nonomiyaauthor=J.+Pangauthor=N.+Peggauthor=W.+W.+Priorauthor=L.+Rougeauthor=L.+Salphatiauthor=D.+Sampathauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=B.+Weiauthor=C.+Wiesmannauthor=P.+Wuauthor=B.+Zhuauthor=A.+Olivero&title=Discovery+of+a+Potent%2C+Selective%2C+and+Orally+Available+Class+I+Phosphatidylinositol+3-Kinase+%28PI3K%29%2FMammalian+Target+of+Rapamycin+%28mTOR%29+Kinase+Inhibitor+%28GDC-0980%29+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer</span></div><div class="casAuthors">Sutherlin, Daniel P.; Bao, Linda; Berry, Megan; Castanedo, Georgette; Chuckowree, Irina; Dotson, Jenna; Folks, Adrian; Friedman, Lori; Goldsmith, Richard; Gunzner, Janet; Heffron, Timothy; Lesnick, John; Lewis, Cristina; Mathieu, Simon; Murray, Jeremy; Nonomiya, Jim; Pang, Jodie; Pegg, Niel; Prior, Wei Wei; Rouge, Lionel; Salphati, Laurent; Sampath, Deepak; Tian, Qingping; Tsui, Vickie; Wan, Nan Chi; Wang, Shumei; Wei, Bin Qing; Wiesmann, Christian; Wu, Ping; Zhu, Bing-Yan; Olivero, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7579-7587</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of 2 (GDC-0980, I), a class I PI3K and mTOR kinase inhibitor for oncol. indications, is described. mTOR inhibition was added to the class I PI3K inhibitor 1 (GDC-0941) scaffold primarily through the substitution of the indazole in 1 for a 2-aminopyrimidine.  This substitution also increased the microsomal stability and the free fraction of compds. as evidenced through a pairwise comparison of mols. that were otherwise identical.  Highlighted in detail are analogs of an advanced compd. 4 that were designed to improve soly., resulting in 2.  This compd., is potent across PI3K class I isoforms with IC50s of 5, 27, 7, and 14 nM for PI3Kα, β, δ, and γ, resp., inhibits mTOR with a Ki of 17 nM yet is highly selective vs. a large panel of kinases including others in the PIKK family.  On the basis of the cell potency, low clearance in mouse, and high free fraction, 2 demonstrated significant efficacy in mouse xenografts when dosed as low as 1 mg/kg orally and is currently in phase I clin. trials for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-3-5KDI509bVg90H21EOLACvtfcHk0liaxZEO7rTfSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Ort7%252FJ&md5=ba7ede710885b51fffa63977fc64d3f5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm2009327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2009327%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDoston%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFreidman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPegg%26aufirst%3DN.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DRouge%26aufirst%3DL.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DOlivero%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520Class%2520I%2520Phosphatidylinositol%25203-Kinase%2520%2528PI3K%2529%252FMammalian%2520Target%2520of%2520Rapamycin%2520%2528mTOR%2529%2520Kinase%2520Inhibitor%2520%2528GDC-0980%2529%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7579%26epage%3D7587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarpong, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershner, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span> </span><span class="NLM_article-title">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900028r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=39-43&author=S.+D.+Knightauthor=N.+D.+Adamsauthor=J.+L.+Burgessauthor=A.+M.+Chaudhariauthor=M.+G.+Darcyauthor=C.+A.+Donatelliauthor=J.+I.+Luengoauthor=K.+A.+Newlanderauthor=C.+A.+Parrishauthor=L.+Ridgersauthor=M.+A.+Sarpongauthor=S.+J.+Schmidtauthor=G.+S.+Van+Allerauthor=J.+D.+Carsonauthor=M.+A.+Diamondauthor=P.+A.+Elkinsauthor=C.+M.+Gardinerauthor=E.+Carverauthor=S.+A.+Gilbertauthor=R.+R.+Gontarekauthor=J.+R.+Jacksonauthor=K.+L.+Kershnerauthor=L.+Luoauthor=K.+Ragaauthor=C.+S.+Sherkauthor=C.+Sungauthor=D.+Suttonauthor=P.+J.+Tumminoauthor=R.+J.+Wegrzynauthor=K.+R.+Augerauthor=D.+Dhanak&title=Discovery+of+GSK2126458%2C+a+Highly+Potent+Inhibitor+of+PI3K+and+the+Mammalian+Target+of+Rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span></div><div class="casAuthors">Knight, Steven D.; Adams, Nicholas D.; Burgess, Joelle L.; Chaudhari, Amita M.; Darcy, Michael G.; Donatelli, Carla A.; Luengo, Juan I.; Newlander, Ken A.; Parrish, Cynthia A.; Ridgers, Lance H.; Sarpong, Martha A.; Schmidt, Stanley J.; Van Aller, Glenn S.; Carson, Jeffrey D.; Diamond, Melody A.; Elkins, Patricia A.; Gardiner, Christine M.; Garver, Eric; Gilbert, Seth A.; Gontarek, Richard R.; Jackson, Jeffrey R.; Kershner, Kevin L.; Luo, Lusong; Raha, Kaushik; Sherk, Christian S.; Sung, Chiu-Mei; Sutton, David; Tummino, Peter J.; Wegrzyn, Ronald J.; Auger, Kurt R.; Dhanak, Dashyant</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-43</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase α (PI3Kα) is a crit. regulator of cell growth and transformation, and its signaling pathway is the most commonly mutated pathway in human cancers.  The mammalian target of rapamycin (mTOR), a class IV PI3K protein kinase, is also a central regulator of cell growth, and mTOR inhibitors are believed to augment the antiproliferative efficacy of PI3K/AKT pathway inhibition. 2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide (GSK2126458, 1 (I)) has been identified as a highly potent, orally bioavailable inhibitor of PI3Kα and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.  Compd. 1 is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBH6_ywCnjCrVg90H21EOLACvtfcHk0lgXFQa00Vu3jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D&md5=72fcca85702dba95529ac03281e0bdbc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml900028r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900028r%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DRidgers%26aufirst%3DL.%26aulast%3DSarpong%26aufirst%3DM.%2BA.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DDiamond%26aufirst%3DM.%2BA.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26aulast%3DCarver%26aufirst%3DE.%26aulast%3DGilbert%26aufirst%3DS.%2BA.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKershner%26aufirst%3DK.%2BL.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DRaga%26aufirst%3DK.%26aulast%3DSherk%26aufirst%3DC.%2BS.%26aulast%3DSung%26aufirst%3DC.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DWegrzyn%26aufirst%3DR.%2BJ.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520GSK2126458%252C%2520a%2520Highly%2520Potent%2520Inhibitor%2520of%2520PI3K%2520and%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D39%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Garcia-Martinez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">412</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=412&publication_year=2009&pages=29-42&author=J.+M.+Garcia-Martinezauthor=J.+Moranauthor=R.+G.+Clarkeauthor=A.+Grayauthor=S.+C.+Cosulichauthor=C.+M.+Chrestaauthor=D.+R.+Alessi&title=Ku-0063794+Is+a+Specific+Inhibitor+of+the+Mammalian+Target+of+Rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Martinez%26aufirst%3DJ.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DR.%2BG.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DCosulich%26aufirst%3DS.%2BC.%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKu-0063794%2520Is%2520a%2520Specific%2520Inhibitor%2520of%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%2520%2528mTOR%2529%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D412%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Biochemical, Cellular, and in Vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6232</span><span class="NLM_x">–</span> <span class="NLM_lpage">6240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6232-6240&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Shiauthor=W.+Zhangauthor=J.+Lucasauthor=B.+Shorauthor=J.+Kimauthor=J.+Verheijenauthor=K.+Curranauthor=D.+J.+Malwitzauthor=D.+C.+Coleauthor=J.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=P.+Nowakauthor=A.+Zask&title=Biochemical%2C+Cellular%2C+and+in+Vivo+Activity+of+Novel+ATP-Competitive+and+Selective+Inhibitors+of+the+Mammalian+Target+of+Rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DShor%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520Cellular%252C%2520and%2520in%2520Vivo%2520Activity%2520of%2520Novel%2520ATP-Competitive%2520and%2520Selective%2520Inhibitors%2520of%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6232%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchlow, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, M.</span><span> </span><span class="NLM_article-title">AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with in Vitro and in Vivo Antitumor Activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=288-298&author=C.+M.+Chrestaauthor=B.+R.+Daviesauthor=I.+Hicksonauthor=T.+Hardingauthor=S.+Cosulichauthor=S.+E.+Critchlowauthor=J.+P.+Vincentauthor=R.+Ellsonauthor=D.+Jonesauthor=P.+Siniauthor=D.+Jamesauthor=Z.+Howardauthor=P.+Dudleyauthor=G.+Hughesauthor=L.+Smithauthor=S.+Maguireauthor=M.+Hummersoneauthor=K.+Malaguauthor=K.+Menearauthor=R.+Jenkinsauthor=M.+Jacobsenauthor=G.+C.+M.+Smithauthor=S.+Guichardauthor=M.+Pass&title=AZD8055+Is+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+ATP-Competitive+Mammalian+Target+of+Rapamycin+Kinase+Inhibitor+with+in+Vitro+and+in+Vivo+Antitumor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DHarding%26aufirst%3DT.%26aulast%3DCosulich%26aufirst%3DS.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DEllson%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DSini%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DZ.%26aulast%3DDudley%26aufirst%3DP.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DMaguire%26aufirst%3DS.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DJenkins%26aufirst%3DR.%26aulast%3DJacobsen%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DPass%26aufirst%3DM.%26atitle%3DAZD8055%2520Is%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520ATP-Competitive%2520Mammalian%2520Target%2520of%2520Rapamycin%2520Kinase%2520Inhibitor%2520with%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Antitumor%2520Activity%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D288%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fundo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presnot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torode, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, K. G.</span><span> </span><span class="NLM_article-title">Identification and Optimization of Novel and Selective Small Molecular Weight Kinase Inhibitors of mTOR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5898</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5898-5901&author=K.+A.+Menearauthor=S.+Gomezauthor=K.+Malaguauthor=C.+Baileyauthor=K.+Blackburnauthor=X.+Cockcroftauthor=S.+Ewenauthor=A.+Fundoauthor=A.+L.+Gallauthor=G.+Hermannauthor=L.+Sebastianauthor=M.+Sunoseauthor=T.+Presnotauthor=E.+Torodeauthor=I.+Hicksonauthor=N.+M.+Martinauthor=G.+C.+M.+Smithauthor=K.+G.+Pike&title=Identification+and+Optimization+of+Novel+and+Selective+Small+Molecular+Weight+Kinase+Inhibitors+of+mTOR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DBlackburn%26aufirst%3DK.%26aulast%3DCockcroft%26aufirst%3DX.%26aulast%3DEwen%26aufirst%3DS.%26aulast%3DFundo%26aufirst%3DA.%26aulast%3DGall%26aufirst%3DA.%2BL.%26aulast%3DHermann%26aufirst%3DG.%26aulast%3DSebastian%26aufirst%3DL.%26aulast%3DSunose%26aufirst%3DM.%26aulast%3DPresnot%26aufirst%3DT.%26aulast%3DTorode%26aufirst%3DE.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DPike%26aufirst%3DK.%2BG.%26atitle%3DIdentification%2520and%2520Optimization%2520of%2520Novel%2520and%2520Selective%2520Small%2520Molecular%2520Weight%2520Kinase%2520Inhibitors%2520of%2520mTOR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5898%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefever, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Discovery of 4-Morpholino-6-aryl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">8010</span><span class="NLM_x">–</span> <span class="NLM_lpage">8024</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9013828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=8010-8024&author=J.+C.+Verheijenauthor=D.+J.+Richardauthor=K.+Curranauthor=J.+Kaplanauthor=M.+Lefeverauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=W.+G.+Zhangauthor=J.+Lucasauthor=I.+Hollanderauthor=A.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yuauthor=A.+Zask&title=Discovery+of+4-Morpholino-6-aryl-1H-pyrazolo%5B3%2C4-d%5Dpyrimidines+as+Highly+Potent+and+Selective+ATP-Competitive+Inhibitors+of+the+Mammalian+Target+of+Rapamycin+%28mTOR%29%3A+Optimization+of+the+6-Aryl+Substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9013828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9013828%26sid%3Dliteratum%253Aachs%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DLefever%26aufirst%3DM.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAyral-Kaloustian%26aufirst%3DA.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25204-Morpholino-6-aryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520Highly%2520Potent%2520and%2520Selective%2520ATP-Competitive%2520Inhibitors%2520of%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%2520%2528mTOR%2529%253A%2520Optimization%2520of%2520the%25206-Aryl%2520Substituent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D8010%26epage%3D8024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[<i>h</i>][1,6]naphthyridin-2(1<i>H</i>)-one (Torin2) as a Potent, Selective, and Orally Available Mammalian Target of Rapamycin (mTOR) Inhibitor for Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1473</span><span class="NLM_x">–</span> <span class="NLM_lpage">1480</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101520v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1473-1480&author=Q.+Liuauthor=J.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=W.+Hurauthor=T.+Ahmedauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+of+9-%286-Aminopyridin-3-yl%29-1-%283-%28trifluoromethyl%29phenyl%29benzo%5Bh%5D%5B1%2C6%5Dnaphthyridin-2%281H%29-one+%28Torin2%29+as+a+Potent%2C+Selective%2C+and+Orally+Available+Mammalian+Target+of+Rapamycin+%28mTOR%29+Inhibitor+for+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm101520v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101520v%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25209-%25286-Aminopyridin-3-yl%2529-1-%25283-%2528trifluoromethyl%2529phenyl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2520%2528Torin2%2529%2520as%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520Mammalian%2520Target%2520of%2520Rapamycin%2520%2528mTOR%2529%2520Inhibitor%2520for%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1473%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Mortensen, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin-Ninkovic, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevlin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khmbatta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisonette, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fultz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankar, S.</span><span> </span><span class="NLM_article-title">Discovery and SAR Exploration of a Novel Series of Imidazo[4,5-<i>b</i>]pyrazin-2-ones as Potent and Selective mTOR Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6793</span><span class="NLM_x">–</span> <span class="NLM_lpage">6799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1016%2Fj.bmcl.2011.09.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=21978683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6793-6799&author=D.+S.+Mortensenauthor=S.+M.+Perrin-Ninkovicauthor=R.+Harrisauthor=B.+G.+S.+Leeauthor=G.+Shevlinauthor=M.+Hickmanauthor=G.+Khmbattaauthor=R.+R.+Bisonetteauthor=K.+E.+Fultzauthor=S.+Sankar&title=Discovery+and+SAR+Exploration+of+a+Novel+Series+of+Imidazo%5B4%2C5-b%5Dpyrazin-2-ones+as+Potent+and+Selective+mTOR+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors</span></div><div class="casAuthors">Mortensen, Deborah S.; Perrin-Ninkovic, Sophie M.; Harris, Roy; Lee, Branden G. S.; Shevlin, Graziella; Hickman, Matt; Khambatta, Gody; Bisonette, Rene R.; Fultz, Kimberly E.; Sankar, Sabita</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6793-6799</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report here the discovery of a novel series of selective mTOR kinase inhibitors.  A series of imidazo[4,5-b]pyrazin-2-ones, represented by screening hit 1, was developed into lead compds. with excellent mTOR potency and exquisite kinase selectivity.  Potent compds. from this series show >1000-fold selectivity over the related PI3Kα lipid kinase.  Further, compds. such as 2 achieve mTOR pathway inhibition, blocking both mTORC1 and mTORC2 signaling, in PC3 cancer cells as measured by inhibition of pS6 and pAkt (S473).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWly4sBJXgerVg90H21EOLACvtfcHk0ljJut1LSxTV0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr3P&md5=d422a7d505c1032951547d997ac2e033</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.035%26sid%3Dliteratum%253Aachs%26aulast%3DMortensen%26aufirst%3DD.%2BS.%26aulast%3DPerrin-Ninkovic%26aufirst%3DS.%2BM.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DB.%2BG.%2BS.%26aulast%3DShevlin%26aufirst%3DG.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DKhmbatta%26aufirst%3DG.%26aulast%3DBisonette%26aufirst%3DR.%2BR.%26aulast%3DFultz%26aufirst%3DK.%2BE.%26aulast%3DSankar%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520SAR%2520Exploration%2520of%2520a%2520Novel%2520Series%2520of%2520Imidazo%255B4%252C5-b%255Dpyrazin-2-ones%2520as%2520Potent%2520and%2520Selective%2520mTOR%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6793%26epage%3D6799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robarge, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Potent, Selective, and Orally Bioavailable Inhibitors of Mammalian Target of Rapamycin (mTOR) Kinase Based on a Quaternary Substituted Dihydrofuropyrimidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3426</span><span class="NLM_x">–</span> <span class="NLM_lpage">3435</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200215y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3426-3435&author=F.+Cohenauthor=P.+Bergeronauthor=E.+Blackwoodauthor=K.+K.+Bowmanauthor=H.+Chenauthor=A.+G.+DiPasqualeauthor=J.+A.+Eplerauthor=M.+F.+T.+Koehlerauthor=K.+Lauauthor=C.+Lewisauthor=L.+Liuauthor=C.+Q.+Lyauthor=S.+Malekauthor=J.+Nonomiyaauthor=D.+F.+Ortwineauthor=Z.+Peiauthor=K.+D.+Robargeauthor=S.+Siderisauthor=L.+Trinhauthor=T.+Truongauthor=J.+Wuauthor=X.+Zhaoauthor=J.+P.+Lyssikatos&title=Potent%2C+Selective%2C+and+Orally+Bioavailable+Inhibitors+of+Mammalian+Target+of+Rapamycin+%28mTOR%29+Kinase+Based+on+a+Quaternary+Substituted+Dihydrofuropyrimidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm200215y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200215y%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DEpler%26aufirst%3DJ.%2BA.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DRobarge%26aufirst%3DK.%2BD.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTrinh%26aufirst%3DL.%26aulast%3DTruong%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3DPotent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Inhibitors%2520of%2520Mammalian%2520Target%2520of%2520Rapamycin%2520%2528mTOR%2529%2520Kinase%2520Based%2520on%2520a%2520Quaternary%2520Substituted%2520Dihydrofuropyrimidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3426%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Maira, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chène, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Echeverría, C.</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maira%2C+S.-M.%3B+Stauffer%2C+F.%3B+Brueggen%2C+J.%3B+Furet%2C+P.%3B+Schnell%2C+C.%3B+Fritsch%2C+C.%3B+Brachmann%2C+S.%3B+Ch%C3%A8ne%2C+P.%3B+De+Pover%2C+A.%3B+Schoemaker%2C+K.%3B+Fabbro%2C+D.%3B+Gabriel%2C+D.%3B+Simonen%2C+M.%3B+Murphy%2C+L.%3B+Finan%2C+P.%3B+Sellers%2C+W.%3B+Garc%C3%ADa-Echeverr%C3%ADa%2C+C.Mol.+Cancer+Ther.+2008%2C+7%2C+1851%E2%80%931863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0ljJut1LSxTV0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.-M.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DCh%25C3%25A8ne%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarc%25C3%25ADa-Echeverr%25C3%25ADa%26aufirst%3DC.%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><div class="note"><p class="first last">For an example of the use of PC3 cells to evaluate mTOR activity, see:</p></div><span class="NLM_contrib-group">Dan, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, A. S.</span><span> </span><span class="NLM_article-title">Regulation of Mammalian Target of Rapamycin Activity in PTEN-Inactive Prostate Cancer Cells by I κB Kinase α</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">6263</span><span class="NLM_x">–</span> <span class="NLM_lpage">6269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6263-6269&author=H.+C.+Danauthor=M.+Adliauthor=A.+S.+Baldwin&title=Regulation+of+Mammalian+Target+of+Rapamycin+Activity+in+PTEN-Inactive+Prostate+Cancer+Cells+by+I+%CE%BAB+Kinase+%CE%B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDan%26aufirst%3DH.%2BC.%26aulast%3DAdli%26aufirst%3DM.%26aulast%3DBaldwin%26aufirst%3DA.%2BS.%26atitle%3DRegulation%2520of%2520Mammalian%2520Target%2520of%2520Rapamycin%2520Activity%2520in%2520PTEN-Inactive%2520Prostate%2520Cancer%2520Cells%2520by%2520I%2520%25CE%25BAB%2520Kinase%2520%25CE%25B1%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6263%26epage%3D6269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Anand, N. K.; Arcalas, A.; Blazey, C. M.; Buhr, C. A.; Cannoy, J.; Ephsteyn, S.; Johnson, H. W.B.; Joshi, A.; Kim, B. G.; Leahy, J. W.; Lee, M. S.; Ma, S.; Mac, M. B.; Nuss, J. M.; Takeuchi, C. S.; Wang, L.; Wang, Y.</span><span> </span><span class="NLM_article-title">Benzoxazepin-4-(5<i>H</i>)-yl Derivatives and Their Use To Treat Cancer</span>. PCT Int Appl. WO2010118208A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=N.+K.+Anand&author=A.+Arcalas&author=C.+M.+Blazey&author=C.+A.+Buhr&author=J.+Cannoy&author=S.+Ephsteyn&author=H.+W.B.+Johnson&author=A.+Joshi&author=B.+G.+Kim&author=J.+W.+Leahy&author=M.+S.+Lee&author=S.+Ma&author=M.+B.+Mac&author=J.+M.+Nuss&author=C.+S.+Takeuchi&author=L.+Wang&author=Y.+Wang&title=Benzoxazepin-4-%285H%29-yl+Derivatives+and+Their+Use+To+Treat+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DN.%2BK.%26atitle%3DBenzoxazepin-4-%25285H%2529-yl%2520Derivatives%2520and%2520Their%2520Use%2520To%2520Treat%2520Cancer%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><div class="note"><p class="first last">For an example of the use of this straightforward method for the analysis of the kinetics of enzyme reactions, see:</p></div><span class="NLM_contrib-group">Krohn, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, J. M.</span><span> </span><span class="NLM_article-title">Interpreting Enzyme and Receptor Kinetics: Keeping It Simple, but Not Too Simple</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1016%2FS0969-8051%2803%2900132-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm3007933&amp;key=14698785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWisrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=819-826&author=K.+A.+Krohnauthor=J.+M.+Link&title=Interpreting+Enzyme+and+Receptor+Kinetics%3A+Keeping+It+Simple%2C+but+Not+Too+Simple"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple</span></div><div class="casAuthors">Krohn, Kenneth A.; Link, Jeanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">819-826</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The hyperbolic parabola is commonly used to summarize kinetics for enzyme reactions and receptor binding kinetics.  Depending on the exptl. conditions, certain assumptions are valid but others might be violated so that the parameters used to fit this hyperbolic function, the max. asymptote and the equil. const., require different interpretations.  The first topic of this review compares enzyme-induced transformations and receptor binding in terms of the appropriate assumptions.  The second topic considers the complication of adding a competitive inhibitor as an enzyme substrate or a receptor ligand and the subtleties of inferring the equil. dissocn. const. from the concn. of inhibitor (for example unlabeled drug) that leads to the midpoint, IC50, of an inhibition curve.  Receptor binding may be measured directly by a concn. assay or as a pharmacodynamic response variable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3yoMxChxIPrVg90H21EOLACvtfcHk0lgEYjUtkj_MAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWisrfJ&md5=d62f241658499c5d6d5d6ca1e056ed06</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2803%2900132-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252803%252900132-X%26sid%3Dliteratum%253Aachs%26aulast%3DKrohn%26aufirst%3DK.%2BA.%26aulast%3DLink%26aufirst%3DJ.%2BM.%26atitle%3DInterpreting%2520Enzyme%2520and%2520Receptor%2520Kinetics%253A%2520Keeping%2520It%2520Simple%252C%2520but%2520Not%2520Too%2520Simple%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D819%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><div class="note"><p class="first last">For an example of the use of MCF7 cells to evaluate mTOR activity, see:</p></div><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span> </span><span class="NLM_article-title">mTOR, a Novel Target in Breast Cancer: The Effect of CCI-779, an mTOR Inhibitor, in Preclinical Models of Breast Cancer</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=249-258&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Discafaniauthor=W.-G.+Zhangauthor=J.+Skotnickiauthor=P.+Frostauthor=J.+J.+Gibbons&title=mTOR%2C+a+Novel+Target+in+Breast+Cancer%3A+The+Effect+of+CCI-779%2C+an+mTOR+Inhibitor%2C+in+Preclinical+Models+of+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26atitle%3DmTOR%252C%2520a%2520Novel%2520Target%2520in%2520Breast%2520Cancer%253A%2520The%2520Effect%2520of%2520CCI-779%252C%2520an%2520mTOR%2520Inhibitor%252C%2520in%2520Preclinical%2520Models%2520of%2520Breast%2520Cancer%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2001%26volume%3D8%26spage%3D249%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Huckle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M.</span><span> </span><span class="NLM_article-title">The Preparation of Some 2,3-Dihydro-1,4-benzoxazepin-5(4<i>H</i>)-ones and Related Compounds</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span><span class="NLM_x">–</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3007933&amp;key=10.1039%2Fjr9650001137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADyaF2MXltFKltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1965&pages=1137-1141&author=D.+Huckleauthor=I.+M.+Lockhartauthor=M.+Wright&title=The+Preparation+of+Some+2%2C3-Dihydro-1%2C4-benzoxazepin-5%284H%29-ones+and+Related+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The preparation of some 2,3-dihydro-1,4-benzoxazepin-5(4H) ones and related compounds</span></div><div class="casAuthors">Huckle, D.; Lockhart, I. M.; Wright, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">1137-41</span>CODEN:
                <span class="NLM_cas:coden">JCSOA9</span>;
        ISSN:<span class="NLM_cas:issn">0368-1769</span>.
    </div><div class="casAbstract">The action of hydrazoic acid on 4-chromanone leads to the formation of 2,3-dihydro-1,4-benzoxazepin-5(4H)-one (I, R = R1 = H).  The syntheses of other I are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1tvJvmirqHrVg90H21EOLACvtfcHk0lgEYjUtkj_MAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXltFKltA%253D%253D&md5=a7fe414f08b210a06a1f5535296707c8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2Fjr9650001137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9650001137%26sid%3Dliteratum%253Aachs%26aulast%3DHuckle%26aufirst%3DD.%26aulast%3DLockhart%26aufirst%3DI.%2BM.%26aulast%3DWright%26aufirst%3DM.%26atitle%3DThe%2520Preparation%2520of%2520Some%25202%252C3-Dihydro-1%252C4-benzoxazepin-5%25284H%2529-ones%2520and%2520Related%2520Compounds%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1965%26spage%3D1137%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Vernier, J. M.; Ripka, W.; May, J.; Bounaud, P.; O’Connor, P.; Hopkins, S.; Burkel, H.</span><span> </span><span class="NLM_article-title">Antitumor Hedgehog Signaling Inhibitors</span>. PCT Int Appl. WO2011014888A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+M.+Vernier&author=W.+Ripka&author=J.+May&author=P.+Bounaud&author=P.+O%E2%80%99Connor&author=S.+Hopkins&author=H.+Burkel&title=Antitumor+Hedgehog+Signaling+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVernier%26aufirst%3DJ.%2BM.%26atitle%3DAntitumor%2520Hedgehog%2520Signaling%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Zou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falck, J. R.</span><span> </span><span class="NLM_article-title">Ag(I)-Promoted Suzuki–Miyaura Cross-Couplings of <i>n</i>-Alkylboronic Acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">7213</span><span class="NLM_x">–</span> <span class="NLM_lpage">7215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=7213-7215&author=G.+Zouauthor=Y.+K.+Reddyauthor=J.+R.+Falck&title=Ag%28I%29-Promoted+Suzuki%E2%80%93Miyaura+Cross-Couplings+of+n-Alkylboronic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DG.%26aulast%3DReddy%26aufirst%3DY.%2BK.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26atitle%3DAg%2528I%2529-Promoted%2520Suzuki%25E2%2580%2593Miyaura%2520Cross-Couplings%2520of%2520n-Alkylboronic%2520Acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D7213%26epage%3D7215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, J. M.</span><span> </span><span class="NLM_article-title">Pd-Catalyzed <i>N</i>-Arylation of Heteroarylamines</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3481</span><span class="NLM_x">–</span> <span class="NLM_lpage">3484</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0265923" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3007933&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1Omur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=3481-3484&author=J.+Yinauthor=M.+M.+Zhaoauthor=M.+A.+Huffmanauthor=J.+M.+McNamara&title=Pd-Catalyzed+N-Arylation+of+Heteroarylamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-Catalyzed N-Arylation of Heteroarylamines</span></div><div class="casAuthors">Yin, Jingjun; Zhao, Matthew M.; Huffman, Mark A.; McNamara, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3481-3484</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed N-(hetero)arylation of a no. of heteroarylamines including 2-aminopyridines, 2-aminothiazoles, and their analogs has been realized using Xantphos as the ligand.  Weak bases such as Cs2CO3, Na2CO3, and K3PO4 were used in most cases to allow for the introduction of functional groups.  Choice of the base and solvent was crit. for the success of these reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpto0A1OmazwbVg90H21EOLACvtfcHk0ljwPxvnyNSsyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1Omur8%253D&md5=95f39b69250ce41d7c97d66ecc7f1ae8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fol0265923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0265923%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DM.%2BM.%26aulast%3DHuffman%26aufirst%3DM.%2BA.%26aulast%3DMcNamara%26aufirst%3DJ.%2BM.%26atitle%3DPd-Catalyzed%2520N-Arylation%2520of%2520Heteroarylamines%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D3481%26epage%3D3484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ibrahim, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, H. W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolfrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banica, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heald, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattheakis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipway, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, G.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of Potent and Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1368</span><span class="NLM_x">–</span> <span class="NLM_lpage">1381</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201533b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1368-1381&author=M.+A.+Ibrahimauthor=H.+W.+B.+Johnsonauthor=J.+W.+Jeongauthor=G.+L.+Lewisauthor=X.+Shiauthor=R.+T.+Noguchiauthor=M.+Williamsauthor=J.+W.+Leahyauthor=J.+M.+Nussauthor=J.+Woolfreyauthor=M.+Banicaauthor=F.+Bentzienauthor=Y.-C.+Chouauthor=A.+Gibsonauthor=N.+Healdauthor=P.+Lambauthor=L.+Mattheakisauthor=D.+Matthewsauthor=A.+Shipwayauthor=X.+Wuauthor=W.+Zhangauthor=S.+Zhouauthor=G.+Shankar&title=Discovery+of+a+Novel+Class+of+Potent+and+Orally+Bioavailable+Sphingosine+1-Phosphate+Receptor+1+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm201533b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201533b%26sid%3Dliteratum%253Aachs%26aulast%3DIbrahim%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DH.%2BW.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BW.%26aulast%3DLewis%26aufirst%3DG.%2BL.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DNoguchi%26aufirst%3DR.%2BT.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DLeahy%26aufirst%3DJ.%2BW.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DWoolfrey%26aufirst%3DJ.%26aulast%3DBanica%26aufirst%3DM.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DChou%26aufirst%3DY.-C.%26aulast%3DGibson%26aufirst%3DA.%26aulast%3DHeald%26aufirst%3DN.%26aulast%3DLamb%26aufirst%3DP.%26aulast%3DMattheakis%26aufirst%3DL.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DShipway%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DShankar%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Orally%2520Bioavailable%2520Sphingosine%25201-Phosphate%2520Receptor%25201%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1368%26epage%3D1381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Leahy, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhr, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, H. W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannoy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heald, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougheed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plonowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeber, O.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase γ Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5467</span><span class="NLM_x">–</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300403a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5467-5482&author=J.+W.+Leahyauthor=C.+A.+Buhrauthor=H.+W.+B.+Johnsonauthor=B.+G.+Kimauthor=T.+Baikauthor=J.+Cannoyauthor=T.+P.+Forsythauthor=J.+W.+Jeongauthor=M.+S.+Leeauthor=S.+Maauthor=K.+Nosonauthor=L.+Wangauthor=M.+Williamsauthor=J.+M.+Nussauthor=E.+Brooksauthor=P.+Fosterauthor=L.+Goonauthor=N.+Healdauthor=C.+Holstauthor=C.+Jaegerauthor=S.+Lamauthor=J.+Lougheedauthor=L.+Nguyenauthor=A.+Plonowskiauthor=J.+Songauthor=T.+Stoutauthor=X.+Wuauthor=M.+F.+Yakesauthor=P.+Yuauthor=W.+Zhangauthor=P.+Lambauthor=O.+Raeber&title=Discovery+of+a+Novel+Series+of+Potent+and+Orally+Bioavailable+Phosphoinositide+3-Kinase+%CE%B3+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm300403a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300403a%26sid%3Dliteratum%253Aachs%26aulast%3DLeahy%26aufirst%3DJ.%2BW.%26aulast%3DBuhr%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DH.%2BW.%2BB.%26aulast%3DKim%26aufirst%3DB.%2BG.%26aulast%3DBaik%26aufirst%3DT.%26aulast%3DCannoy%26aufirst%3DJ.%26aulast%3DForsyth%26aufirst%3DT.%2BP.%26aulast%3DJeong%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DNoson%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DBrooks%26aufirst%3DE.%26aulast%3DFoster%26aufirst%3DP.%26aulast%3DGoon%26aufirst%3DL.%26aulast%3DHeald%26aufirst%3DN.%26aulast%3DHolst%26aufirst%3DC.%26aulast%3DJaeger%26aufirst%3DC.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DLougheed%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DPlonowski%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DStout%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYakes%26aufirst%3DM.%2BF.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLamb%26aufirst%3DP.%26aulast%3DRaeber%26aufirst%3DO.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Series%2520of%2520Potent%2520and%2520Orally%2520Bioavailable%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5467%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E8Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E8Z','PDB','1E8Z'); return false;">PDB: 1E8Z</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3007933&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-6%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm3007933" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3007933" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679949a33c013d7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
